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Abstract 
 
The cohesin complex is essential for proper sister chromatid segregation during cell division 
and post-replicative DNA repair. Cohesin is also important for the regulation of gene expression. 
However, the mechanisms by which cohesin impacts gene expression remain incompletely 
understood. Owing to its vital role in cell division and DNA repair, loss of cohesin can indirectly 
impact gene expression programme in cycling cells. Thus, in order to investigate cohesin’s role in 
gene regulation, a conditional knockout system was used which allowed rapid depletion of the 
cohesin subunit RAD21 and avoided secondary stress-induced effects on gene expression. Acute 
depletion of cohesin in mouse embryonic stem (ES) cells did not lead to a global collapse in 
pluripotency. Instead, the impact of cohesin depletion was limited to about 600 genes and was 
locus-specific in terms of direction of deregulation. A subset of deregulated genes was selected 
based on the positioning of cis-regulatory elements and relevance to the pluripotent state and 
the role of cohesin in mediating long-range interactions was analysed using chromosome 
conformation capture (3C). Interestingly, cohesin binding, DNA looping and transcriptional 
changes were not always correlated. At some of the loci tested, these interactions were 
maintained after removal of cohesin, questioning models where cohesin regulates gene 
expression solely by mediating long-range interactions.  
One of the pluripotency factors affected by cohesin depletion in ES cells was Myc. 
Experiments analysing the expression of Myc showed that it was post-transcriptionally 
upregulated, specifically in cohesin deficient ES cells growing in defined media supplemented with 
ERK and GSK3β inhibitors (2i media). Further investigation revealed that contrary to the previously 
reported downregulation of Myc upon cohesin depletion, cohesin was not essential for Myc 
expression in various cell types.  
In separate experiments, I investigated if cohesin was required for the transcriptional 
activation of a silent gene in response to extracellular stimuli. Results from IFNγ induction of 
cohesin deficient non-cycling mouse embryonic fibroblasts (MEFs) showed that cohesin was 
important for the activation of MHC class II genes and their master regulator Ciita. The expression 
of MHC class I genes and the associated regulatory factors remained unaffected by cohesin 
depletion. Further evidence is provided for the involvement of cohesin in regulating transcription 
by modulating RNA polymerase processivity and through the action of PTIP subunit of the MLL 
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complexes. Altogether my work gives an insight into the role of cohesin in mediating long-range 
DNA interactions important for regulation of gene expression and explores novel mechanisms of 
gene activation by cohesin.
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Chapter 1 : Introduction 
The genetic material present inside a cell forms the very basis of life ranging from unicellular 
to multicellular organisms. One of the key processes required for the continuation of life is the 
faithful transmission of this genetic material from one generation to the next through cell division. 
In eukaryotic cells, DNA has to be accurately replicated followed by a precise segregation of the 
resulting sister chromatids between the daughter cells. The cohesin protein complex, plays a 
critical role in this process by holding the two replicated sister chromatids together from the time 
of their synthesis. This facilitates efficient DNA repair by homologous recombination and proper 
chromosome alignment at the spindle apparatus until they are separated later in mitosis and 
meiosis (Hirano, 2006; Jeppsson et al., 2014). Another important attribute of the genome is its 
role in determining the cellular identity, a process which requires the establishment of specific 
gene expression programmes. Cohesin’s role in this process of modulating gene expression is 
increasingly being appreciated now as it has emerged as an important contributor to the spatial 
organisation of chromatin within the nucleus (Merkenschlager, 2010). However, much of the 
mechanistic details of how cohesin is involved in the intricate regulation of gene expression 
remain to be elucidated and require further investigation. Given the extensive implications of this 
remarkable architectural complex in controlling genomic integrity and function, a thorough 
analysis of its mechanisms of action is of immense significance. 
1.1 The cohesin protein complex and its role in the cell cycle 
Structural maintenance of chromosomes (SMC) complexes, comprising of cohesin, 
condensin and the Smc5/6 complexes in eukaryotic cells , are central regulators of chromosome 
dynamics and are important for the control of sister chromatid cohesion, chromosome 
condensation, DNA replication, DNA repair (Jeppsson et al., 2014). The cohesin protein complex, 
formed of the Smc1-Smc3 heterodimer, establishes sister chromatid cohesion between 
duplicating sister chromatids in S phase. The bulk of these cohesin complexes are released at the 
onset of mitosis in prophase and the chromosomes undergo extensive condensation. 
Chromosome condensation is facilitated by the progressive loading of the condensin complexes 
composed of the Smc2-Smc4 subunits. This results in the formation of metaphase chromosomes 
with well-resolved sister chromatids due to compaction of each arm of the chromosome. The 
Introduction 
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condensed sister chromatids are finally segregated into daughter cells at the onset of anaphase 
triggered by their separation due to proteolytic cleavage of the centromeric cohesin (Figure 1.1). 
Thus, the cohesin and condensin SMC complexes each perform distinct functions to facilitate 
proper chromosome organisation and orientation essential for their faithful transmission into 
daughter cells (Shintomi and Hirano, 2010). 
 
Figure 1.1 Schematic representation of the role of SMC complexes in sister chromatid segregation during 
cell cycle. Replicated sister chromatids are held together by the action of cohesin during S phase. At the 
onset of mitosis, bulk of the cohesin dissociates from chromosome arms whereas condensin associates 
with them to induce condensation. These processes lead to the formation of metaphase chromosomes in 
which sister chromatids are microscopically distinguishable from each other. In late mitosis, residual 
cohesin is cleaved, thereby facilitating separation of sister chromatids towards opposite spindle poles 
(Adapted from Shintomi and Hirano, 2010). 
Proteins of the cohesin complex were identified in several independent genetic screens for 
mutants that were defective in chromosome segregation or DNA damage repair (Michaelis et al., 
1997; Losada et al., 1998). The subunits of the core complex and its associated regulatory proteins 
which indirectly contribute to cohesion have been highly conserved during evolution and have 
several orthologs in animal cells (see Table 1 for nomenclature of subunits in eukaryotes) (Sumara 
et al., 2000; Remeseiro and Losada, 2013). Together they help the cohesin ring complex to 
mediate sister chromatid cohesion in a cell-cycle regulated manner to ensure proper segregation 
of chromosomes during cell division. 
Introduction 
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Table 1.1 Regulatory factors and subunits of the cohesin complex 
 
Proteins in red correspond to meiotic isoforms (Remeseiro and Losada, 2013) 
 
1.1.1 Molecular architecture of the core cohesin complex 
The core cohesin complex consists of a heterodimer of two SMC (structural maintenance of 
chromosomes) proteins, SMC1A and SMC3, and two non-SMC proteins, RAD21 (Mcd1/Scc1 in S. 
cerevisiae) and STAG1 or STAG2 (Scc3 in S. cerevisiae and SA in D. melanogaster) (Figure 1.2). The 
SMC proteins are large ATPases possessing globular N- and C- terminal domains separated by a 
long amphipathic α-helix interrupted by a central globular domain. The polypeptide chains of SMC 
proteins fold back on themselves around the central “hinge” domain to form an intramolecular 
coiled-coil structure with the N- and C- terminal sequences forming a terminal ATPase “head”. 
The hinge domains can tightly bind each other and allow heterodimerization of the Smc1 and 
Smc3 subunits (Haering et al., 2002; Hirano and Hirano, 2002). Scc1, belonging to the kleisin family 
of proteins, connects the ATPase domains of Smc1 and Smc3 creating a tripartite ring. The N-
terminus of Scc1 binds the ATPase domain of Smc3 and the C-terminus binds to Smc1 (Schleiffer 
et al., 2003). Scc1 is further associated with the fourth subunit Scc3 (Losada et al., 2000). The 
structure of Scc3 has not been determined yet and its functions are not well understood. It is 
thought to interact with several proteins including CTCF (Rubio et al., 2008).  
High-resolution microscopy and biochemical studies show that the cohesin ring structure 
thus formed has a diameter of 40nm, considerably larger than an extended 10nm nucleosomal 
chromatin fibre. Additionally, the findings that opening of the cohesin ring by site-specific 
proteolytic cleavage of Scc1 or Smc3 is sufficient to release cohesin from chromosomes, suggest 
Introduction 
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that the ring structure can topologically embrace two sister chromatids (Haering et al., 2002; 
Gruber et al., 2003). The ring structure thus provides the vital feature of the cohesin complex 
which allows it to entrap DNA strands and mediate cohesion. 
Figure 1.2 The molecular framework of the cohesin complex and its 
associated proteins. The core ring shaped structure is formed of four 
subunits (colored in orange) – Smc1, Smc3, Rad21 and SA1/2. The 
Smc1 and Smc3 polypeptide chains fold back on themselves to form 
anti-parallel coiled-coil with a ‘hinge’ domain at one end and a 
globular ‘ATPase’ head at the other. The hinge domains of Smc1 and 
Smc3 associate with each other through strong intermolecular 
interactions while the ATPase heads are bridged by the Rad21 
subunit. Rad21 is further associated with the SA1/SA2 (Scc3) subunit. 
The binding of Pds5, Wapl and Sororin – the regulatory factors (in 
blue), helps modulate cohesin association with DNA (Losada, 2014).  
 
1.1.2 Loading, establishment and removal of the cohesin complex during cell 
cycle 
The association of the cohesin complex subunits with chromatin is highly regulated and 
involves the interplay between the activities of several associated regulatory proteins. In budding 
yeast, cohesin is loaded onto chromosomes at the end of G1 phase (Guacci et al., 1997; Michaelis 
et al., 1997). In vertebrates, however, the loading is initiated already in telophase following 
reformation of the nuclear envelope (Losada et al., 1998; Sumara et al., 2000). In S. cerevisiae this 
process requires the activity of the heterodimeric cohesin-loading factor Scc2-Scc4 (Ciosk et al., 
2000) and the ability of Smc1-Smc3 to bind and hydrolyse ATP (Arumugam et al., 2003; Weitzer 
et al., 2003). In addition, it has been proposed that the Smc dimer has to be opened at the hinge 
region in order to permit DNA entry (Gruber et al., 2006).  It is therefore possible that the 
Scc2/Scc4 complex promotes loading of cohesin onto DNA by stimulating its ATPase activity, 
which might in turn allow transient opening of the hinge domain. Human cohesin also requires 
NIPBL (yeast Scc2 homolog) and its partner MAU2 (yeast Scc4 homolog) for chromatin loading 
(Seitan et al., 2006; Watrin et al., 2006). In Xenopus egg extracts, Scc2/Scc4 is recruited to the 
assembly of pre-replicative complexes (pre-RCs) on DNA (Takahashi et al., 2004). In budding yeast, 
however, the pre-RC protein Cdc6 is dispensable for cohesin loading (Uhlmann and Nasmyth, 
1998), suggesting that Scc2/Scc4 recruitment to DNA may occur by different mechanisms in 
different species. In fact, recent biochemical studies reconstituting the loading reaction onto 
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naked DNA indicate that cohesin has an intrinsic ability to load topologically on DNA but the 
process is inefficient unless NIPBL is present (Murayama and Uhlmann, 2014). 
Cohesin loading, however, does not ensure its stable association with DNA. Live cell imaging 
studies suggest that cohesin is constantly being exchanged from chromatin throughout 
interphase with a residence time of less than 25 minutes. During S phase, the equilibrium shifts 
towards a more stable association with chromatin and the half-life of cohesin binding increases 
considerably (Gerlich et al., 2006). The rapid turnover of bound cohesin complexes has been 
attributed to the ‘anti-establishment’ activity of WAPL (wings apart-like protein homolog) and 
PDS5. Wapl was identified as a regulator of mitotic chromosome morphology in Drosophila (Vernì 
et al., 2000). Two recent studies also showed that Wapl inactivation stabilized cohesin on 
chromosomes in interphase and cells displayed chromosome segregation errors (Haarhuis et al., 
2013; Tedeschi et al., 2013). It is thought that Wapl releases cohesin from chromatin by transiently 
opening the ring gate between Smc3 and Rad21 by binding to the ATPase head of the Smc3 
subunit (Chan et al., 2012; Buheitel and Stemmann, 2013; Chatterjee et al., 2013; Eichinger et al., 
2013). As a result, the fraction of cohesin that is bound to chromatin is an outcome of the 
opposing actions of NIPBL-MAU2 and PDS5-WAPL. 
During S phase, the cohesin complex entraps the replicated DNA strands and establishes 
stable cohesion. In order to do so, cells need to antagonise the cohesin destabilising activity of 
WAPL. This process requires the acetylation of two lysine residues in the SMC3 head domain by 
the cohesin acetyl-transferases (CoATs) ESCO1 and ESCO2 (Eco1 in yeast), as well as the binding 
of the protein sororin to PDS5 (Hou and Zou, 2005; Rolef Ben-Shahar et al., 2008; Unal et al., 2008; 
Zhang et al., 2008; Nishiyama et al., 2010). The binding of Sororin to PDS5 has been proposed to 
displace WAPL, thereby preventing its unloading action. Smc3 acetylation also facilitates DNA 
replication fork progression. The restriction of cohesion establishment to S-phase can thus be 
attributed to the cell cycle regulation of CoAT and its interaction with the components of the DNA 
replication machinery (Lyons and Morgan, 2011; Higashi et al., 2012). 
Most cohesin is released from chromatin at the onset of mitosis by the prophase 
dissociation pathway. This requires the activity of three protein kinases – cyclin-dependent kinase 
1 (CDK1), aurora kinase B (AURKB) and polo-like kinase 1 (PLK1). CDK1 and AURKB phosphorylate 
sororin to drive its dissociation from PDS5, thus allowing PDS5-WAPL to unload cohesin. PLK1 
phosphorylates the SA subunit, further facilitating cohesin release (Shintomi and Hirano, 2010). 
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However, a small proportion of cohesin, mostly enriched at centromeres is protected from the 
prophase pathway by the action of shugoshin 1 (SGO1) bound to protein phosphatase 2A (PP2A). 
SGO1-PP2A recognises cohesin bound sororin and prevents its phosphorylation. This centromeric 
cohesin allows the alignment of chromosomes at the metaphase plate. Activation of anaphase 
promoting complex (APC) at the onset of anaphase leads to the degradation of securin and 
activation of separase. Separase cleaves the Rad21 subunit, thereby destroying the integrity of 
the ring and allows separation of the sister chromatids (Gutiérrez-Caballero et al., 2012). The 
cohesin complexes released during mitosis by the prophase pathway can be reused in the 
following G1 phase. This, however, requires cohesin to be deacetylated and the task is performed 
by cohesin deacetylases (CoDACs) Hos1 in yeast and HDAC8 in humans (Beckouët et al., 2010; 
Borges et al., 2010; Deardorff et al., 2012a). This whole process of cohesin loading, establishment, 
unloading and reuse can be depicted in the form of a regulatory cycle as in Figure 1.3. 
 
Figure 1.3 The cohesin cycle. Cohesin is loaded onto chromatin during late mitosis and early G1 phase by 
the NIPBL-MAU2 heterodimer and is maintained in a dynamic equilibrium by the unloading action of PDS5 
and WAPL. Upon initiation of DNA replication, ESCO1/ESCO2 acetylates SMC3 leading to the recruitment 
of sororin to PDS5. Sororin displaces WAPL and establishes stable cohesion between replicated sister 
chromatids. In prophase, most of the sororin, except that protected by SGO1-PP2A at centromeres, is 
released and cohesin is unloaded. At the onset of anaphase, separase cleaves the centromeric RAD21 and 
allows sister chromatid segregation. The released cohesin can then be reused after deacetylation by HDAC8 
(Losada, 2014). 
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1.1.3 Canonical cohesin functions 
The primary functions of the cohesin complex are attributed to its ability to entrap DNA 
strands within the ring structure and provide cohesion. The precise regulation of its association 
with chromatin during the cell cycle allows cohesin to facilitate faithful chromosome segregation. 
During cell division, cohesin holds the newly replicated sister chromatids together. This helps to 
achieve a proper back-to-back orientation of the sister-kinetochores at the metaphase plate and 
their attachment to microtubules from opposite spindle poles. Cohesion prevents premature 
separation of sister chromatids under the pulling forces of spindle fibres until all chromosomes 
achieve bipolar attachment (biorientation). At the onset of anaphase, cohesin rings are opened, 
dissolving the cohesive forces which allows the segregation of one copy of the replicated DNA to 
each daughter cell (Losada, 2014). 
Cohesin also has an important role in maintaining genome stability through post-replicative 
DNA double-strand break (DSB) repair in mitotic and meiotic cells (Klein et al., 1999; Sjögren and 
Nasmyth, 2001). In mitotic cells, cohesion can be established in response to DNA damage in G2 
phase in the absence of DNA replication. Cohesion then facilitates the use of sister chromatid as 
the template for the repair of the double strand break through homologous recombination. In 
meiotic cells, cohesin holds the bivalent chromosomes together during chiasmata formation 
(reciprocal recombination event) where programmed DNA double-strand breaks are repaired 
preferentially using non-sister chromatids (Peters et al., 2008; Nasmyth and Haering, 2009). In 
addition to homologous recombination mediated DNA repair, cohesin is also involved in DNA 
damage checkpoint activation during S and G2/M phase transitions (Wu and Yu, 2012; Ball et al., 
2014). Increasing evidence suggests that cohesin also plays a role in stabilizing stalled DNA 
replication forks at regions which are difficult to replicate, such as telomeres and centromeres, 
and promotes their restart (Remeseiro et al., 2012; Carretero et al., 2013).  
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1.2 Non-canonical cohesin functions and their role in disease and 
development 
As cohesin is essential for chromosome segregation during cell division, a homozygous null 
mutation in any of the core complex subunits or the regulatory factors would be deleterious for 
a cell and result in embryonic lethality. However, hypomorphic and/or heterozygous mutations in 
cohesin subunits and its regulators have been observed in several human malignancies and 
genetic disorders collectively known as cohesinopathies. It is also thought that infertility and 
increased frequency of children with birth defects in ageing women could be due to aneuploidy 
resulting from reduced cohesion in oocytes that have been arrested in G2 phase for decades 
(Jessberger, 2012). It is suspected that increased chromosomal instability may favour cancerous 
growth of cells, but interestingly, patient cells with cohesinopathies show limited cohesion 
defects and instead display altered transcriptional profiles. Studies in several model organisms 
have demonstrated that cohesin plays an important role in regulating gene expression. 
Nonetheless, much remains to be understood about how mutations in cohesin affect the 
transcriptional activity of cells leading to developmental defects. In order to be able to deduce 
the mechanistic links, features of some cohesinopathies and cohesin associated cancers along 
with studies in model organisms will be discussed below in detail. 
1.2.1 Cohesinopathies 
Human genetic disorders related to dysfunction of cohesin and its associated regulators are 
collectively known as cohesinopathies. They are characterised by both physical and mental 
developmental anomalies. The most prevalent cohesinopathy is Cornelia de Lange Syndrome 
(CdLS). CdLS is a congenital multi-system disorder and has an incidence of between 1:10,000 and 
1:30,000 live births. Classical CdLS patients show pre- and postnatal growth retardation, 
microcephaly, developmental delay, cognitive impairment, facial dysmorphia, hirsutism and 
upper limb defects ranging from small hands to severe forms of oligodactyly and truncation of the 
forearms. Typical features include fine arched eyebrows, low-set posteriorly rotated ears, long 
philtrum, thin upper lip, depressed nasal bridge and anteverted nares (Figure 1.4) (Mannini et al., 
2013). Patients are also reported to have recurrent infections at high frequency accompanied by 
a decrease in T regulatory cells, T follicular cells and antibody deficiency (Jyonouchi et al., 2013). 
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Figure 1.4 Phenotypic characteristics of CdLS patients. (A-D) 28 year old girl with truncating mutations in 
NIPBL showing typical developmental limb defects and craniofacial abnormalities. 
CdLS is a genetically heterogenous diagnosis with heterozygous mutations in NIPBL found 
in at least 60% of CdLS probands. Patients with frameshift or nonsense mutations of NIPBL that 
result in NIPBL haploinsufficiency often exhibit more severe phenotypes compared to missense 
mutations (Gillis et al., 2004). Mutations in X-linked SMC1 and SMC3 on chromosome 10 are also 
found in a minor subset of clinically milder CdLS cases (~5% and <1% respectively). SMC mutations 
are mostly missense mutations and patients show mental retardation as the primary symptom, 
with other abnormalities being fewer and/or milder (Musio et al., 2006; Deardorff et al., 2007). 
Non-sense or missense mutations that cause a loss of HDAC8 activity with a concomitant SMC3 
hyperacetylation and increased chromatin retention of cohesin during mitosis, have also been 
found in a subset of CdLS patients with phenotype similar to those of NIPBL mutations (Deardorff 
et al., 2012a). Unlike SMC mutations, CdLS patients with RAD21 mutations exhibit classical CdLS 
phenotypic characteristics but have milder cognitive impairment (Deardorff et al., 2012b). 
Overall, CdLS patients with NIPBL, SMC1/3, RAD21, HDAC8 display specific yet overlapping clinical 
features encompassing neuro-developmental defects (Ball et al., 2014). Cells from CdLS patients 
do not display cohesion defects, although they do show increased sensitivity to DNA damage 
(Dorsett and Ström, 2012) and show changes in gene expression (Liu et al., 2009). 
Another cohesinopathy, Roberts Syndrome (RBS) or SC Phocomelia, is a rare disorder 
caused by homozygous mutations in ESCO2 (Vega et al., 2005). RBS patients have a wide range of 
clinical phenotypes that include upper and lower limb defects, growth retardation, craniofacial 
anomalies and mental retardation with limited similarity to CdLS patients. RBS chromosomes 
exhibit premature centromere separation and heterochromatin puffing, indicative of a sister 
chromatid cohesion defect (Tomkins et al., 1979). Additionally, RBS cells show increased apoptosis 
and also display slower replication fork progression, which may contribute to reduced 
proliferation of critical progeniters (Terret et al., 2009). More recently, it was observed that Eco1, 
and to a lesser extent, Smc1 mutations (but not Scc2 mutations), lead to decreased rRNA 
production and ribosomal biogenesis resulting in translational defects. Similar defects were seen 
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in RBS patients with ESCO2 mutations (Bose et al., 2012). Increasing evidence now also points 
towards involvement of transcriptional dysregulation in RBS as ESCO2 has been implicated in 
recruitment of chromatin modifiers apart from its acetyltransferase activity (Kim et al., 2008a; 
Choi et al., 2010). 
Genome-wide transcriptional analysis of 16 mutant cell lines from severely affected CdLS 
probands was used to identify a unique profile of dysregulated gene expression. This was further 
validated in 101 patient samples and serves as a diagnostic and classification tool (Liu et al., 2009). 
This gene set was also shown to be deregulated in two tested RBS probands indicating an overlap 
in transcriptional abnormalities, consistent with the similarity of developmental defects observed 
in the two diseases. Furthermore, it is speculated that other genetic mutation disorders displaying 
similar phenotypes as CdLS and increased genotoxic sensitivity, might fall under the same 
umbrella of cohesin associated birth defects and may help explain the occurrence of CdLS in the 
remaining 35% of the probands (Skibbens et al., 2013). 
1.2.2 Cohesin mutations in human malignancies 
Mutations in genes encoding cohesin subunits and its regulators have been identified in 
several types of tumours. Initially, NIPBL mutations were identified in colorectal cancer (Barber 
et al., 2008) and later STAG2 mutations were found in glioblastoma, Ewing’s sarcoma and 
melanoma. STAG2 mutations are most common in urothelial bladder cancer (Solomon et al., 
2013). In AML, Down syndrome related acute megakaryocytic leukaemia and other myeloid 
neoplasms, however, mutations across most cohesin subunits have been described (Kon et al., 
2013). In a recent exome sequencing study of 4,742 human cancer samples across 21 cancer 
types, STAG2 was identified as one of the 12 genes that are mutated at substantial frequencies in 
at least four tumour types (Lawrence et al., 2014). Although most identified mutations are 
heterozygous, the presence of SMC1A and STAG2 genes on the X-chromosome can make their 
mutation functionally homozygous, at least in males and in somatic cells in females with randomly 
inactivated X-chromosome. Since a single hit is sufficient for the loss of STAG2 function and STAG1 
might partially compensate for its loss, STAG2 mutations might be observed at a higher rate 
(Losada, 2014).  
Cohesin dysfunction could affect tumorigenesis by increasing genomic instability due to 
faulty DNA replication and/or repair and chromosome segregation. Even though aneuploidy and 
genomic instability are detrimental to cell survival, they can favour tumour formation. However, 
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an association between aneuploidy and cohesin mutations in cancer has only been reported in 
some studies but not in others (Solomon et al., 2011; Balbás-Martínez et al., 2013). The 
contribution of cohesin mutations in deregulating the expression of crucial tumour suppressors 
or oncogenes could be important but remains to be investigated. 
1.2.3 Non-mitotic cohesin functions in gene regulation and development 
Cohesin functions beyond its primary role in sister chromatid cohesion were first suggested 
based on the observation that in vertebrate cells cohesin is loaded onto DNA during telophase 
(i.e. long before cohesion is established) and the bulk of it dissociates again in prophase (i.e. 
before cohesion is dissolved) (Losada et al., 1998; Sumara et al., 2000; Gerlich et al., 2006). 
Cohesin was also found associated with DNA in post-mitotic neurons which do not replicate DNA 
again and hence don’t require cohesion (Wendt et al., 2008). The idea that these non-canonical 
functions might be related to chromatin structure and gene expression were first sparked by 
genetic experiments in yeast and Drosophila. In S. cerevisiae, mutations in Smc1 and Smc3 
inactivated the boundary elements that prevent the spread of heterochromatin from the silent 
HMR locus into neighbouring regions (Donze et al., 1999). In Drosophila wing margin cells, Nipped-
B, the fly ortholog of Scc2, was discovered as a protein required for the activation of cut and 
Ultrabithorax homeobox genes and was speculated to facilitate enhancer-promoter 
communication (Rollins et al., 1999). Later, Drosophila Wapl mutants were identified which 
showed defects in position effect variegation (Vernì et al., 2000). Further evidence for cohesin’s 
role in gene regulation came from studies which reported developmental defects in model 
organisms due to mutations in cohesin and cohesin regulators. MAU-2 mutants were found to be 
defective in axon guidance (Bénard et al., 2004; Seitan et al., 2006) while Rad21 mutants in 
Drosophila displayed severe axon pruning defects during nervous system development (Pauli et 
al., 2008). In zebrafish, cohesin is required for the transcription of runx transcription factors and 
hematopoiesis (Horsfield et al., 2007) while reduced dosage of Nipbl lead to multiple heart and 
gut defects with no chromosome segregation defects (Muto et al., 2011).  
To increase the understanding of cohesin’s role in development, several mouse models 
have been used. Mice partially deficient for Nipbl (~30% reduction) recapitulate several features 
of CdLS and display modest but significant transcriptional deregulation of many genes (Kawauchi 
et al., 2009). Neural crest cell-specific inactivation of Nipbl or Mau2 during mouse development 
results in craniofacial defects (Smith et al., 2014). Mouse embryos lacking the SA1 subunit show 
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a clear developmental delay and die before birth. They display defects in telomere cohesion along 
with altered transcriptional profiles related to CdLS (Remeseiro et al., 2012). Mice lacking PDS5 
also die perinatally and show developmental defects resembling CdLS pathology (Zhang et al., 
2007). Additionally, ESCO2 deficiency in mice results in very early embryonic lethality (Whelan et 
al., 2012). Similarly, Wapl-/- mice die before birth (Tedeschi et al., 2013). 
As most cohesin deficient mouse models show early lethality, scope for detailed analysis is 
limited. Nonetheless, strategies have been developed to study locus-specific effects of cohesin 
depletion by knockdown or conditional knockout methods. These studies have reinforced the role 
of cohesin in transcription which will be discussed in detail later. Experiments also show that 
different cohesin functions require different amounts of cohesin. In budding yeast, even 13% of 
normal cohesin levels are enough to support sister chromatid cohesion but cells show defects in 
DNA repair and chromosome condensation (Heidinger-Pauli et al., 2010). Likewise, reduction of 
cohesin levels by 80% in Drosophila cells has dramatic effects on gene expression, but has no 
significant effect on cohesion or chromosome segregation (Schaaf et al., 2009). These studies 
along with observations in CdLS patients, suggest that gene transcription is more sensitive to 
perturbations in cohesin levels while the more conserved cohesin functions in cohesion are more 
resistant to cohesin dosage.  
An important consideration while studying effects of cohesin depletion on gene expression 
is the dissociation of its functions in gene regulation from its essential functions in cell cycle and 
sister chromatid cohesion. As depicted in Figure 1.5, gene expression changes observed can be a 
direct or an indirect consequence of cohesin depletion.  
 
Figure 1.5 Direct and indirect effects of cohesin depletion. Cohesin depletion in cycling cells may lead to 
indirect effects on gene expression due to activation of stress response pathways upon perturbation of 
cohesin’s mitotic functions. A more direct effect of cohesin on transcription can instead be studied during 
interphase. 
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In cycling cells, cohesin deficiency can lead to incomplete DNA replication, accumulation of 
DNA damage and prolonged activation of cell cycle checkpoints, causing the cells to initiate the 
expression of stress response genes. Thus, the gene expression changes observed can be an 
indirect effect of stress signals instead of the absence of cohesin. As a result, it is important to 
study the role of cohesin in transcription either in non-dividing cells or at early time points before 
secondary effects due to stress response pathways set in. To date, studies in post-mitotic 
Drosophila neurons have provided the clearest distinction between cohesin’s cell division-related 
and cell division-independent functions where cohesin deficient neurons showed defective axon 
pruning due to deregulated expression of ecdysone receptor (Pauli et al., 2008, 2010; Schuldiner 
et al., 2008). Studies in non-cycling  mouse thymocytes further demonstrated that cohesin is 
required for the rearrangement of the T cell receptor alpha locus (Seitan et al., 2011) and the 
regulation of approximately 1000 other genes (Seitan et al., 2013). 
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1.3 Cohesin and transcription 
Cohesin binds to DNA in association with CTCF and other tissue-specific transcription 
factors. It then facilitates long-range chromatin interactions, a function attributed to the ability 
of cohesin ring to entrap DNA strands. These prevailing concepts are discussed further below. 
However, much remains to be understood of this process in order to explain the impact of cohesin 
deficiency on gene expression. 
1.3.1 Cohesin localisation in the genome 
In budding yeast S. cerevisiae and fission yeast S. pombe, cohesin is primarily located 
downstream of active genes at sites of convergent transcription (Lengronne et al., 2004; Gullerova 
and Proudfoot, 2008). In budding yeast, it is believed that cohesin is loaded at active gene 
promoters by Scc2 and then slides along the DNA, possibly pushed by RNA polymerase. In fission 
yeast, however, bidirectional transcription at convergent genes causes RNAi-dependent 
formation of heterochromatin proteins and the recruitment of cohesin. This mechanism is 
thought to be important for the correct termination of transcription (Gullerova and Proudfoot, 
2008). In Drosophila, cohesin binding almost completely co-localises with the Scc2 homolog 
Nipped-B.  Here Nipped-B and cohesin binding is enriched at a subset of active genes as well as 
DNA replication origins, but largely excluded from silenced genes (Misulovin et al., 2008).  
In mammalian cells, two distinct types of cohesin binding sites have been described. At 
active promoters and enhancers, cohesin co-localises with NIPBL, Mediator and cell-type specific 
transcription factors (Kagey et al., 2010; Schmidt et al., 2010; Nitzsche et al., 2011; Faure et al., 
2012; Prickett et al., 2013). For example, cohesin co-localises with estrogen receptor binding in 
MCF7 breast cancer cells and with liver-specific transcription factors in HepG2 hepatocellular 
carcinoma cells (Schmidt et al., 2010). The strongest cohesin binding sites, however, show an 
enrichment for the consensus sequence motif of the DNA binding protein CTCF. Cohesin co-
localises extensively with CTCF, and siRNA-mediated knockdown of CTCF abolishes cohesin 
recruitment (Parelho et al., 2008a; Rubio et al., 2008; Stedman et al., 2008; Wendt et al., 2008). 
It was further shown that the cohesin subunit Scc3 interacts directly with CTCF (Rubio et al., 2008). 
Together, these studies provide the first mechanism for the sequence-specific localisation of 
cohesin along the mammalian chromosome arms. CTCF functions as a transcriptional regulator 
and as an architectural protein at insulators, boundary elements. It also acts as a genome 
organiser by formation of chromatin loops (Ong and Corces, 2014). Knockdown studies indicated 
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the requirement of cohesin for CTCF functions and demonstrated a functional link between CTCF 
and cohesin (Parelho et al., 2008a; Wendt et al., 2008; Nativio et al., 2009) thus providing the first 
rationale for non-canonical cohesin functions. CTCF binding itself is regulated not just by DNA 
sequence but also by the epigenetic state of chromatin, for example DNase I hypersensitivity and 
DNA methylation. As a result CTCF binding and cohesin localisation on DNA is cell-type specific 
(Parelho et al., 2008b; Nativio et al., 2009). Together these mechanisms of cohesin localisation on 
DNA allow for the integration of genetic and epigenetic information to achieve highly cell type 
specific binding patterns. 
1.3.2 Cohesin as a mediator of long-range chromatin interactions 
Transcriptional regulation requires the cooperation of sequence-specific factors, chromatin 
modifiers and long-range interactions between gene regulatory elements. In the past, most 
genome organisation studies relied exclusively on the use of microscopy based techniques which 
lack the resolution necessary to observe individual physical interactions between DNA regulatory 
elements. These microscopy techniques are now complemented by the molecular technique of 
chromosome conformation capture (3C) (Dekker et al., 2002). The basic methodology involves 
the use of chemical crosslinking to secure 3D contacts between genomic loci occurring in live cells. 
The crosslinked chromatin is then digested with a restriction enzyme and religated in a dilute 
solution so that only loci that were in contact in vivo (and thus fixed together by crosslinking) will 
be ligated together. Ideally, each ligation product should correspond to a pair of loci that were in 
contact in vivo at the time of crosslinking. These ligation products can then be assayed to quantify 
the frequency of contacts between specific loci. Several variations of the original 3C technique 
(4C, 5C, Hi-C) have now been developed which allow the measurement of genomic contacts with 
varying scope and throughput (Figure 1.6). A related technique is ChIA-PET, which couples ChIP 
with 3C to focus on interactions between genomic loci mediated by a protein of interest (Gorkin 
et al., 2014). Collectively, 3C based technologies have allowed an unprecedented view of genomic 
interactions and their role in regulating transcription. These studies have also established cohesin 
as an important contributor to long-range DNA interactions and genome organisation 
(Merkenschlager and Odom, 2013). 
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Figure 1.6 Detection of chromatin interactions by 3C based methods. a) Formaldehyde crosslinked 
chromatin is digested with restriction enzyme or sonication. Fragments are then religated in a diluted 
solution which prevents random ligation and favours ligation of crosslinked products in close proximity. 
The purified DNA can then be analysed as detailed in b). In classical 3C experiments, single ligation products 
are detected by PCR using locus-specific primers. 4C uses inverse PCR to generate genome-wide interaction 
profiles for a single loci. 5C identifies several million interactions in parallel between two large sets of loci. 
Hi-C is an unbiased genome-wide adaptation of 3C where the staggered DNA ends are filled by biotinylated 
nucleotides and the ligation products are directly sequenced. The resolution of the map depends on the 
depth of sequencing. Adapted from Dekker et al., 2013. 
Based on the discovery of cohesin’s association with CTCF, it was hypothesised that the 
cohesin ring structure can connect distant CTCF associated genomic regions and form chromatin 
loops by entrapping the DNA strands. This dependence of CTCF-based long-range interaction on 
cohesin was first demonstrated for the mouse Ifng locus. A conserved CTCF binding site 60-70 kb 
upstream of the Ifng coding region contacts two other CTCF sites, one in the first intron of Ifng 
and the other about 100 kb downstream of the locus selectively in T helper 1 cells which inducibly 
express Ifng. Both CTCF and cohesin are required for these interactions and reduced interactions 
correlated with reduced expression. But while cohesin knockdown abolished these interactions, 
CTCF binding at these sites remained relatively unaffected. It was concluded that CTCF recruits 
cohesin but the local chromosome conformation of Ifng is defined by cohesin, not CTCF (Hadjur 
et al., 2009).  
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Several other genomic loci have since been shown to have cohesin-dependent chromatin 
interactions. At the imprinted H19/IGF2 locus, cohesin is required for the CTCF-mediated 
chromatin loops that separate the genes into active and inactive domains. The IGF2/H19 
imprinting control region (ICR) comprises a cluster of CTCF binding sites. ICR is selectively 
methylated in sperm, but not in ova. Consequently, CTCF selectively binds at the unmethylated 
ICR of the maternal allele and acts as an insulator where it blocks the interaction of a distal 
enhancer with the IGF2 promoter. This restricts the IGF2 promoter in an inactive domain and 
prevents its expression. Methylation of the paternal ICR precludes CTCF binding and abrogates 
insulator activity. The distal enhancer can now interact with IGF2 promoter so that paternal IGF2 
is expressed (Murrell et al., 2004). Deletion of cohesin leads to disruption of long-range 
interactions and changes expression levels of the IGF2 gene (Nativio et al., 2009).  
Another example is the β-globin locus where cohesin is involved in both CTCF-dependent 
insulator interactions and CTCF-independent enhancer-promoter interactions. CTCF binds to the 
5’ and 3’ boundaries of the locus forming a loop while the distal enhancer present in the locus 
control region (LCR) interacts with the globin genes present inside the loop in a developmental-
stage specific manner (Splinter et al., 2006). This process requires the expression of lineage-
specific transcription factors and is associated with increased binding of Nipbl and cohesin at the 
interaction sites of β-globin but not the foetal globin genes upon erythroid differentiation. 
Depletion of Nipbl or cohesin decreased both the insulator interaction and LCR enhancer-
promoter interaction, but CTCF depletion only affected the insulator interaction. In accordance 
with this, cohesin depletion and not CTCF depletion, lead to decreased β-globin expression (Chien 
et al., 2011). 
The examples discussed above suggest that cohesin and CTCF-mediated interactions are 
important for the regulation of complex loci with multicluster genes. This is also the case for the 
proto-cadherin loci (Kawauchi et al., 2009; Hirayama et al., 2012; Monahan et al., 2012; 
Remeseiro et al., 2012), the MHC class II gene cluster (Majumder and Boss, 2011), the 
apolipoprotein gene cluster (Mishiro et al., 2009), the HoxA locus (Kim et al., 2011), X 
chromosome inactivation region (Spencer et al., 2011) and the T cell receptor alpha (Tcra),  
immunoglobulin κ light chain, immunoglobulin heavy chain (Igh) lymphocyte receptor loci 
(Degner et al., 2011; Guo et al., 2011; Ribeiro de Almeida et al., 2011; Seitan et al., 2011). At these 
loci, cohesin and CTCF orchestrate and fine tune the expression of genes in a cell-type specific 
manner by mediating long-range DNA interactions and partitioning gene clusters into chromatin 
Introduction 
 
36 
 
domains. Seitan et al. (2011) first demonstrated a cell division-independent role of cohesin in 
transcriptional regulation in mammalian cells (Figure 1.7). They analysed the role of cohesin in 
the rearrangement of the Tcrα locus. Lymphocyte receptor loci like the Tcrα, contain hundreds of 
coding elements arranged over large genomic regions. To make functional receptors, these 
regions have to be rearranged. This process of somatic recombination is mediated by Rag1 and 
Rag2 recombinases. The recruitment of Rag2 is coupled to transcription of Tcrα. This provides a 
mechanism to rearrange the receptor in the appropriate cells at the appropriate time 
(Merkenschlager and Odom, 2013).  Loss of the Rad21 subunit in non-dividing CD4+CD8+ double 
positive thymocytes (DPTs) reduced interactions between the Tcra gene promoter (TEA) and 
enhancer (Eα), thereby reducing Tcra transcription and rearrangement which further impaired 
thymocyte differentiation (Seitan et al., 2011).  
 
 
Figure 1.7 Cohesin and CTCF link regulatory elements at the Tcra locus. Cohesin binding sites flank the 
major regulatory elements of Tcra, the TEA promoter and the Eα enhancer. Cohesin facilitates enhancer-
promoter interactions over a distance of 80kb and promotes Tcra transcription and rearrangement. Jα: 
Joining region with T-cell receptor elements, Cα: constant region, Dad1: neighbouring housekeeping gene, 
Arrows indicate long-range interactions between cohesion binding sites (Seitan et al., 2012).  
 
In addition to its role in association with CTCF, cohesin co-localises with the loading factor 
Nipbl and Mediator components at enhancer elements in mouse embryonic stem (ES) cells. 
Cohesin bound enhancers of key pluripotency genes like Nanog were found to interact with their 
respective promoters (Kagey et al., 2010). Similarly, cohesin was found associated with a large 
fraction of cis-regulatory modules (CRMs) defined by the binding of multiple tissue-specific 
transcription factors in mouse liver cells. Additionally, Pol II was detected at nearly half of all 
predicted extragenic CRMs, even though most of these were not transcribed. This suggests that 
the Pol II at extragenic CRMs is transcriptionally engaged at a promoter, and interacts with the 
CRMs through cohesin-mediated looping. This interpretation is supported by the observation that 
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Pol II ChIP signals are reduced at a quarter of the predicted CRMs upon cohesin depletion, which 
is higher than the frequency of Pol II reduction at active promoters (Faure et al., 2012). Several 
other studies (discussed in section 1.4.2) have further elucidated cell-type specific binding of 
cohesin at enhancers and its role in enhancer-promoter interactions.  
Collectively, a common theme emerges from these studies which suggests that cohesin 
contributes to gene regulation by mediating chromosomal interactions in cis. It can facilitate CTCF 
insulator function by forming a DNA loop and separating genes into an inactive domain. 
Conversely, it may help bring genes and their enhancers in the same loop to promote gene 
activation while excluding the insulators or silencers away from the gene. It is also directly 
associated with enhancer-promoter interactions. Loss of such cohesin-mediated interactions can 
thus affect gene expression causing downregulation or upregulation of the genes involved 
depending on the genomic context. However, much of the global gene expression changes 
observed upon cohesin depletion remain unexplained and are difficult to predict because of the 
complexity and multiplicity of these interactions at a given genetic loci. Additionally, it remains to 
be established whether the observed changes in DNA interaction upon cohesin depletion are the 
cause or a consequence of changes in gene transcription. 
Genome-wide studies have further provided a more global view of cohesin localisation at 
cis-regulatory DNA elements involved in long-range interactions. Cohesin binds at active 
promoters marked by H3K4me3 modifications, and at putative enhancer elements, that can be 
identified by the presence of H3K4me1, p300, low H3K4me3 with or without H3K27ac mark 
(active or poised enhancers respectively) (Heintzman et al., 2009; Creyghton et al., 2010; Rada-
Iglesias et al., 2011). These binding sites are usually CTCF-independent and are often associated 
with NIPBL and Mediator (Kagey et al., 2010). Activities of promoters and enhancers as well as 
their association with cohesin are highly cell-type specific and respond to external stimuli or 
developmental cues. Insulators, on the other hand display CTCF-cohesin binding which is largely 
invariant across diverse cell types (Heintzman et al., 2009; Faure et al., 2012; Phillips-Cremins et 
al., 2013) (Table 1.2). Such diverse cohesin based interactions are observed in developing mouse 
limbs as shown by SMC1A ChIA-PET (DeMare et al., 2013). Additionally, WAPL depletion in cells, 
which ‘locks’ cohesin onto chromatin, results in chromatin compaction and formation of axial 
(vermicelli) structures in interphase chromosomes that can be visualised by light microscopy 
(Tedeschi et al., 2013). This information along with observations from Hi-C based genome 
interactome maps of several cell-types have implicated cohesin mediated long-range DNA 
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interactions in not only local gene regulation but also as architectural components determining 
global genome organisation, albeit with distinct combinations of CTCF and other tissue-specific 
transcription factors (Gorkin et al., 2014). 
Table 1.2 Cohesin associated genomic regulatory elements 
 
Genome-wide Hi-C interactome maps have revealed that the genome is organised into 
compartments of either active or repressed chromatin. These compartments are further 
separated into genomic units known as ‘Topologically Associated Domains’ (TADs) (Dixon et al., 
2012; Nora et al., 2012). TADs are a structural unit of chromatin organisation comprising of 
regions which show high local contact frequency that are separated by sharp boundaries, across 
which contacts are relatively infrequent. The average size of a TAD is approximately 1Mb and each 
TAD contains several genes and enhancers. It is hypothesised that these self-interaction domains 
constrain looping interactions between enhancers and promoters and set the boundaries for 
coordinated gene regulation. The boundaries between TADs are largely invariant across cell types 
and are also highly conserved between mouse and human. This suggests that such physical 
partitioning of the genome is a fundamental principle of the hierarchical genome 
organisation(Gorkin et al., 2014). Moreover, TADs are not detectable during mitosis, indicating 
that their function is specific to interphase when transcription is most active (Naumova et al., 
2013).  
CTCF binding sites are highly enriched at TAD boundaries (Dixon et al., 2012) and deletion 
of a specific TAD boundary containing CTCF binding sites led to increased interactions between 
adjacent TADs (Nora et al., 2012). At a global scale, knockdown of CTCF expression leads to an 
increase in inter-domain interactions but does not completely abrogate TAD boundaries (Zuin et 
al., 2013). Likewise, loss of cohesin also leads to increased inter-domain interactions (Sofueva et 
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al., 2013), however, the impact is less than that of CTCF loss (Zuin et al., 2013). Interestingly, 
depletion of cohesin in non-cycling thymocytes did not affect architectural compartments (Seitan 
et al., 2013). Nonetheless, cohesin was required for specific long-range interactions within the 
compartments. Lineage-specific genes like those involved in haematopoiesis and lymphocyte 
activation were specifically deregulated upon cohesin depletion. Intriguingly, gene expression 
was perturbed across the whole range of expression spectrum where genes with low levels of 
expression were more often up-regulated whereas genes with high expression were more often 
down-regulated. This systematic skewing lead to compression of the dynamic range of gene 
expression away from the extremes towards a more average expression (Seitan et al., 2013). 
Rapid cleavage of the Rad21 subunit in HEK293 cells and cohesin depletion in postmitotic 
astrocytes also resulted in a global loss of intra-TAD interactions (Sofueva et al., 2013; Zuin et al., 
2013). Together these studies signify the role of cohesin as a genome organiser where it helps 
demarcate the TAD boundaries along with coordinating gene expression within TADs while 
restricting interactions across TAD boundaries. 
1.3.3 Cohesin mediated regulation of the transcriptional machinery and 
associated components 
Apart from its role in mediating long-range DNA interactions, cohesin can directly affect the 
activity of RNA polymerase. Transcription is tightly regulated at the stages of initiation, elongation 
and termination. The basic steps constitute the formation of pre-initiation complex (PIC) 
containing RNA Pol II and several general transcription factors (GTFs). This is followed by the 
phosphorylation of Ser5 residues on YSPTSPS heptapeptide repeat consensus sequence present 
in the CTD of Pol II. Ser5 phosphorylation allows promoter escape for the Pol II and marks the 
initiation of transcription. Pol II then pauses in the 5’ region of the transcription unit and only 
progresses into productive elongation on stimulation by appropriate signals, a phenomenon 
known as promoter-proximal pausing (or transcriptional stalling). Pol II pausing acts as an 
important checkpoint before Pol II is committed to transcribe the gene. The pausing action is 
attributed to the activity of pause factors, DRB-sensitivity inducing factor (DSIF) and negative 
elongation factor (NELF), which remain bound to Pol II at the pause site downstream of the TSS. 
In the presence of appropriate signals, positive transcription elongation factor b (P-TEFb) is 
recruited to the genes. P-TEFb then phosphorylates the DSIF and NELF subunits along with the 
Ser2 residues in Pol II CTD licensing the Pol II into productive elongation. The CTD of Pol II can thus 
be used as an indicator of Polymerase activity. At active genes, Ser5 phosphorylation is high at 
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TSS and is present along the gene body. Ser2 phosphorylation on the other hand is enriched in 
the gene body and at transcription termination sites. Each of these mentioned steps can be rate 
limiting and provide several avenues for regulation of the transcriptional output (Saunders et al., 
2006; Zhou et al., 2012).   
Cohesin can aid transcription initiation by facilitating the binding of transcription factors at 
sub-optimal sequence motifs. This is suggested by a recent genome-wide study which analysed 
the co-localisation of cohesin with a large set of tissue-specific transcription factors, RNA Pol II 
and histone modifications in mouse liver cells. They observed that binding of tissue-specific 
transcription factors, master regulators and enhancer-associated chromatin marks at sites with 
low motif scores, coincided with strong cohesin-non-CTCF binding sites. The authors further 
showed that specific transcription factor modules with lower motif scores were preferentially 
destabilised in Rad21 haploinsufficient cells (Faure et al., 2012).  Based on these observations, the 
authors suggest that cohesin can stabilise large protein-DNA complexes and allow efficient 
transcription factor binding even at sites with low motif scores. 
In Drosophila, cohesin preferentially binds genes with promoter-proximal paused RNA 
polymerase (Fay et al., 2011; Schaaf et al., 2013). However, cohesin depletion can have opposing 
impact on the transcription of these genes (Schaaf et al., 2009). As such these studies indicate a 
complex relationship between cohesin binding and transcriptional elongation in Drosophila. 
Similar studies on the global effects of cohesin on Pol II pausing and elongation have not yet been 
conducted in mammalian cells. However, in one study on mouse ES cells, knockdown of Smc3 
expression resulted in reduced promoter-proximal Pol II occupancy at many Ell3 (a Pol II 
elongation factor) responsive genes (Lin et al., 2012a). It remains to be seen whether the observed 
changes in Pol II occupancy were caused by reduced gene expression or were a direct 
consequence of cohesin depletion. 
Cohesin has also been shown to affect the processivity of RNA Polymerase in association 
with CTCF, possibly by physically stalling the movement of Pol II. The latency transcripts of 
Kaposi’s sarcoma-associated herpesvirus (KSHV) contain cohesin-CTCF binding sites in the first 
intron. During latency a paused form of Pol II is loosely associated with the promoter region but 
is converted into an active elongating form upon reactivation induced by Rad21 depletion. Similar 
effects on pausing and transcription were seen at the endogenous c-Myc gene which also contains 
a cohesin-CTCF site in the first intron. These findings suggest that RNA Pol II pauses at intragenic 
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cohesin-CTCF binding sites which regulates the transcriptional status of the gene (Kang and 
Lieberman, 2011; Chen et al., 2012). This is also true for the p53 target PUMA gene where cohesin-
CTCF binding acts as a transcriptional block and prevents read-through of the full length PUMA 
gene (Gomes and Espinosa, 2010). The rate of transcriptional elongation is also known to impact 
the process of alternative splicing. At the CD45 locus as well as genome-wide, intragenic CTCF 
binding promotes the inclusion of weak exons by mediating local RNA Pol II pausing at 
alternatively spliced sites (Shukla et al., 2011).  
Moreover, cohesin localisation at sites of convergent transcription in budding and fission 
yeast reveal that cohesin is associated with transcriptional termination in these organisms 
(Lengronne et al., 2004; Gullerova and Proudfoot, 2008).  
In addition to regulating Pol II processivity, cohesin and CTCF also control the transcription 
of non-coding RNAs as seen during Igh rearrangement, ataxin-7 transcription and the 
transcription of Xist, Tsix involved in X-chromosome inactivation (Degner et al., 2011; Sopher et 
al., 2011; Spencer et al., 2011). At the chicken lysozyme gene promoter, CTCF binding at the -
2.4kb insulator element blocks enhancer function. Upon induction by LPS, CTCF is evicted by the 
transcription of a non-coding RNA originating from the -2.4/-2.7kb region thus facilitating 
enhancer-promoter communication and transcription (Lefevre et al., 2008). CTCF and cohesin also 
regulate ribosomal DNA (rDNA) transcription and ribosomal biogenesis (van de Nobelen et al., 
2010; Bose et al., 2012). rDNA locus contains hundreds of copies of the rDNA genes only some of 
which are actively transcribed. The activity of spacer promoters, which give rise to non-coding 
RNAs required for rDNA transcription, is regulated by CTCF binding. Cohesin is also reported to 
bind to non-coding RNAs transcribed from active enhancers (eRNAs) which is important for the 
upregulation of the target genes (Wang et al., 2011a). 
Altogether, these examples indicate that apart from mediating long-range DNA 
interactions, cohesin can modulate gene expression by the regulation of RNA polymerase 
processivity and production of non-coding regulatory RNAs. However, much of this aspect 
remains to be explored in further detail. 
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1.3.4 Cohesin and the MLL complex 
So far most studies have investigated how cohesin impacts the formation of long-range DNA 
interactions between enhancers and promoters. However, it is noteworthy that one of the 
prerequisites for promoter and enhancer activation is the methylation of lysine 4 residue on 
histone H3 - H3K4me3 and H3K4me1 modifications at promoters and enhancers respectively 
(Heintzman et al., 2009; Creyghton et al., 2010; Rada-Iglesias et al., 2011). Even though the 
importance of H3K4me1 modifications for enhancer function has been recognised, the molecular 
effectors of these cell-type specific histone marks are yet to be determined. Given the extensive 
binding of cohesin at cell-type specific active enhancers and promoters, it is possible that cohesin 
plays a role in the establishment of these chromatin modifications. One can speculate that the 
cohesin protein complex brings about this effect by interacting with and recruiting histone 
modifying enzymes like the histone methyltransferases to the site of an enhancer.  
Mammalian cells contain six major methyltransferases belonging to the MLL/Set1 family of 
proteins (Figure 1.8). Although all the six family members are capable of H3K4 methylation in 
vitro, their activity requires the presence of additional   accessory subunits, some of which are 
differentially associated with distinct family members.  
 
Figure 1.8 H3K4 methyltransferases in mammals. 
Mammalian cells have three major complexes with 
methyltransferase activity composed of the main 
catalytic subunits SET1A/SET1B, MLL1/MLL2 or 
MLL3/MLL4 along with accessory subunits. Paxip1 
(or PTIP) specifically associates with the MLL3/4 
complexes. Subunits common to all complexes are 
shown in green; complex-specific subunits are 
shown in blue, orange, pink and magenta (Hu et al., 
2013). 
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Set1a and Set1b (homologous to yeast and Drosophila Set1) are responsible for bulk of the 
H3K4me3 in metazoan cells. Evidence suggests that Set1a/b complexes are recruited directly by 
the Pol II machinery and its occupancy is restricted to TSS by the activity of Cfp1 (CXXC1) 
(Shilatifard, 2012; Calo and Wysocka, 2013). Enhancer-associated H3K4me1 modifications are 
attributed to the activity of the MLL3/4 complex. In Drosophila, depletion of Trr, a Drosophila 
homolog of MLL3/4 affects global H3K4me1 levels in vivo, whereas knockdown of Set1 (or Trx) 
has a minor effect (Ardehali et al., 2011; Herz et al., 2012). Furthermore, MLL complex binding is 
not restricted to promoters but is also present at intergenic regions and gene bodies with many 
of the intergenic sites overlapping enhancers (Herz et al., 2012). More concrete evidence in 
mammalian cells, comes from a recent study which shows that MLL4 is essential for enhancer 
activation during cell differentiation (Lee et al., 2013). MLL4 exhibited cell-type- and 
differentiation-stage-specific genomic binding and was predominantly localized on enhancers 
along with lineage-determining transcription factors. Depletion of MLL4 markedly decreased 
H3K4me1/2, H3K27ac, Mediator and Polymerase II levels on enhancers and led to severe defects 
in cell-type-specific gene expression during adipogenesis and myogenesis (Lee et al., 2013). In 
fact, PTIP (Pax interaction with transcription-activation domain protein-1, also known as Paxip1), 
a subunit specifically associated with the MLL3/4 complex also plays a critical role in adipogenesis 
(Cho et al., 2009). The association of MLL1/2 with specific enhancers has only been documented 
in individual studies so far (Jeong et al., 2011; Kawabe et al., 2012). But in mouse ES cells, MLL2 
directs H3K4me3 deposition on bivalent promoters (Hu et al., 2013; Denissov et al., 2014). 
Altogether, current evidence suggests that in mammalian cells, MLL3/4 complex is the major 
player in making the H3K4me1 histone modifications at enhancers. 
Interestingly, studies on Paxip1 – a subunit of the MLL3/4 complex, provide a possible 
connection between cohesin and the MLL3/4 complexes. Biochemical analysis showed that PTIP 
interacts with SMC1 (Patel et al., 2007) and is required for SMC1 to be able to successfully repair 
DNA damage (Wu et al., 2009). Additionally, there is some overlap of the binding of PTIP with 
cohesin binding sites at the Igh and the Tcrα lymphocyte receptor loci where both cohesin and 
PTIP have independently been shown to be required for proper long-range interactions and 
transcription ensuring Immunoglobulin class switch recombination, Tcra locus rearrangement and 
thymocyte differentiation (Daniel et al., 2010; Degner et al., 2011; Schwab et al., 2011; Seitan et 
al., 2011). The PTIP subunit itself is not required for the methytransferase activity of the MLL3/4 
complex (Shilatifard, 2012). Nevertheless, PTIP is required for maintenance of embryonic stem 
Introduction 
 
44 
 
cell pluripotency and Paxip1 homozygous mutant mice are embryonic lethal by day 9.5 (Cho et 
al., 2003). Together these findings suggest that PTIP can play a significant role in transcriptional 
regulation.  However, Daniel et al. (2010) noted that impact of Paxip1 depletion on transcription 
was limited to only a few genes. They suggested that PTIP is required for the expression of specific 
genes either through the deployment of the MLL3/4 complex or possibly by recruiting other 
transcription factors. The role of PTIP in cohesin-mediated gene regulation has not been explored. 
An additional intriguing observation further supports the idea that cohesin might function 
through the MLL3/4 complex in gene regulation. Kabuki syndrome, a rare congenital disorder, is 
associated with mutations in the KMT2D (MLL4) gene. Children with Kabuki syndrome usually 
have distinctive facial features and show mild to moderate mental impairment. Typical facial 
features include arched eyebrows, elongated and wide-set eyes, thick eyelashes, flat nasal tip, 
cleft palate and large or cupped ears. Other characteristic features include short stature, skeletal 
abnormalities and developmental delay (Cuscó et al., 2008; Bokinni, 2012). These clinical features 
presented in Kabuki syndrome patients are remarkably similar to those observed in patients with 
CdLS (Figure 1.9). Though genetic studies so far have not tested for the presence of cohesin 
mutations in Kabuki syndrome patients, or KMT2D mutations in CdLS patients, similar phenotypic 
characters support the idea that cohesin might regulate gene expression through the activity of 
effector proteins like the MLL3/4 complex.  
 
Figure 1.9 Kabuki syndrome patients display CdLS like features. Kabuki patients typically have elongated 
and wide-set eyes, flat nasal tip, cleft palate, large cupped ears and show other skeletal defects along with 
mild to severe mental retardation (Cuscó et al., 2008). 
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1.4 Cohesin’s role in embryonic stem cell pluripotency 
Embryonic stem cells are derived from the inner cell mass (ICM) of the pre-implantation 
blastocyst-stage embryo. They have the remarkable property of self-renewal and are capable of 
differentiating into different cell types of all lineages of the developing and adult organism i.e. 
they are pluripotent. Consequently, these cells retain the ability to participate in normal 
development upon reinjection into an embryo, including the formation of functional gametes, 
even after indefinite propagation in vitro. These exceptional properties of ES cells are attributed 
to their unique transcriptional profile (Jaenisch and Young, 2008). Transcription factors OCT4, 
SOX2, NANOG form the core of the ES transcriptional regulatory network and are essential for the 
maintenance of a robust pluripotent state. These transcription factors function together to 
positively regulate their own promoters forming autoregulatory circuits. They co-occupy and 
activate the expression of genes necessary for maintaining the ES cell state, while contributing to 
repression of genes encoding lineage-specific transcription factors and thus prevent exit from the 
pluripotent state (Boyer et al., 2005).  ES cells express uniformly high levels of OCT4 and protein 
levels are tightly regulated. Reduction or overexpression of OCT4 leads to differentiation of ES 
cells (Niwa et al., 2000). OCT4 acts synergistically with SOX2 in regulating various ES-specific 
genes. NANOG, on the other hand is necessary for the acquisition of pluripotency but is 
dispensable once pluripotency is achieved (Chambers et al., 2007). Additional ES-specific 
regulators required for the maintenance of pluripotency have been uncovered by several RNAi 
studies and examination of protein purification partners. These regulators like KLF4, ESRRB, MYC, 
SALL4, TCF3, DAX1, NAC1, TCF2L1, ZFP281 etc. form a part of the expanded ES pluripotency 
network. These factors often co-bind the same genomic regions along with the core 
transcriptional regulators OCT4 and SOX2 (Yeo and Ng, 2013). In addition to the unique 
transcriptional profile, ES cells also possess a highly dynamic and accessible ‘open’ chromatin 
landscape with a lower abundance of constitutive heterochromatin than most differentiated cells. 
This chromatin feature is likely to be important for attaining the transcriptionally permissible 
pluripotent state (Gaspar-Maia et al., 2011). 
The silencing of developmental regulators in ES cells is also tightly regulated in such a way 
that the cells remain amenable to perturbation elicited by developmental stimuli. Most of the 
transcriptionally silent genes are marked by bivalent chromatin where promoters are associated 
with both the gene activating histone mark H3K4me3 and the repressive H3K27me3 modifications 
(Azuara et al., 2006; Bernstein et al., 2006). These genes are also bound by Polycomb group (PcG) 
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proteins which catalyse repressive H3K27me3 modifications and H2AK119 ubiquitination. It is 
thought that bivalency poises genes for expression and prevents their permanent silencing, so 
that they remain sensitive to differentiation signals. In the presence of appropriate signals, 
specific signal transducers are recruited which then overcome the H3K27me3-mediated 
repression and activate the lineage-specifying genes (Vastenhouw and Schier, 2012). Lineage 
commitment is also accompanied by rapid reduction in OCT4, NANOG and other ES-specific TFs 
by transcriptional and post-transcriptional mechanisms.  
Once established, the differentiated state is stable and can be inherited through cell 
division. However, experimental approaches have been developed that allow the cell fate to be 
modified or even reverted to a pluripotent state through a process known as reprogramming. 
Three main strategies have so far been employed to achieve reprogramming: somatic cell nuclear 
transfer (SCNT), cell fusion and induced pluripotent stem (iPS) cell generation by forced 
expression of transcription factor combinations (Tada et al., 1997; Wilmut et al., 1997; Takahashi 
and Yamanaka, 2006). Reprogramming mediated by transferring the somatic cell nuclei into 
enucleated oocytes (SCNT) provided the first demonstration that the differentiated state is 
reversible (Gurdon et al., 1958). Subsequent studies based on cell fusion showed that cellular 
identity can be modified by trans-acting factors (Tada et al., 1997). The identity of transcriptional 
regulators required for reprogramming was revealed by a pioneering work from the Yamanaka 
lab (Takahashi and Yamanaka, 2006). Ectopic expression of OCT4, SOX2, KLF4 and MYC (OSKM) 
could convert fibroblasts into iPS cells. Since then, several epigenetic and transcriptional 
regulators have been employed to reset cellular identity with greater efficiency (Morris and Daley, 
2013). It is of immense medical importance to be able to generate stem cells from somatic cells 
of patients. These can potentially be used for tissue repair, organ regeneration and cell 
replacement therapies. 
1.4.1 Extrinsic signalling in ES cell transcriptional regulation 
ES cells were initially derived by explanting blastocysts or ICMs on a layer of mitotically 
inactivated fibroblasts in medium containing fetal calf serum (Smith and Hooper, 1983). It was 
later discovered that the cytokine Leukemia Inhibitory Factor (LIF) can substitute for feeder cells 
(Smith et al., 1988). LIF promotes continual self-renewal by activating the transcription factor 
STAT3 (signal transducer and activator of transcription 3) (Nichols et al., 1998). Subsequently, 
BMP4 (bone morphogenetic protein 4) was shown to replace the need for serum, an effect which 
was reproduced by forced expression of Id (inhibitor of DNA binding) genes, allowing ES cells to 
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be cultured in defined conditions (Ying et al., 2003a). Thus conventional ES cell culture relies on 
extrinsic stimulation of STAT3 by LIF and a parallel induction of ID proteins by serum factors or 
BMP4.  
 
Figure 1.10 Signal transduction pathways affected by 2i and serum/BMP4 + LIF. Left panel: ES cell 
signalling in 2i supplemented media. PD03 inhibits the pro-differentiation MAPK/ERK signalling pathways. 
CHIR inhibits GSK3 and leads to the activation of canonical Wnt signalling through β-catenin stabilisation. 
Together these inhibitors allow the maintenance of ES cells in a ground state of pluripotency. Right panel: 
ES cells cultured in Serum/BMP4 + LIF media. LIF and BMP4 activate STAT3 and Smad proteins respectively, 
which are required for the maintenance of ES cell in pluripotent state (Adapted from Marks and 
Stunnenberg, 2014). 
 
Further studies have shown that ES cells possess opposing signalling pathways that govern 
the balance between self-renewal and differentiation. OCT4 and SOX2, in addition to the 
activation of pluripotency genes, also promote the expression of the autocrine factor FGF4 
(fibroblast growth factor 4), which in turn activates the Erk signalling pathway that favours 
differentiation (Kunath et al., 2007). These findings suggested that LIF and BMP4 act downstream 
of the Erk signalling pathway to block differentiation. Expanding upon this observation, Smith and 
colleagues showed that dual inhibition of the pro-differentiation MEK (MAP Kinase/ER Kinase) 
and GSK3 (Glycogen synthase kinase 3β) signalling by small molecule inhibitors, in conventional 
serum-cultured mouse ES cells, reinforced their capacity for self-renewal. The MEK inhibitor PDO3 
(PD0325901) and the GSK3 inhibitor CHIR (CHIR99021), in combination known as “2i”, allow 
robust ES cell self-renewal in the absence of serum or LIF (Ying et al., 2008). Inhibition of GSK3 
results in an increase in the anabolic processes and activation of canonical Wnt signalling through 
β-catenin stabilisation (Wray et al., 2011) (Figure 1.10). GSK3 is likely to exert β-catenin 
independent effects on ES cells as well. Notably, MAPK (Mitogen Activated Protein Kinase) and 
GSK3 signalling have been shown to have opposing effects on protein translation and on c-Myc 
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stability (Sears, 2004; Wu and Pan, 2010). Remarkably, the use of 2i+LIF defined media made it 
possible to derive ES cell lines from all strains of mice with high efficiency (Nichols et al., 2009).  
ES cells growing in conventional serum and LIF culture conditions, form colonies that are 
composed of a mixture of undifferentiated and differentiated cells (Figure 1.11). In fact, analysis 
has shown that ES cells in conventional culture conditions display heterogeneous expression of 
transcription factors like NANOG, STELLA, REX1, ESRRB, HEX, KLF4 and TBX3. For example, NANOG 
is not expressed in all OCT4-expressing undifferentiated ES cells. ES cells with knockin GFP 
reporters for NANOG can be sorted into NANOG-low and NANOG-high expressing populations. 
Sorted fractions can re-establish the parental distribution of Nanog expression showing that the 
expression is dynamic. However, NANOG-low cells are functionally more prone to differentiation 
(Chambers et al., 2007). Thus heterogeneous expression reflects different cell states that coexist 
within the population despite their genetic homogeneity. Such stochastic changes in gene 
expression may provide a window of opportunity to direct lineage allocation in response to 
developmental cues (Torres-Padilla and Chambers, 2014).  
 
Figure 1.11 Nanog expression is heterogeneous in conventional serum ES cell cultures. A) ES cell colonies 
formed from single cells are morphologically different in 2i and serum conditions. B) Immunostaining 
images for Oct4 and Nanog expression in ES cells cultured in LIF+Serum or 2i. Oct4 expression is more or 
less uniform in both conditions. Serum+LIF ES cells show varying degrees of Nanog expression ranging from 
high to low while 2i ES cells are homogenously high for Nanog (Adapted from (Wray et al., 2010). 
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ES cells cultured in 2i medium are believed to be in a ‘ground’ or ‘naïve’ state of pluripotency 
equivalent to cells from the early epiblasts (Nichols and Smith, 2009). In 2i+LIF medium, mouse 
ES cells form colonies efficiently and these colonies are composed purely of undifferentiated cells. 
They have homogenously high NANOG expression (Figure 1.11) and do not show intrinsic 
fluctuations of gene expression as observed in conventional media. This is likely to result from the 
elimination of the differentiation-promoting effects of FGF4-MAPK signalling together with the 
consolidating effect of GSK3 inhibition. Thus, it is suggested that the pluripotency network, 
headed by OCT4/SOX2, NANOG and KLF4 is inherently self-sustainable, but extremely sensitive to 
destabilisation by exogenous signals and elimination or neutralisation of such signals captures the 
ES cells in a naïve state (Wray et al., 2010). 
Genome-wide analysis reveals that culture conditions impose distinctive transcriptome and 
epigenome properties on mouse ES cells. Nearly 25% of the genes show 2-fold or greater 
differences in expression between 2i and serum conditions. Genes associated with metabolic 
processes are upregulated in 2i while those associated with differentiation are downregulated 
(Marks et al., 2012). 2i ES cells have much lower c-Myc expression (Ying et al., 2008) possibly 
resulting in the observed upregulation of cell cycle inhibitors p16, p19 and p21. Nonetheless, ES 
cells continue to proliferate rapidly, reflecting their freedom from cyclin checkpoint controls 
(Stead et al., 2002). Promoter-proximal RNA polymerase pausing is also more prominent in 2i than 
in serum. This may be explained by the induction of c-Myc in serum which facilitates pause release 
(Rahl et al., 2010). In terms of epigenetic modifications, H3K4me3 marks are similar between 2i 
and serum but there is a striking difference in the pattern of H3K27me3 deposition. Even though 
the global levels of H3K27me3 are similar between 2i and serum, the localisation of this mark at 
repressed genes is greatly diminished in 2i cells with no apparent increase in transcription. 
Overall, serum ES cells have more bivalently marked genes. Additionally, 2i ES cells have lower 
DNA methylation than serum ES cells (Ficz et al., 2013; Habibi et al., 2013; Hackett et al., 2013; 
Leitch et al., 2013; Marks and Stunnenberg, 2014). 
1.4.2 Cohesin as a regulator of pluripotency 
Cohesin subunits have repeatedly been identified in RNAi screens performed in ES cells, as 
factors required for the maintenance of pluripotency (Ding et al., 2009; Hu et al., 2009; Kagey et 
al., 2010; Nitzsche et al., 2011). However, it is unclear from these studies whether the 
requirement of cohesin is due to its necessary functions in cell division or due to its direct roles in 
regulating expression of pluripotency genes.  Kagey et al., (2010) found that the Mediator complex 
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and Nipbl were also necessary for ES cell self-renewal. They showed that individual knockdown of 
the Med12, Smc1a and Nipbl each had the same effect on ES cell state as loss of Oct4 itself in 
terms of reduced expression of pluripotency associated transcription factors and upregulation of 
genes encoding developmentally important transcription factors. They further provided evidence 
that cohesin and NIPBL biochemically interact with the Mediator complex and co-localise on DNA 
at CTCF-independent cohesin binding sites associated with enhancers and promoters of active 
genes. To test if the enhancer-promoter associated cohesin was involved in DNA looping, they 
performed 3C experiments at the Oct4, Nanog, Phc1 and Lefty1 loci. This analysis indicated that 
the promoters of these pluripotency associated genes interacted with their respective enhancers 
only in ES cells but not in MEFs, where these genes are not expressed and show no cohesin 
binding. These observations suggested that cohesin is involved in enhancer-promoter interactions 
in a cell-type specific manner and may thus contribute to the regulation of pluripotency genes 
(Kagey et al., 2010; Phillips-Cremins et al., 2013). 
Since then, several studies have further analysed the role of cohesin and transcription 
factors in organising the chromatin structure and maintenance of a transcription profile unique 
to pluripotent state. It is observed that regions with high density of binding sites for key 
pluripotency TFs OCT4, SOX2 and NANOG (OSN) cluster together, and are highly enriched for long-
range DNA interactions suggesting that OSN are directly involved in higher order genome 
organisation in ES cells (Denholtz et al., 2013). This is supported by the demonstration that loss 
of either OCT4 or NANOG diminishes long-range DNA contacts (regions separated by more than 
5Mb) between OSN-bound regions. Moreover, insertion of an ectopic NANOG binding site is 
sufficient to create long-range contacts with the endogenous OSN-bound regions. Interestingly, 
these long-range OSN bound contact sites are not enriched for cohesin and CTCF binding. This 
suggests that OSN can shape the higher order structure of the genome independent of the 
architectural proteins. Although OSN also anchor shorter-range cis-regulatory interactions that 
do require cohesin (de Wit et al., 2013). Oct4 expression itself is facilitated by KLF4 mediated 
recruitment of cohesin (Wei et al., 2013; Zhang et al., 2013a).  
Comparison of chromosomal contacts and genome-wide TF binding between ES cells and 
differentiated progeny has revealed dynamic enhancer landscapes based on cohesin, CTCF and 
other TF binding which allow coordinated gene expression changes in a tissue-specific manner. 
During differentiation, loss of interactions is often found to be associated with loss of cohesin and 
TF binding and reduced expression of pluripotency genes along with the formation of new 
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cohesin-mediated contact sites at lineage-specifying genes  (Apostolou et al., 2013; Kieffer-Kwon 
et al., 2013; Phillips-Cremins et al., 2013; Zhang et al., 2013b).  
The process of somatic cell reprogramming to iPS cells also seems to require cohesin and 
Mediator subunits as their knockdown severely reduces the efficiency of iPS cell generation. This 
has again been related to the inability of cells to induce the expression of pluripotency genes like 
Oct4 and Nanog in the absence of enhancer-promoter interactions (Apostolou et al., 2013; Wei 
et al., 2013; Zhang et al., 2013a). However, it is noteworthy that generation of iPS cells requires 
active cellular proliferation. Thus it is not clear whether cohesin depletion impairs iPS generation 
directly due to transcriptional deregulation or is a consequence of the cells inability to divide 
properly in the absence of cohesin. In order to truly understand the role of cohesin in early steps 
of reprogramming, independent of its cell cycle-dependent functions, Lavagnolli et al., (2014) 
used the cell fusion system. They fused somatic human cells with mouse ES cells that could be 
conditionally and rapidly depleted of cohesin to form heterokaryons with two spatially discrete 
nuclei within a shared cytoplasm. The heterokaryon stage persists without cell division for up to 
3 days, after which nuclear fusion occurs, giving rise to tetraploid hybrid cells. Heterokaryon 
formation is accompanied by the activation of pluripotency genes and the extinction of lineage-
specific genes in the somatic nuclei (Pereira et al., 2008; Soza-Ried and Fisher, 2012). Therefore, 
cell fusion-mediated heterokaryon formation allowed the investigation of the role of cohesin in 
early events of somatic cell reprogramming in the absence of cell division. Interestingly, cohesin-
depleted mouse ES cells consistently induced the human pluripotency-associated genes POU5F1 
(OCT4), NANOG, SOX2, REX1, and CRIPTO more strongly and with faster kinetics than control ES 
cells. These experiments indicated that cohesin is not required for the ability of ES cells to induce 
pluripotency gene expression by somatic nuclei in heterokaryons, and that cohesin-deficient ES 
cells initiate the reprogramming of somatic cell nuclei more potently than wild type ES cells 
(Lavagnolli, 2013). The increased reprogramming efficiency was attributed in part to Myc 
overexpression in cohesin-deficient mouse ES cells which enhanced somatic cell DNA replication 
(this work Section 4.1, Lavagnolli et al., 2015), previously shown to facilitate heterokaryon-
mediated reprogramming (Tsubouchi et al., 2013). In contrast, cohesin-deficient somatic cells had 
defective DNA replication and reprogrammed poorly in heterokaryons. Nuclear transfer 
experiments further showed that cohesin is not required for DNA replication-independent 
reprogramming of cohesin-deficient somatic cells in Xenopus oocytes (Figure 1.12) (Lavagnolli et 
al., 2015). Overall, these studies show that the role of cohesion in somatic cell reprogramming is 
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therefore at least in part to facilitate DNA replication in heterokaryon-mediated reprogramming 
and cell division in iPS cell-mediated reprogramming. 
 
 
Figure 1.12 Cohesin’s role in reprogramming of somatic cells towards pluripotency. (Top) Acute cohesin 
deletion in mouse ES cells increases their ability to reprogram somatic cells after heterokaryon formation 
partly due to enhanced DNA replication induced by Myc overexpression. (Middle) Cohesin depletion in 
somatic cells impairs DNA replication and induction of pluripotency gene expression in ES cell 
heterokaryons. (Bottom) Pluripotency gene expression in cohesin-deficient somatic cell nuclei is induced 
efficiently by nuclear transfer experiments where reprogramming occurs in the absence of DNA replication. 
(Adapted from Lavagnolli et al., 2015.) 
 
Together, current evidence suggests that cohesin potentially has a role in regulating the 
expression of pluripotency associated genes but much of the details of its function in this process 
remain to be determined. 
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1.5 Myc and its regulation by cohesin 
MYC regulates a multitude of biological processes ranging from cell proliferation, 
metabolism, growth, angiogenesis, metastasis, genomic instability to stem cell self-renewal. 
Deregulated Myc expression due to translocation, gene amplification or aberrant signalling 
promotes unrestrained cell proliferation and is frequently associated with human malignancies 
(Dang, 2012). Myc is also important for the maintenance of pluripotency and its induced 
expression along with that of Oct4, Sox2 and Klf4 can reprogram fibroblasts into a pluripotent 
stem cell state (Chappell and Dalton, 2013). Given its pivotal role in cellular processes and its 
potential as a therapeutic target for cancer treatment, it is of extreme importance to understand 
the molecular details of its various functions and modes of regulation. 
1.5.1 Cellular functions of MYC 
A large part of MYC’s contribution to cellular processes is attributed to its role as a 
transcriptional regulator. MYC binds to DNA as a heterodimer with MAX (MYC-associated factor-
X) (Hurlin and Huang, 2006). The canonical Myc E box DNA binding motif (5’-CAGGTG-3’) occurs 
very frequently in the human genome (Xie et al., 2005) and MYC has been shown to extensively 
bind at regions of active chromatin (Dang, 2012; Nie et al., 2012). MYC is believed to increase 
transcription by the recruitment of histone acetyltransferases (Cowling and Cole, 2006). 
Additionally, it has been shown that recruitment of pTEFb by MYC stimulates the release of 
paused RNA polymerase partly by phosphorylation of Pol II CTD (Rahl et al., 2010). Recent studies 
suggest that MYC functions predominantly as a universal amplifier of active transcription (Lin et 
al., 2012b; Nie et al., 2012), although it can also repress certain transcriptional targets (Meyer and 
Penn, 2008; Sabò et al., 2014; Walz et al., 2014).  
Elevated levels of c-Myc cause a broad spectrum of cellular effects. Myc promotes cellular 
growth and proliferation by boosting biosynthetic and metabolic pathways, rRNA synthesis, 
ribosomal protein biogenesis. It also plays a critical role in cell cycle progression. MYC is essential 
for G1 to S phase transition. It abrogates the transcription of cell cycle checkpoint genes, inhibits 
the function of cyclin-dependent kinase (CDK) inhibitors while also activating the expression of 
genes required for cell cycle progression (Obaya et al., 1999). Interestingly, overexpression of MYC 
in the absence of specific survival factors triggers apoptosis by the activation of p53-dependent 
pathways. In parallel, MYC induces the expression of pro-apoptotic molecules like BIM (BCL2-like 
11) and represses the expression of anti-apoptotic BCL2 and BCL-XL proteins (Dang et al., 2005). 
Introduction 
 
54 
 
Thus MYC lies at the crossroads of several growth promoting and cellular survival signal 
transduction pathways. In ES cells, MYC is important for the establishment and maintenance of 
the pluripotency transcriptional programme (Chappell and Dalton, 2013) where it forms a stem 
cell module of target genes distinct from the core transcriptional network but more similar to that 
of cancer cells (Kim et al., 2010). MYC downregulation is required for the ES cells to exit cell cycle 
and undergo differentiation (Wilson et al., 2004).  
MYC also has transcription-independent functions (Cole and Cowling, 2008). MYC promotes 
the translation of specific mRNAs by promoting the methylation of the 5’ mRNA guanine or ‘cap’ 
(Cowling and Cole, 2007). MYC also plays an important role in the initiation of DNA replication. It 
binds to numerous components of the pre-replicative complex, including MCM proteins, ORC2, 
CDC6 and CDT1 and recruits them to sites of active replication origins. Studies in both Xenopus 
and mammalian cells suggest that MYC functions to control the selection of replication origins 
and governs the number of active replication origins. Consequently, depletion of MYC decreased 
DNA synthesis and addition of recombinant MYC protein rescued DNA synthesis (Dominguez-Sola 
et al., 2007). Thus MYC functions are multifaceted and encompass a wide variety of cellular 
processes. 
1.5.2 Regulation of MYC expression 
Physiological levels of MYC are precisely regulated by several extracellular and intracellular 
signals operating through an array of transcription factors, chromatin modifiers and regulatory 
RNAs that are brought to the Myc promoter and cis-regulatory elements. Myc mRNAs are spliced 
from primary transcripts containing three exons using multiple reading frames. The MYC protein 
is encoded from the exons 2 and 3 with two universally expressed forms arising from an AUG 
codon at the 5’ end of exon 2 and a CUG initiation codon at the 3’ end of exon 1, respectively (Liu 
and Levens, 2006). The Myc promoter acts as a key convergence node for a whole host of 
transcription factors such as CNBP, FBP, BRD4 and TCF. General Myc expression can be considered 
to be pseudo-constitutive where its expression within  each cell type is controlled by a customised 
set of TFs and chromatin factors (Levens, 2010). Genome-wide association studies have identified 
common single nucleotide polymorphisms (SNPs) that are linked with multiple cancers. Detailed 
analysis shows that several of these SNPs lie in enhancer elements that are often involved in DNA 
looping with the Myc promoter in a context specific manner (Pomerantz et al., 2009; Tuupanen 
et al., 2009; Ahmadiyeh et al., 2010; Sotelo et al., 2010; Wasserman et al., 2010; Wright et al., 
2010; Sur et al., 2012; Kieffer-Kwon et al., 2013; Shi et al., 2013). 
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However, transcription alone cannot account for the enormous differences observed in 
mRNA expression in response to either proliferative or anti-proliferative stimuli (Blanchard et al., 
1985). In fact, Myc mRNA is very short lived and has a very rapid turnover rate with a half-life in 
the order of 15-20 minutes. Myc mRNA decay occurs via two mechanisms. The first is a 
translation-independent mechanism involving the shortening of the poly(A) tail and is regulated 
by AU-rich sequences in the 3’ untranslated region (UTR) (Jones and Cole, 1987). The second is 
translation-dependent where a portion of mRNA corresponding to the CTD of the protein, known 
as coding region determinant, is bound by another protein, and hence, protected from 
endonuclease attack (Bernstein et al., 1992). In addition, Myc mRNA stability can be influenced 
by its association with ribosomes where treatment of cells with translational inhibitors prolongs 
its half-life (Ross, 1995). A further level of translational modulation is provided by the action of 
miRNAs like let-7 which inhibit Myc expression (Kim et al., 2009b).  Precise levels of MYC protein 
and its activity are also regulated by a series of phosphorylation events. ERK mediated 
phosphorylation of the Ser62 residue on MYC increases protein stability and causes a rapid 
accumulation of MYC in early G1 phase. In late G1, phosphorylation of Thr58 by GSK-3β directs 
MYC ubiquitination and proteasomal degradation causing rapid downregulation (Sears, 2004). 
Therefore, MYC levels in the cell are tightly regulated at both transcriptional and post-
transcriptional level. 
Several reports have suggested that cohesin is also involved in the transcriptional regulation 
of the c-Myc gene. Rad21 depleted zebrafish embryos showed a downregulation of the 
endogenous Myc gene expression. Depletion of Rad21 or Nipped-B in Drosophila also reduced 
the expression of Myc and its target genes (Rhodes et al., 2010). Later studies in MCF7 breast 
cancer cell lines showed that siRNA mediated RAD21 depletion decreased Myc expression and 
blocked estradiol-mediated activation of Myc (McEwan et al., 2012). Proteomic profiling of cell 
lines from CdLS patients also revealed a deregulated network of proteins centred around MYC 
(Gimigliano et al., 2012). Together these experiments suggest that cohesin positively regulates 
Myc expression. However, it is noteworthy that the above studies also exhibited an upregulation 
of p53 and Mdm2 expression, markers of cellular stress, upon cohesin depletion. Thus it is difficult 
to conclude from the above studies whether the impact on Myc expression is a direct or an 
indirect consequence of cohesin depletion. Interestingly, Wapl depletion in serum starved non-
dividing MEFs, which increases the association of cohesin complex with DNA, also caused a 
downregulation of Myc expression (Tedeschi et al., 2013). These findings point towards a 
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potential role of cohesin in Myc regulation but require a more careful analysis to understand its 
role more definitively.  
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1.6 The major histocompatibility complex genes and their regulation 
by cohesin and CTCF 
The immune system uses several mechanisms to recognise, interpret and respond to 
pathogens. One of the key processes is to be able to detect a pathogenic antigen and be able to 
discriminate it from self-antigens. Every mammalian species possesses a tightly linked cluster of 
genes, the major histocompatibility complex (MHC), whose products act as antigen-presenting 
structures for T cells which selectively recognise non-self antigens (Kindt et al., 2007).  
The MHC genes were first identified by the work of Peter Gorer and George Snell as they 
established that the antigens encoded by these genes took part in the rejection of transplanted 
tumors in inbred strains of mice. Today it is known that the major histocompatibility complex is a 
collection of genes arrayed within a long continuous stretch of DNA on chromosome 6 in humans, 
known as the HLA complex and on chromosome 17 in mice, referred to as the H-2 complex (Figure 
1.13). The MHC-encoded class I and class II molecules serve as the peptide-binding transport and 
display proteins, evoking effector response upon recognition by T cells. Other gene products, 
some also encoded within the MHC, participate in either the formation or translocation of 
peptides, or the trafficking of MHC molecules from the intracellular compartments to plasma 
membrane. Together they provide for antigen processing and presentation (Kindt et al., 2007). 
 
Figure 1.13 The major histocompatibility complex in mouse and human. The MHC is referred to as the H-
2 complex in mice and as the HLA complex in humans. In both species the MHC is organized into a number 
of regions encoding class I and class II gene products. The class I and class II gene products shown in this 
figure are considered to be the classical MHC molecules. 
The array of MHC genes, spanning a genomic region of about 4 Mb, provides an excellent 
prospect to study how the expression of constituent genes involved in the same pathway of 
antigen processing and presentation is coordinately co-regulated in a cell-type specific manner in 
spite of being separated by large genomic distances and investigate the role of cohesin in this 
process. 
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1.6.1 The class I and class II MHC molecules 
The Class I MHC genes encode glycoproteins expressed on the surface of nearly all 
nucleated cells. They are designated as HLA-A, HLA-B and HLA-C in humans and H2-K, H2-D and 
H2-L in mice. MHC Class I molecules consist of a 45-kDa transmembrane polypeptide α chain 
associated with a 12-kDa light chain β2 microglobulin molecule. Their major function is 
presentation of peptide antigens to CD8+ cytotoxic T cells. These peptides are derived from 
endogenous intracellular proteins digested in the cytosol. The digested peptides are transported 
into the endoplasmic reticulum where they interact with the class I MHC molecules before being 
presented on the cell surface. The peptide-binding cleft on the top surface of the MHC class I 
molecules is large enough to bind a peptide of 8-10 amino acids. In normal, healthy cells, class I 
molecules display self-peptides resulting from normal turnover of self-proteins. In case of an 
infection, by a virus for example, the cell will display viral peptides as well as self-antigens 
associated with MHC class I molecules. The presented antigen is recognised by the T cell receptors 
(TCRs) and the interaction is stabilised by the co-receptor CD8. CD8+ T cells recognise the MHC 
classI:peptide complexes and get activated to kill cells displaying foreign antigens derived from 
cytosolic pathogens. Different cell types express different levels of MHC class I molecules. The 
highest levels are expressed by lymphocytes, where they constitute approximately 1% of the total 
plasma membrane proteins. In contrast, fibroblasts, muscle cells, hepatocytes and neural cells 
express very low levels of MHC class I molecules (Kindt, 2006; Alberts, 2008). 
The class II MHC genes encode the α and β glycoprotein chains of the MHC class II molecules 
designated as HLA-DR, DP and DQ in humans and H-2IA and –IE in mice. The class II molecules are 
expressed constitutively only by professional antigen presenting cells (APCs), primarily 
macrophages, dendritic cells and B cells. All other cell types lack constitutive expression of MHC-
II molecules, but their expression can be induced under certain conditions, such as upon activation 
in human T cells or by exposure to cytokines, of which interferon γ (IFNγ) is the most potent. Class 
II MHC molecules are comprised of two different polypeptide chains, a 33-kDa α chain and a 28-
kDa β chain associated by non-covalent interactions. The membrane distal portion of a class II 
molecule forms the antigen-binding cleft for the processed antigen of about 13-18 amino acid 
residues. The presented antigens are generally derived from exogenous proteins present in the 
microbes or viruses. The proteins are internalised by phagocytosis or by receptor-mediated 
endocytosis and enter the endocytic processing pathway where they are degraded. The degraded 
antigenic peptides bind to heterodimeric MHC class II molecules and are presented to the helper 
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T cells where the recognition of the antigen by TCRs is stabilised by the co-receptor CD4. CD4 T 
cells are specialised to activate other immune effector cells, for example B cells or macrophages, 
to act against the foreign antigens or pathogens that the presenting cell has taken up (Kindt et al., 
2007; Alberts, 2008).  
Table 1.3: Properties of class I and class II MHC proteins 
 
The MHC locus is highly polymorphic i.e. many alternative forms of the gene, or alleles, exist 
at each locus among the population. As the genes within the locus lie close together, the 
recombination frequency within the locus is fairly low and most individuals inherit the alleles 
encoded by these closely linked loci as two sets, one from each parent. Each set of alleles is 
referred to as a haplotype. Inbred strains of mice that have identical alleles at the MHC loci, have 
been designated as prototype strains. For example, the C57BL/6 mice are assigned the haplotype 
H-2b and the respective alleles are labelled as H-2Kb, H-2Abb etc. MHC polymorphism is of critical 
importance in antigen recognition by T cells. It increases the range of peptides bound by MHC and 
the direct interaction of the MHC molecule with the T-cell receptor (Doan et al., 2012).  
As the MHC-I and MHC-II genes play such a critical role in immune response, their 
expression is tightly regulated at the transcriptional level by a variety of transcription factors that 
interact with conserved cis-regulatory promoter elements. Another level of transcriptional 
control is provided through chromatin histone modifications and long-range DNA interactions 
between regulatory elements. The activation of MHC-I genes is mediated by several conserved 
DNA elements formed of an enhancer A, interferon-stimulated response element (ISRE) and the 
SXY-module (comprising the S/W, X1, X2 and Y boxes). MHC-II promoters differ from MHC-I 
promoters in that they lack the typical enhancer A and ISRE. The sequence and stereo-specific 
alignment of the various boxes in SXY-module is highly conserved and critical for its functioning 
in constitutive and inducible transcriptional activation of MHC genes. The X box is bound by RFX 
(regulatory factor X), a trimeric complex composed of RFX5, RFXANK and RFXAP (Steimle et al., 
1995; Durand et al., 1997; Masternak et al., 1998; Nagarajan et al., 1999). The X2BP complex that 
includes CREB, recognises the X2 box (Moreno et al., 1999). The trimeric NF-Y complex, composed 
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of NF-YA, NF-Yb and NF-YC, binds to the Y box (Mantovani, 1999). Together, the SXY-module is 
cooperatively bound by this multi-protein complex which acts as an enhanceosome. The assembly 
of the enhanceosome results in the formation of an enhancer surface that optimally interacts 
with and recruits the transcriptional apparatus (Thanos and Maniatis, 1995) driving the 
transactivation of the MHC genes (Figure 1.14). 
1.6.2 CIITA: the master regulator of MHC class II expression 
As the enhanceosome components are expressed more or less ubiquitously, they fail to 
account for either the cell-type specificity or the IFNγ inducibility of MHC II expression. This 
function can be attributed to the class II transactivator (CIITA) gene. CIITA was identified by 
complementation cloning using MHC II negative mutant cell lines. CIITA expression was necessary 
and sufficient to restore the expression of all MHC II isotypes in cells from patients with bare 
lymphocyte syndrome which show a total lack of MHC class II expression (Steimle et al., 1993, 
1994). Indeed, CIITA exhibits a cell-specific, cytokine-inducible and differentiation-stage-specific 
pattern of expression that precisely parallels that of MHC class II genes. In addition, CIITA 
expression is controlled and induced by IFNγ. Thus CIITA acts as a master transcriptional regulator 
essential for MHC II transcription and contributes to the activation of MHC-I promoters (Steimle 
et al., 1993; Martin et al., 1997). So far, MHC II and related genes remain the major known targets 
of CIITA. However, there is growing evidence that CIITA may influence the expression of additional 
genes. (LeibundGut-Landmann et al., 2004). 
CIITA belongs to the large NLR (nucleotide binding domain, leucine-rich repeat containing) 
family of proteins (Harton et al., 2002). The N-terminal activation domain is necessary for 
transcriptional activation. The centrally located NBD (nuclear binding domain) contains a GTP-
binding domain which is required for the nuclear import of CIITA. The C-terminal LRRs (leucine 
rich repeats) are also important for nuclear import and for interactions with other proteins 
(Harton and Ting, 2000). As CIITA lacks a DNA binding motif, it exerts its transactivating function 
through protein-protein interactions with the components of the MHC-enhanceosome bound to 
the proximal SXY regulatory module in MHC promoters (Zhu et al., 2000; Jabrane-Ferrat, 2003). 
In addition, it forms a network of multiple interactions with various transcriptional cofactors. 
CIITA interacts with several chromatin modifying proteins including histone acetyltransferases 
(HATs like CBP/p300, pCAF and SRC-1), histone methyltransferases (HMTs like CARM1), ATP-
dependent remodelling enzymes (BRG1) and histone deacetylases (HDAC1, weakly with HDAC2). 
Introduction 
 
61 
 
CIITA also recruits multiple components of the basal transcription machinery including TBP, 
components of the TAF||D complex, the kinases CDK7, CDK9 and pTEFb (Zika and Ting, 2005). 
Thus, CIITA acts as the central molecule modulating the chromatin structure, MHC enhanceosome 
assembly and transcription initiation and elongation processes. Therefore, it controls the 
transcription of MHC genes II genes by coordinating the temporal recruitment of distinct cofactors 
in response to cytokines and other stimuli (Figure 1.14). 
 
 
 
Figure 1.14 MHC II enhanceosome on the HLA-DRa promoter. MHC II promoters share a common set of 
cis-acting elements including the S-X-Y module which binds the heterotrimeric transcription factor NF-Y, 
the RFX complex and CREB. These ubiquitously expressed transcription factors bind the S-X-Y module in a 
stereospecific and cooperative manner and provide a surface for CIITA recruitment upon IFNγ treatment, 
which is essential for MHC II expression. CIITA interacts with an array of TAFs, elongation factors like pTEFb, 
kinases like CDK7, CDK9 and chromatin remodelling factors like HATs, HMTs, BRG1, HDACs and mediates 
the transcription of these genes [modified from Zika and Ting, 2005]. 
The regulation of CIITA expression occurs primarily at the level of transcription of the 
MHC2TA gene which involves the cell-type or stimulus-specific usage of its four different 
promoters (pI to pIV) (Figure 1.15). Promoters pI, pIII and pIV are highly conserved between 
human and mouse genes. Promoter pII has only been found in the human gene. It displays very 
low transcriptional activity and its significance remains unknown. The different promoters do not 
share any sequence homology and are not co-regulated. Each promoter precedes a distinct first 
exon which is alternatively spliced to the shared downstream exons. Thus transcription from 
Introduction 
 
62 
 
these promoters produces three types of transcripts possessing different 5’ ends (Muhlethaler-
Mottet et al., 1997). Experiments in knockout mouse strains lacking one or more of the promoter 
regions have allowed researchers to define more precisely the function of each promoter in vivo 
(Waldburger et al., 2001; Pai et al., 2002). Each of these promoters has a different function and is 
active only in specific cell types or in response to particular stimuli. Conventional dendritic cells 
and IFNγ induced macrophages (cells of myeloid origin) predominantly use the pI promoter for 
CIITA expression. In B cells and activated human T cells of lymphoid origin, transcription initiates 
from pIII (Lennon et al., 1997). Unlike conventional dendritic cells, CIITA expression in 
plasmacytoid dendritic cells (pDC) is also controlled by pIII. pIV is essential for CIITA expression in 
response to IFNγ signals in cells of non-hematopoietic origin. pIV also drives CIITA expression in 
cortical thymic epithelial cells which constitutively express MHC II molecules required for the 
positive selection of CD4+ T cells (Waldburger et al., 2001; LeibundGut-Landmann et al., 2004). 
 
 
Figure 1.15 CIITA promoter usage. Expression of the CIITA gene is controlled by three independent 
promoters having different functions: pI is used in cells of myeloid origin (conventional dendritic cells (DC), 
macrophages); pIII is active in cell of lymphoid origin (B cells, activated human T cells, pDC); pIV is necessary 
for responsiveness to IFNγ in non-hematopoietic cells and is expressed constitutively in thymic epithelial 
cells. The three types of CIITA mRNA encode three different isoforms differing only at their N-terminal 
ends. The significance of the pII promoter present in human gene is still not known. 
The activity of the CIITA promoters is further regulated by several epigenetic mechanisms 
and interacting factors. Activation of pIII in B cells requires CREB-1, PU.1. IRF-4 and E47 
transcription factors to interact with the different regulatory motifs present in the promoter 
region (van der Stoep et al., 2004). Transcription mediated by CIITA-pI in immature dendritic cells 
requires binding of PU.1, IRF-8, NF-κB and Sp-1 to the promoter (Smith et al., 2011).  
CIITA expression also needs to be repressed in order to downregulate MHC II expression 
under certain physiological and pathological situations. For example, immature dendritic cells 
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shut down de novo synthesis of MHC II molecules when they undergo maturation in response to 
an infection. This is mediated by a global repression mechanism implicating histone deacetylation 
spanning the CIITA regulatory region. During terminal differentiation of B cells into plasma cells, 
CIITA expression is actively silenced by Blimp-1 (Piskurich et al., 2000). Trophoblast cells and 
embryonic stem cells lack the expression of MHC II molecules both constitutively and after 
exposure to IFNγ which is thought to be critical in preventing rejection of the fetus by the maternal 
immune system. These cells are hypermethylated at CpG dinucleotides present in the pIV region 
rendering the cells unable to activate CIITA transcription (Morris et al., 2000; van den Elsen et al., 
2000). More recently, a trophoblast derived non-coding RNA has been shown to suppress CIITA 
expression through an inhibitory domain (Geirsson et al., 2003). MHC molecules also play a pivotal 
role in presenting tumor derived antigens and hence in activating and regulating antitumor 
immune response. Consequently, malignant cells employ the strategy of downregulating MHC 
expression in order to evade elimination by immune system. Loss of constitutive MHC II 
expression is observed in tumor cells of hematopoietic origin while tumor cells of non-
hematopoietic origin show the inability to induce MHC II expression in response to IFNγ (García-
Lora et al., 2003). This inability to express MHC II has been attributed to hypermethylation of the 
CIITA locus (van den Elsen et al., 2003) and to the activity of histone deacetylases (Magner et al., 
2000). A variety of pathogens (cytomegalovirus (CMV), Mycobacterium bovis, Chlamydia, 
varicella-zoster virus and Epstein Barr virus (EBV)) have also developed mechanisms to down-
regulate MHC II expression in order to escape immune surveillance by the hosts (Harton and Ting, 
2000). 
1.6.3 IFNγ mediated CIITA induction 
Interferon γ (IFNγ) is a soluble cytokine which plays important roles in innate and adaptive 
immunity against viral and intracellular bacterial infections and tumor control. It is produced by 
CD4+ T helper cell type 1 (Th1) lymphocytes, CD8+ cytotoxic T cells, natural killer (NK) cells, B cells, 
natural killer T (NKT) cells and professional APCs (Schroder and Hertzog, 2004). IFNγ production 
is responsive to cytokines secreted by APCs like IL-12, IL-18 and TNFα (Munder et al., 2001). IFNγ 
binds to the IFNγ receptor (IFNGR) and primarily signals through the Jak-Stat pathway. Ligand 
binding induces JAK2 autophosphorylation and activation, which allows JAK1 
transphosphorylation by JAK2. The activated JAK1 phosphorylates IFNGR to form docking sites for 
latent STAT1. Next, STAT1 gets phosphorylated and dissociates from the receptor. The dissociated 
STAT1 enters the nucleus and binds to promoter elements to initiate or suppress transcription of 
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IFNγ regulated genes (Subramaniam et al., 2001). Exposure to IFNγ leads to upregulation of 
several genes in the antigen presentation pathway (like TAP1, MHC I heavy chain, β2 microglobulin 
MHC II chains, CIITA), apoptosis, immunomodulation, Th development, leukocyte trafficking and 
production of NO intermediates (Schroder and Hertzog, 2004). CIITA is one of the key effector 
genes of the IFNγ response pathway. On exposure to IFNγ, STAT1 translocates to the nucleus and 
binds cooperatively with the constitutively expressed USF-1 at the GAS element and E box present 
at the pIV promoter of CIITA within 5-30 mins. This is followed by IRF1 binding. IRF1 must first be 
transcribed and translated. It appears at the promoter only after 30-120 mins. IRF1 binding 
coincides with CIITA transcriptional activation. This dependence on IRF1 explains the delayed 
kinetics of CIITA induction by IFNγ (Steimle et al., 1994). CIITA pIV activation is also accompanied 
by increased H3 and H4 acetylation (Morris et al., 2002). Inhibitors of HDAC, such as trichostatin-
A (TSA), enhance CIITA and MHC II gene transcription, whereas the recruitment of HDACs causes 
the dissociation of CIITA, NF-Y and RFX from the MHC II gene promoter (Magner et al., 2000; 
Osborne et al., 2001; Kanaseki et al., 2003; Zika et al., 2003). The SWI/SNF ATPase BRG1 is another 
important factor required  for transcriptional activation as the cells lacking expression of BRG1 
fail to induce CIITA expression following IFNγ exposure (Pattenden et al., 2002). BRG1 primarily 
acts as a local chromatin remodeler by means of nucleosomal sliding or strand exchange which 
alters the winding of DNA around histones. These changes in chromatin structure increase its 
accessibility to DNA‐binding proteins, such as activators and/or the general transcription 
machinery (Trotter and Archer, 2008). At CIITA pIV, BRG-1 recruitment facilitates the deposition 
of active histone marks which further aids the formation of long-range chromatin and promoter 
interactions through many interdependent remote enhancers. At the uninduced locus, many sites 
form BRG1 independent loops. The site at +59 kb loops and contacts the site at -50 kb and the 
element at -8 kb bridges this complex to pIV. BRG1 is recruited to the -50 kb site which triggers 
the appearance of an active histone mark. This change is crucial, as subsequent IFNγ-induced 
recruitment of transcription factors, histone modifications and additional loops, show BRG1 
dependency. Thus BRG1 recruitment makes the promoter poised for induction (Ni et al., 2008). 
IFNγ activated expression of CIITA can also be suppressed by a number of different stimuli 
including TGFβ, IL-1. IL-4 and IL-10. Suppressor of cytokine signaling (SOCS1) is induced by IFNγ 
which further negatively regulates the IFNγ signal transduction pathway by binding to JAK2 and 
inhibiting its kinase activity. Similar to SOCS1, nitric oxide – which is produced by macrophages 
upon IFNγ stimulation – may act as feedback inhibitor of MHC II synthesis by inhibiting CIITA 
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expression. Statins (HMG-CoA reductase inhibitors), known for their cholesterol-lowering effect, 
also exhibit anti-inflammatory properties due to inhibition of IFNγ induced CIITA activation  
(LeibundGut-Landmann et al., 2004).  
1.6.4 Role of cohesin and CTCF in MHC regulation 
The MHC gene cluster is interspersed with several CTCF and cohesin binding sites which are 
reported to be involved in the regulation of MHC expression. The intergenic region between the 
HLA-DRB1 and HLA-DQA1 genes in the human MHC contains a CTCF binding site – XL9, which has 
enhancer-blocking activity (Majumder et al., 2006). This site serves as a focus for long-range 
interactions with the promoters of the HLA-DRB1 and HLA-DQA1 genes (Majumder et al., 2008). 
These interactions are dependent on the presence of both CTCF and CIITA. Knockdown of CTCF 
resulted in decreased expression of HLA-DRB1 and HLA-DQA1, reduced histone acetylation at 
these gene promoters and the loss of their interaction with the XL9 site. CIITA and CTCF co-
immunoprecipitate, suggesting that the two factors interact directly or indirectly through a 
complex of factors (Majumder et al., 2008). Further investigation identified ten other CTCF 
binding sites within the human MHC region and it was shown that all CIITA-regulated genes within 
the MHC II locus required CTCF for maximal expression. The five non-CIITA constitutively 
expressed genes within the locus (TAP1, TAP2, PSMB8, PSMB9 and BRD2) were not affected by 
CTCF depletion.  In the basal state, a set of self-interactions were observed between the CTCF 
sites which were independent of MHC II gene transcription (similar in B cells and fibroblasts) and 
occurred in the absence or presence of CIITA. An additional set of interactions was observed 
between the CTCF sites and the proximal promoter regions of MHC II genes, but only in the 
presence of CIITA. These interactions were also dependent on CTCF and siRNA mediated 
depletion of CTCF lead to loss of interactions and disrupted transcription of MHC II genes. Thus, 
CTCF organises the MHC II locus into a basal architecture of interacting foci and DNA loops that 
rearranges in the presence of CIITA. Loss of gene expression upon disruption of DNA interactions, 
suggests that these structures play a key role in co-regulating MHC II gene expression (Majumder 
and Boss, 2010).  
Cohesin was also found to be associated with each of the CTCF sites identified irrespective 
of MHC II expression but was required for the optimal expression of the HLA-DR and HLA-DQ 
genes. Cohesin interacts with CTCF, RFX5 and CIITA in a DNA dependent manner and is important 
for DNA looping interactions between the HLA-DRA promoter region and the C1 CTCF element. 
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The C1 CTCF binding element lies 24 kb upstream of the HLA-DRA transcription start site and is 
the most 5’ of the CTCF binding sites in the MHC locus. In the transcriptionally inactive state, C1 
interacts with XL9 forming a large chromatin loop that encompasses the HLA-DR subregion. In the 
transcriptionally active state, C1 interacts directly with the HLA-DRA gene. C1 exhibits enhancer 
blocking activity and this was lost upon cohesin depletion and cohesin binding to C1 was 
dependent on CTCF. Cohesin depletion also demonstrated that the interactions between C1 and 
HLA-DRA promoter were dependent on cohesin subunits, but the interaction between the CTCF 
sites themselves were not. Thus cohesin plays an important role in MHC regulation by mediating 
the interactions between promoter regulatory elements and CTCF sites within the MHC locus 
(Majumder and Boss, 2011). Interestingly, both CTCF and cohesin depletion did not have any 
effect on the expression of CIITA (Majumder et al., 2008; Majumder and Boss, 2010, 2011).  
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1.7 Aims of this study 
Studies in various cellular systems from different model organisms and CdLS patient cell 
lines show that cohesin plays an important role in the regulation of gene expression. Cohesin 
associates with DNA at active gene regulatory elements, particularly promoters and enhancers, 
in a cell type-specific manner. Current models suggest that cohesin influences gene expression by 
mediating long-range chromatin interactions between such gene regulatory elements. However, 
the rules governing this process are still unknown. Moreover, it is not clear whether the changes 
observed in the interactions between a gene promoter and its regulatory elements are cause or 
consequence of changes in gene transcription.  
In this thesis, I aim to explore the mechanisms of cohesin mediated gene regulation by 
conditionally depleting the RAD21 subunit of the cohesin complex in different cellular systems. In 
doing so, I intend to analyse the gene expression changes at early time points or in non-dividing 
cells in order to avoid any cell-cycle stress related secondary effects. First, I will investigate the 
impact of cohesin depletion on the gene expression profile of pluripotent mouse ES cells. I will 
further examine enhancer-promoter interactions at some key pluripotency associated genes 
deregulated upon cohesin depletion. Next, I will focus on studying the role of cohesin in 
modulating the expression of Myc gene. Finally, I will test the hypothesis that cohesin plays a vital 
role in the process of gene activation by studying IFNγ-inducible MHC expression in MEFs. Using 
this system, I will also explore if cohesin impacts gene expression by regulating the activity of RNA 
polymerase and if the MLL3/4 complex is an important partner in this process. 
Overall, this study will provide a better understanding of cohesin functions in gene 
regulation, which may help explain the etiology of CdLS and the incidence of cohesin mutations 
in human malignancies.  
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Chapter 2 : Materials and Methods 
 
2.1 Materials  
2.1.1 Antibodies 
RAD21 ab992 (Rabbit polyclonal to Rad21; Abcam, Cambridge, UK). Used for 
Western blot at 1:1000 dilution 
ab154769 (Rabbit polyclonal to Rad21; Abcam, Cambridge, UK). Used for IF 
analysis at 1:100 dilution 
CTCF ab70303 (Rabbit polyclonal to CTCF; Abcam).  
SMC3 ab9263 (Rabbit polyclonal to SMC3; Abcam) Used for Western blot at 
1:1000 dilution. 
OCT4 sc-8628 (Goat polyclonal to Oct3/4; Santa Cruz Biotechnology, Inc., Santa 
Cruz, CA, USA). Used for western blot at 1:50,000 dilution. 
NANOG REC-RCAB0001P (Cosmo Bio, USA) Used for Western blot at 1:500 dilution 
MYC N-262 sc-764 (Rabbit polyclonal to Myc; Santa Cruz Biotechnology). Used 
for Western blot to detect endogenous Myc at 1:1000 dilution. 
Phospho c-MYC ab32029 (Monoclonal to T58+S62 phosphorylated MYC; Abcam). Used for 
Western blot at 1:1000 dilution. 
H3 ab1791 (Rabbit polyclonal anti-mouse histone H3; Abcam, Cambridge, UK). 
H3K4me3 ab8580 (Rabbit polyclonal to anti-histone H3 (tri methyl K4); Abcam).  
Tubulin T9026 (Mouse monoclonal anti-α tubulin; Sigma). Used for western blot at 
1:2000 dilution 
NIPBL A301-779A-3 (Rabbit polyclonal; Bethyl Laboratories ) 
RNA Pol II H224:sc-9001 (Rabbit polyclonal to NTD of Pol II; Santa Cruz Biotechnology) 
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RNA Pol II CTD 
phospho Ser2 
RNA Pol II CTD Ser2-P 3E10 (Rat polyclonal to Ser2 phosphorylated CTD of 
RNA Pol II; Active Motif) 
RNA Pol II CTD 
phospho Ser5 
CTD4H8 (Mouse monoclonal to Ser5 phosphorylated and 
unphosphorylated forms of RNA Pol II CTD) 
STAT1 #9172 (Rabbit polyclonal to STAT1; Cell Signalling technology) used for 
Western blot at 1:1000 dilution 
LAMIN B sc-6216 (Goat polyclonal anti-mouse Lamin B; Santa Cruz Biotechnology, 
Inc., Santa Cruz, CA, USA). Used for western blot at 1:10,000 dilution. 
IgG DakoCytomation Z0259  (Rabbit polyclonal against mouse IgG) 
I-Ak FITC conjugated mouse anti-mouse antibody against I-Ak (Aαk) (BD 
Pharmingen clone 11-5.2). Used at 1:100 dilution for FACS analysis. 
I-Ab FITC conjugated mouse anti-mouse antibody against I-Ab (Aβb) (BD 
Pharmingen clone 25-9-17). Used at 1:100 dilution for FACS analysis. 
H-2Db FITC conjugated mouse anti-mouse antibody against H-2Db (BD 
Pharmingen clone KH95). Used at 1:100 dilution for FACS analysis. 
H-2Dd FITC conjugated mouse anti-mouse antibody against H-2Dk (BD 
Pharmingen clone 34-2-12). Used at 1:100 dilution for FACS analysis. 
 
2.1.2 Reagents 
Doxorubicin (Cat: 11010, Serva Electrophoresis GmBH), Retinoic acid (Sigma R2625), 4’-
Hydroxytamoxifen (Sigma), HDAC inhibitor PCI-34051 (Selleckchem), PhosphoStop (Phosphatase 
inhibitors from Roche Diagnostics GmBH), recombinant mouse interferon-gamma (mIFNγ), Myc 
inhibitor 10058-F4 (Sigma), Proteinase K (Sigma), Protease inhibitor cocktail (11697498001, 
Roche), EDTA free Protease inhibitors (11873580001, Roche), Amersham ECL plus kit (GE 
Healthcare) for Western blot detection, STI-571 (Imatinib), PDO325901 (Stemgent), CHIR99021 
(Stemgent), Quantifast Probe PCR kit (Qiagen).  
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2.1.3 Primers 
2.1.3.1 Genotyping primers 
Gene   Primer sequence 5'-3' 
Rad21 
 F GAAGGTCATGGTTGGCAGAT 
 R CAATCCAAGCTTCATTTGTATTT 
    
Smc3 
 F ACCTGGACCAGAATAGCTGA 
 R CACACTGCTACACCTGAACACA   
    
Cre 
 F GCGGTCTGGCAGTAAAAACTAT 
 R CCGTCAGTACGTGAGATATCT 
    
Trnah3 
 F TGTGCCAGCATCTTTTGCC 
 R GCGTGCTGGAATTAAAAGCC 
 
 
2.1.3.2 RT-qPCR primers for expression analysis 
      Gene     Primer sequence 5'-3' 
H2-Ab1 
 F TGCCTTAGAGATGGCTCTGC 
 R CCATGAACTGGTACACGAAATG 
    
H2-Aa 
 F TGGAGGTGAAGACGACATTG 
 R CTCATCACCATCAAATTCAAATG 
    
H2-K1 
 F CCGCAGAACTCAGAAGTCGC 
 R GAAATACCTCAGCGAGTGTGG 
    
H2-D1 
 F ACATGCCGTGTGTACCATGA 
 R ACACCCAGAACAGCAACGAT 
    
Tap1 
 F CTGGTCACCCTGATCAACCT 
 R TGCGTGGACTTTGCTAGAGA 
    
Ciita 
mRNA 
 F AGACAAGGGTGTGTCGAAGC 
 R CAGTGATGTTGTTTTGGGACA 
    
Ciita pri. 
Transcript 
 F GCCGACCCCCTACATCTCTA 
 R GCCTGCAGAAGTCCTGAGAA 
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      Gene     Primer sequence 5'-3' 
Rfx1 
 F GCAGCTTACCAACATTCAGGT 
 R GACCTGGCCACTCTTAGTGC 
    
Rfx5  F TCGACTTGAAGGGATCTGAAA 
  R GCACAGGCTGCTTCTACCAG 
    
Irf1  F CCTGGGTCAGGACTTGGATA 
  R GAGACTGCTGCTGACGACAC 
    
Socs1  F GGAGACCTCATCCCACCTCT 
  R CCCAGACACAAGCTGCTACA 
    
Tgfb  F TCAGACATTCGGGAAGCAGT 
  R ACGCCAGGAATTGTTGCTAT 
    
Stat1  F CAACATGCTGGTGACAGAGC 
  R AAACTGCCAACTCAACACCTC 
    
Prdm1  F AGTTCCCAAGAATGCCAACA 
  R TTTCTCCTCATTAAAGCCATCAA 
    
Irf2  F TTGTATTGGTAGCGTGGAAAAA 
  R TGGTATCGTATTGGAATTTATCTGC 
    
Irf8  F CCTATGACACACACCATTCAGC 
  R AGAGACGGCAGCCTTCAAGG 
    
Phc1 
 F AACACCACTTCCCCACCTCT 
 R TCCGGTTAACCTGCAATAGG 
    
Paxip1 
 F GCAGCAGCAGCAGCTTTTTG 
 R TGCTCGGGATAGTCCGCAAT 
    
Smc3 
 F CGAAGTTACCGAGACCAAACA 
 R TCACTGAGAACAAACTGGATTGC 
    
Pvt1 
 F GGCTTGCCTGGAGATGTTAC 
 R CAGGTAGCCCGAGAGATGAC 
    
Lefty1 
 F GTTCAGCCAGAACCTTCGAG 
 R GCTCCATTCCGAACACTAGC 
    
Klf4 
 F TCCTTTCCAACTCGCTAACCC 
 R CGGATCGGATAGCTGAAGCTG 
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      Gene     Primer sequence 5'-3' 
    
Il2 
 F AAATGTGTTGTCAGAGCCCT 
 R GTGCCTAGAAGATGAACTTGG 
    
18SrRNA 
 F GTAACCCGTTGAACCCCATT 
 R CCATCCAATCGGTAGTAGCG 
    
bActin 
 F ACCAACTGGGACGATATGGAGAAGA 
 R TACGACCAGAGGCATACAGGGACAA 
    
Myc 
isoA/B 
 F GCCCAAATCCTGTACCTCGTCC 
 R CTCTTCTCCACAGACACCACATCA 
    
Myc isoA 
 F TTTTTGTCTATTTGGGGACAGTG 
 R ACGGAGTCGTAGTCGAGGTC 
    
Myc pri. 
ex1-in1 
 F AGAGCTCCTCGAGCTGTTTG 
 R ACCCCGACTCAGATCTACCC 
    
Myc pri. 
in1-ex2 
 F AAGGGGAGTGGTTCAGGATT 
 R CGCAGATGAAATAGGGCTGT 
    
Myc pri. 
in2-ex3 
 F TTCTCACCTGTGCCCTAACC 
 R GGTTTGCCTCTTCTCCACAG 
    
Rad21 
 F AGGAAGAAGCTTTTGCGTTG 
 R CGCTAAGCTGGGCTCTAATG 
    
Nanog 
 F GCATCTTCTGCTTCCTGGCAA 
 R GAACTATTCTTGCTTACAAGGGTCTGC 
    
Pou5f1 
 F CCCAAGGTGATCCTCTTCTGCTT 
 R GAGAAGGTGGAACCAACTCCCG 
    
Ubc 
 F AGGAGGCTGATGAAGGAGCTTGA 
 R TGGTTTGAATGGATACTCTGCTGGA 
    
Ywhaz 
(HAZ) 
 F CGTTGTAGGAGCCCGTAGGTCAT 
 R TCTGGTTGCGGAAGCATTGGG 
    
Nipbl 
 F CCATGTCCCCATAACTACGCT 
 R AGTTCACCTCTTCTGCTATTC 
    
Mll4 
 F GCTATCACCCGTACTGTGTCAACA 
 R CACACACGATACACTCCACACAA 
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      Gene     Primer sequence 5'-3' 
    
Gapdh 
 F TGCACCACCAACTGCTTAGC 
 R GGCATGGACTGTGGTCATGAG 
    
p53 
 F CCTGGCTGTAGGTAGCGACT 
 R ACTCCTCCATGGCAGTCATC 
    
p21 
 F GCAGACCAGCCTGACAGATT 
 R GAGGGCTAAGGCCGAAGA 
    
Mdm2 
 F TGTGTGAGCTGAGGGAGATG 
 R CACTTACGCCATCGTCAAGA 
    
Sox1 
 F GTGACATCTGCCCCCATC 
 R GAGGCCAGTCTGGTGTCAG 
 
2.1.3.3 Primers for 3C 
Primers for Nanog 3C: 
TAQ PROBE:  [FAM]-TAT CAA GAA GTC AGA AGG AAG TGA GCC GC-[BHQ1] 
Distance from anchor (kb) 3C primer Reverse primer 
Anchor TGGCCTTCAGATAGGCTGAT CCAGGAAGACCCACACTCAT 
Normalisation fragment AAACGGGCTGAAGGGTTATT CCCCGAACATATTCCAAAGA 
3.6 TGAAGACTGCTTTCTCTGtcc CGGACTAACCAAGGGCTACA 
4.3 CTCGAATGTTGGGCTTAGGA TTCTGCCACTCACACCTCAG 
5.1 CCCTCCTCCCTATTCAAACC AGTCAAGGCCACCATAGCC 
6 GTGGGTGCACACAGAGAACA AGGACATGCGTTCAGTCTCC 
8.25 ATGCATTTCATCCCAGCACT TGGGGTTGGAAAAGTCAAAG 
9.1 CTGGAGAGTATTGCGCCTTC CTGGGTTGGTGAAGATTCCA 
12.7 GGTGGAGTGGCATACACCTT CCTGTGGTCTGCTCTCCATT 
13.4 CACCCCCAGACAGACTGATT CAACCAGCCCAGGTTTCTAA 
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Primers for Lefty1 3C: 
TAQ PROBE: [FAM]-CTT CCC TGA GGC TAA CCA GCG ACA GTG-[BHQ] 
Distance from anchor (kb) 3C primer Reverse primer 
Anchor CAGGGACACACACATCCAAG TGTTGTAGCAGGGCCACATA 
Normalisation fragment GTCCTGGACAAGGCTGATGT ACACCACAGGTGGAAGGAAG 
2.7 AGGAGGAGCAAAGGAAGAGC CACTGTTAACATACTTGAGAGGTGAAA 
4.44 CGCAAGCAGGATGTTTTCA TGGTTCTCTCCTCCCATCAT 
6 GCACTGAGCGATACAAACCA TTTTCTGGCATTAGCAAGCA 
9.07 CCCAGTCTTTATGCCATGCT AGTTTACCCATCCCCTCACC 
10.8 AGGGGCAGAGAACATTTGAA TCTTTAACGATGCTGCGATG 
12.3 TGGTCGCCTCACTCCTAGTC TGAGGAGAGACTGCCATGTG 
14.46 GCTGTGTCCAGCCCTCTTAG GGCCAGCATCTCAGCTTTAC 
15.22 CTTTGGCTGCTCCTATCTGG GAATCCCTCCCTGGCTACTC 
16.6 ACGGATGGCAGACCTGTAAG CCTAAGAAGCCACCTTGCAC 
19.1 AGGATGACATAGCCCAGCAC CAGCTCCAGGAACAGACCAT 
 
Primers for Klf4 3C: 
TAQ PROBE2  [FAM]-TCGTGGGAAGACAGTGTGAAAGGTTAGAAA-[BHQ1] 
Distance from anchor (kb) 3C primer Reverse primer 
Anchor TCCCACGTAGTGGATGTGAC CCATTCACAAGCTGACTTGC 
Normalisation fragment CAAAAACCGTGAGTGTGGTG CGAGTGCCTTTCTTCAGTCC 
8.4 CGGAGGCAGGAAGATTAAGA ACTCCTGCTGATGGTTGGAC 
12 ACTGTTGGCCAAAGAGAGGA TGGCCTCGAACTCAGAAATC 
13.4 AGAAATGCAAAGCCCCTAGC GCTGGTTGACTGTGTGAGGA 
15.1 GCTGGTTGACTGTGTGAGGA AGAAATGCAAAGCCCCTAGC 
24.2 AGCATCAGGACCAGAATTCAA TATCCTGCACGGTTCACAAA 
33.4 TCCTGGCCTGCTGTAGAGAT ACAATTCTGGAGGGAGGACA 
44.2 AGAAGCACAGGCAGGACCTA GTGGAACGTTAAGGCTGGAA 
48 CTCAATCCGTCTGTGCTGTG CGGACTTCTCCACGAATCAT 
49.35 TTGACCTCCATCCACATGAA AGAGTTTGCCTGGCTGTGTT 
49.7 GCAGGAGTCAGTTCCCAGAG ACTTCCTGCCCAGCTCAGTA 
51.2 CAACTTGGCAACCTCCTCAT ACCTGTGCTTTCTGGAGTGG 
51.4 GGAACACAATCAAGGTCAGGA TGGGCAGAGAGTGGAAAGTT 
53.8 TGTGGCCTGGATCCCTAATA CTCTCCCCACGAATTAACGA 
56 ATGTCCTGAAGGTTGGCTGT TGCTGAATAGGCACTGGTTG 
58.2 TCATTTGTCCTCCCTCCACT GGCAGATCACAGGAACACCT 
64 TACCATCACAAACCGGACAA CTATGGCAGGCAGGAGACAT 
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Primers for Ciita 3C: 
Taq probe [FAM]-AGGTTCAGGGTGGAAGAGAAGGGGGTAG-[BHQ1] 
Distance from anchor (kb) 3C primer Reverse primer 
-40 CGACCACCTTCACCTTCTTT GATCCCAGGATCCACACAGT 
-32 GACCAGCAGGCTCCTACAAA AAGCTCCTCTCTGGGCTTATG 
-24 CCCTACCATCTGGGGAAACT AAAATCTGGGGTGTCCCATT 
-21 TTGCCCATTCTAAGCCTGAC GGAGGGTCCCACCAGTTAGT 
-19 CTGTCATTGCTTGGATCGTC CCTCTAGCTCCTCGAAAGCA 
-6 ACTACCCCGGCTTCTTCTGT CAGCCAGCCAGTCTATGTGA 
Neighbouring fragment CTGTTGGTGGGACTCAGCTT AGTCTGTTGACAGGCTgctg 
Anchor GAACCTCCAGCTGTGAGTAAGA AACCACTGTCATCCGAGGTC 
8 CAACCTAGCCACCTGCCTTC TTCCCGTGGGAGCTAGATAA 
12 AAGATTTCCCTGACCCTGCT GGACACCTTAGGGTTGGTCA 
22 TGTGGTCTCAAAAGCCACTG CACAGAGAAGTGGGGACAGA 
33 AGATTCGGGGGACTTGATCT TAAGGATGGACTGGCAGCAT 
37 CAGGGAGGAAACTCGAACTG GGGGAATGAACCATCTGCTA 
40 GATGCAACCCTACCTGGAGA AGGAGCTTCGACCAGATGAA 
50 TTTCCTACAGCAAACTGCAAA GGGGTTGGTCTGGGAACTAT 
60 ACATGGGCAGGGTCATTTTA GCGATACCGTCCATCTTAGG 
70 GCCAATAAAACCGACTGGAA CGGATCCCTAAAAGGCAAGT 
74 ATCCTGGAAGGACCTCTGGT GCTCTCTCCCATGAGGATCA 
80 AAATTGGAATTCCCTCAcca AACCCAGAGCACAGAACTGG 
 
2.1.3.4 ChIP primers 
For ChIP in ES cells 
Position/Approximate 
distance from TSS Forward primer Reverse primer 
Nanog promoter CCCTTTAAATCTATCGCCTTGA AAGGTTTTAGGCAACAACCAAA 
Nanog enahncer ACTCCAAGGCTAGCGATTCA CTTATCCAGGGAAGCGGTTT 
   
Lefty1 promoter ACTGGTCTCGAGCCAAGAAA AAGACTCGTCCCTGGTGTGT 
Lefty1 enhancer TTGCACAATGGGCTTGATTA GCAGGGTGACAAACTTGGTT 
   
Klf4 p1 (TSS) CGCCTCTTGCTTAATCTTGG TTAGCAAAGGAAGCCCAGAC 
Klf4 p2 (+15kb) TTCCAGTCCAGTCCCAAGTC CCTGGATGGTCTACGTGCTT 
Klf4 p3 (+50kb) CTTGGACACGGTTTTGGTTT ACTGTGATGTGGCTCTGTCG 
Klf4 p4 (+53kb) CAACTTGGCAACCTCCTCAT ACCTGTGCTTTCTGGAGTGG 
Klf4 p5 (+55kb) TGTGGCCTGGATCCCTAATA CTCTCCCCACGAATTAACGA 
Klf4 p6 (+66kb) TCCCTTGCTAGGCGATAATG GGAGCAAGGAACTTGGCTTA 
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For ChIP in fibroblasts: 
Gene   Primer sequence 5'-3' 
Ciita pI 
 F TCCTTCATCCTGGGTCTCAC 
 R GGCTGGAGAGCAGTGTCTGT 
    
Ciita pIII 
 F AAGCTGGAGCTCACCATGTC 
 R AATTGGGTGACCACAGAAGC 
    
Ciita pIV 
 F AGCGCCACAGATACTCCCTA 
 R CAAAGGGGATCTTGGAGACA 
    
Ciita 
enh2 
 F GGCAAAGTCCAGTTCTGAGG 
 R GTGCATTTCCCGTAAGTGGT 
    
Tap1 TSS 
 F AGCTTCCAGAACAGCCTGAG 
 R AGTGCTGGCGTTTAGAGGAA 
    
H-2K1 
TSS 
 F TTCGCGACTTCTGAGTTCTG 
 R CTGGGTCAGGTCCTTCTGTC 
    
CTCF1 
 F CAGCGCTATCCCTAGTGAGC 
 R CAGAAGGTGGCAGTGTGAGA 
    
CTCF2 
 F GTTTTTGAGGGGCTGTGGAG 
 R TGGATGGCTGTGCTTCATAG 
    
CTCF3 
 F AGATGTCCCTCTGCTGCACT 
 R GGAATTTGCCTCATGCTCTC 
    
Oct4 TSS 
 F GGGTGAGAAGGCGAAGTCTGAA 
 R GTGAGCCGTCTTTCCACCAGG 
    
IL4-6 
 F TCCAGTCCAGTTCCAAAAGGAGC 
 R CAGGATGAGGATATGACTAGCTGTGG 
    
17:16298 
 F AGGACATAGTCGCTTGAGTGATGG 
 R TTGGGCCAGGCTGGTACTTT 
    
Xist7Na 
 F TGGCTTGTACTTCCAGATCAT 
 R AATGTATAAGCAAGCTAGTACGCA 
    
Igf2r-2 
 F GGTCTCGCCAGCTTGCTATTTC 
 R TGGCTAGATGTCATTGTGGTGG 
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2.1.4 Genome wide datasets used 
The ES cell ChIP-sequencing datasets: Mediator, Nipbl, Smc1, Rad21 and CTCF from (Kagey 
et al., 2010); p300, H3K4me1, H3K27ac and H3K4me3 from (Shen et al., 2012). ChIP-seq datasets 
for H3K4me1, H3K4me3, Pol II, CTCF in MEFs are from ENCODE (Bing Ren lab). Macrophage STAT1, 
H3K27ac, H3K4me1 and H3K4me3 ChIP-seq datasets are from (Ostuni et al., 2013). preB Rad21 
and CTCF datasets were generated in our lab. Nipbl and p300 ChIP-seq datasets in activated B 
cells are from (Yamane et al., 2011). ES cell and B cell ChIA-PET datasets are from (Kieffer-Kwon 
et al., 2013). 
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2.2 Methods 
2.2.1 Cell culture 
2.2.1.1 Mouse ES cells in 2i media 
ERT2Cre-Rad21WT/WT (A7 cell line) and ERT2Cre-Rad21lox/lox (A4 cell line) mouse ES cells were 
maintained undifferentiated in N2B27 medium containing 2i and LIF. The composition of N2B27 
+ 2i is as follows: Neurobasal media supplemented with 50% v/v DMEM:F12 media, 0.5% v/v N2 
supplement. 1% v/v B27 supplement, 2mM L-glutamine, antibiotics (100U/ml penicillin/ 
100μg/ml streptomycin) and 100μM β-mercaptoethanol (all from Life Technologies, NY, USA). 
Chemical inhibitors (Ying et al., 2008) were then added at a final concentration of 1μM 
(PD032590) and 3μM (CHIR99021) (Stemgent, MA, USA). Cells were cultured on vessels pre-
coated with 10ng/ml Laminin (Invitrogen) for 2-4 hours. Approximately 0.5x106 cells were plated 
in a well of a 6-well dish. Fresh media was added every day and cells were split as required every 
two days.  
For Rad21 deletion experiments, cells were trypsinised and 0.5x106 cells were replated in a 
laminin coated 6-well plate. The trypsinised cells were used as 0 hour sample. The activity of the 
Cre recombinase was induced by the addition of 100nM 4’-Hydroxytamoxifen (4’-OHT) to culture 
media. Fresh media supplemented with 4’-OHT was added after 36 hours.  
For differentiation, 0.4x106 ES cells were plated on laminin coated plates and cultured in 
N2B27-2i neural differentiation media having the same composition as N2B27 media except with 
twice as much N2 and B27 supplements in the absence of 2i and LIF.  
2.2.1.2 Mouse ES cells in serum media 
ERT2Cre-Rad21WT/WT (mA7 cell line) and ERT2Cre-Rad21lox/lox (mA4 cell line) mouse ES cells 
were maintained in Knockout Dulbecco’s Modified Eagle Medium (KO DMEM) (Life Technologies, 
NY, USA) supplemented with 10% v/v FCS (Life Technologies, NY, USA), 2mM L-glutamine, 
antibiotics (100U/ml penicillin/ 100μg/ml streptomycin), 50μM β-mercaptoethanol, 1mM non-
essential amino acids (NEAA) (Life Technologies, NY, USA) and 1000U/ml leukaemia inhibitory 
factor (LIF). Cells were cultured on vessels coated with 0.1% gelatin (Sigma-Alrich, MA, USA). 
Materials and Methods 
 
79 
 
2.2.1.3 Mouse preB cells 
The Abelson transformed mouse preB cell lines expressing ERT2Cre recombinase and Bcl2 
transgene ( preB ERT2Cre-Rad21lox/WT and preB ERT2Cre-Rad21lox/lox ) were grown in IMDM 
(Iscove’s modified Dulbecco’s medium), 10% v/v FCS (Biosera), 2mM L-Glutamine, 50μM β-
mercaptoethanol and antibiotics (100U/ml penicillin/ 100μg/ml streptomycin) (all reagents from 
GIBCO, Invitrogen). 
2.2.1.4 Preadipocytes 
Transformed Mll3-/-Mll4fl/fl preadipocyte cell lines stably transfected with either GFP or Cre 
expressing adenoviral vector (Mll3-/-Mll4fl/fl + Ad-GFP and Mll3-/-Mll4fl/fl + Ad-Cre preadipocytes) 
were cultured in DMEM supplemented with 10% FCS, 2mM L-Glutamine, 50μM β-
mercaptoethanol and antibiotics (100U/ml penicillin/ 100μg/ml streptomycin) (all reagents from 
GIBCO, Invitrogen). Cells were cultured in 6-well plates and did not require gelatin coating. 
2.2.2 Extraction and culture of MEFs 
Pregnant mice were sacrificed at 13 or 14 d.p.c. (day post-coitum) by cervical dislocation. 
The uterine horns were dissected out, briefly rinsed in 70% (v/v) ethanol and place into a 50 ml 
Falcon tube containing PBS without Ca2+Mg2+ (Gibco, Invitrogen). The following steps were 
carried out in a tissue culture hood under aseptic conditions and using sterile instruments. Uterine 
horns were placed into a Petri dish and each embryo was separated from its placenta and 
embryonic sac. Head and red organs were removed from each embryo. All embryos were washed 
in PBS and placed in a clean Petri dish on ice. The tissue was finely minced using a sterile razor 
blade until they became possible to pipette. The minced tissue was suspended in fresh MEF 
medium [450 ml of DMEM, 50 ml of FCS (10% (v/v)), 5 ml of 200 mM L-glutamine (1/100 (v/v)), 5 
ml of Penicillin-streptomycin (1/100 (v/v)]. 1 ml of 0.05% trypsin/EDTA (Gibco, Invitrogen) was 
added to the suspension, along with 100K units of DNase I (USB), per embryo. The tissue was 
transferred into a 50 ml Falcon tube and incubated for 15 min at 37 °C. After each 5 min of 
incubation, cells were dissociated by pipetting up and down thoroughly. The trypsin was 
inactivated by adding about 1 volume of freshly prepared MEF medium. The cells were 
centrifuged at low-speed (1200 rpm or 210g), 5 min, and the supernatant was carefully removed. 
The cell pellet was resuspended in warm MEF medium and plated on a 10cm dish. Fresh media 
was added the next day and confluent cells were split and frozen for future use (passage P0). 
These MEFs were cultured in serum containing MEF media (DMEM+ 10% FCS) in a low oxygen 
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incubator (5% CO2, 3% O2). These primary MEFs can be expanded in culture for upto 5-6 passages 
after which they start senescing and eventually stop dividing. For serum starvation, the MEFs were 
cultured in DMEM supplemented with 1% FCS and 5 ml of Penicillin-streptomycin (1/100 (v/v). 
2.2.3 RNA extraction and cDNA synthesis 
RNA extraction was performed using the QIAshredder and RNeasy Mini kits (Qiagen, 
Valencia, CA), and residual DNA was eliminated using DNA-free kit (Ambion) according to 
manufacturer’s instructions. 
RNA was then reverse transcribed using SuperscriptTM First-Strand Synthesis system 
(Invitrogen). 1ug of total RNA was diluted in RNase free water to a final volume of 11uL and 
supplemented with 1uL of 10mM dNTP mix (Invitrogen) and 1uL of oligo (dT) (Invitrogen). The 
mixture was incubated at 65°C for 5 min and put on ice for 1min, when 1 uL of 0.1M DTT, 4uL of 
5X first strand buffer, 1uL of RnaseOUT (Invitrogen) and 1uL of 200 U/uL Superscript III were 
added. A reaction mixture without the enzyme was also set up as a control (designated “-RT”). 
The mixture was incubated at 25°C for 5 min, at 50°C for 1 h and at 75°C for 15 min. cDNAs of 
interest were then detected by real-time quantitative PCR. 
2.2.4 Real-time quantitative PCR analysis (RT-qPCR) 
Real-time quantitative PCR (RT-qPCR) of cDNA was carried out on an OpticonTM DNA 
engine using Opticon Monitor 3 software (MJ Research Inc.) under the following cycling 
conditions: an initial denaturating step at 95°C for 15 min, 40 cycles of denaturation at 94°C for 
15 sec, annealing at 60°C for 30 sec, elongation at 72°C for 30sec at which point the fluorescence 
was read at 72°C, 75°C, 78°C and 83°C. The melting curve was determined from 70°C to 90°C, at 
0.2°C intervals. PCR reactions included 2X Syber-Green PCR Mastermix (Qiagen), 1uM primers and 
1uL of template in a 10uL reaction volume. A reaction without DNA was included to control for 
the formation of primer dimmers and each measurement was performed in duplicate. The RT-
qPCR data analysis was performed with the Opticon Monitor 3 software and the relative 
abundance of sequences was calculated using the ΔΔC(T) method. The primer amplification 
efficiencies of all primers were tested and confirmed on serial RNA dilutions to be equivalent and 
close to 2. When the amplification efficiency is close to 2, the relative amount of PCR products 
between reactions 1 and 2 can be calculated as 2-ΔC(T)1/2-ΔC(T)2, C(T) being the threshold cycle at 
which fluorescence due to PCR products becomes detectable above background. Ywhaz and Ubc 
were generally used for gene expression data normalisation.  
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RT-qPCR of ChIP samples were carried out as the cDNA RT-qPCR except that 0.5uL of DNA, 
2x SYBR-Green PCR Mastermix (BioRad, Bio Rad Laboratories Inc., Waltham, MA) and a 3min 
enzyme activation period were used instead.  
All experiments were performed atleast as ‘n’ independent biological replicates with each 
sample being analysed on the PCR in duplicates. 
2.2.5 Genomic DNA extraction and genomic PCR 
One million cells or mouse tails for genotyping were lysed by resuspension in 100μl of lysis 
buffer (100mM Tris-Cl pH 8.5, 5mM EDTA, 0.2% SDS, 200mM NaCl, 100µg/ml Proteinase K), 
followed by overnight incubation at 65°C. DNA was then precipitated by an equal volume of 
isopropanol. Genomic DNA was amplified using 1U of HotStarTaq™ DNA Polymerase (Qiagen) in 
a final reaction volume of 10μl, with 1 X HotStarTaq™ buffer (Qiagen), 0.2mM dNTPs (Life 
Technologies, Invitrogen), 0.2mM primers, and 1μl DNA as prepared above. PCR amplification was 
performed using the following cycle: 15 minutes at 95°C, followed by 40 cycles of denaturation at 
95°C for 30 seconds, primer annealing at 55°C for 30 seconds, and elongation at 72°C for 30 
seconds. PCR products were separated by electrophoresis on 1% agarose gels and visualised by 
ethidium bromide staining. 
2.2.6 Western Blot 
Whole cell extracts were prepared by direct lysis of cells (5min at 95°C and subsequent vortexing) 
in protein sample buffer (50mM Tris-HCl pH6.8, 1% SDS, 10% glycerol, 0.001% Bromophenol Blue, 
5% β-mercaptoethanol) (Laemmli, 1970). 1x106 cells were resuspended in 100µl 1x sample buffer. 
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) was carried out with the 
Bio-Rad minigel system. 15-25µl of protein sample and the benchmark pre-stained protein ladder 
(Invitrogen) were loaded on an acrylamide (BioRad) stacking gel [4% (w/v) acrylamide, 0.125M 
Tris (pH6.8), 0.1% (w/v) SDS, 0.1% (w/v) ammonium persulphate, and 0.1% (v/v) N,N,N’,N’-
tetramethylethylenediamine and separated in a 8% or 10% acrylamide resolving gel [8% or 10% 
(w/v) acrylamide, 0.4M Tris (pH8.8), 0.1% (w/v) SDS, 0.1% (w/v) ammonium persulphate, and 
0.1% (v/v) N,N,N’,N’-tetramethylethylenediamine using Tris-glycine electrophoresis buffer [1.5% 
(w/v) Tris, 7.2% glycine, 0.5% (w/v) SDS]. Resolved gels were blotted onto a Protran nitrocellulose 
transfer membrane (Schleicher & Schuell Bioscience) in transfer buffer (48mM Trizma base(pH 
9.2), 39mM glycine, 0.037% (w/v) SDS and 20% (v/v) methanol) using the trans-blot semi-dry 
electrophoretic transfer apparatus (BioRad). The membranes were incubated for 30min with 
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blocking buffer [5% (w/v) milk powder (Marvel), 1.2g/L Tris pH7.4, 8.75g/L NaCl] followed by 
primary antibody incubation diluted in blocking buffer for 2h at room temperature, with agitation. 
After washing 3 times in wash buffer [1.2g/L Tris pH7.4, 8.75g/L NaCl] for 10min, blots were 
incubated with horseradish peroxidise-coupled secondary antibodies in blocking buffer for 1h at 
room temperature. The secondary antibodies used were anti-mouse HRP (1:2000, GE Healthcare), 
anti-rabbit HRP (1:5,000, GE Healthcare). Detection was done with the ECL-Plus western blotting 
detection kit (Amersham, Amersham Pharmacia Biotech, Little Chalfont, UK) following 
manufacturer’s instructions and using Kodak X-Omat photographic films. 
For quantitative Western blot, resolved gels were blotted onto PVDF membranes instead 
of nitrocellulose membranes. Before use, the PVDF membranes were preincubated in methanol 
for 30 secs and subsequently soaked in MiliQ water for 1 min and transferred into transfer buffer 
for 5 min. Blocking was done using Rocklands blocking buffer MB-070 (proprietary protein 
formulation in TRIS buffered saline at pH 7.6). Rest of the procedure was similar as described 
above. Fluorescently labelled secondary antibodies were used for detection. Signals were 
quantified by the Odyssey Imaging system (LI-COR biosciences). 
2.2.7 Immunofluorescence (IF) 
Sterile glass coverslips were placed in 6-well plates and cells were cultured onto these 
coverslips. At appropriate time points samples were fixed with 4% paraformaldehyde (PFA) in PBS 
for 15 minutes at room temperature. Fixed samples were washed in PBS and, for intracellular 
staining, samples were permeabilised with 0.5% Triton X‐100 for 5 min. Samples were incubated 
sequentially in blocking solution [3% Normal Goat Serum (Vector), 0.1% Triton X-100 in PBS] for 
30 min at room temperature in a humid chamber. Primary antibody was diluted in blocking 
solution at specific dilutions (see section 2.1.1) and added to the samples for 2h at room 
temperature or incubated overnight at 4°C in a humid chamber. Coverslips were washed 3 times 
in PBS and incubated with secondary antibodies coupled with appropriate fluorophores 
(Molecular Probes) that were diluted in blocking solution for 1h at room temperature in a dark 
humid chamber. Cells were then washed twice in PBS and mounted in Vecatshield (Vector 
Laboratories, Peterborough, UK) with DAPI (0.1μg/ml). Samples were visualised using a TCS SP5 
Leica laser scanning confocal microscope. Images were processed using Leica Confocal software 
and ImageJ. Microscope settings and laser power were kept constant between controls and 
samples. 
 
Materials and Methods 
 
83 
 
2.2.8 Inter-species heterokaryon formation - Cell Fusion 
Cell fusion experiments were performed as described previously (Pereira et al., 2008). Inter-
species heterokaryons can be generated by cell fusion of adherent ES cells and lymphocytes (non-
adherent cells). The resulting heterokaryons will attach to gelatin coated dishes. Heterokaryons 
(cells in which parental nuclei share the same cytoplasm but remain discrete) were cultured under 
conditions that promote mES self-renewal. Briefly, mES and hB cells were mixed at a ratio 1:1 and 
washed twice in PBS. The supernatant was completely removed and 1mL of pre-warmed 
polyethylene glycol (PEG) (Sigma) was added to the pellet of cells over 60 sec. The mixture was 
incubated at 37°C for 90 sec with constant stirring. Then 4mL of serum-free medium (DMEM; 
Invitrogen) were carefully added over a period of 3 min, followed by 10mL of DMEM and 
incubation at 37°C for 3 min. After centrifugation (1350 rpm or 275g, 5 min), the pellet was 
allowed to swell in complete medium for 3 min. Cell mixtures were then resuspended and 
cultured under conditions promoting the maintenance of undifferentiated mES cells at 0.5x106 
cells/cm2. Non-fused mES cells were eliminated by the addition of puromycin (1.5 μg/ml 
puromycin; Sigma) 6-12 hours after fusion onwards.  
2.2.9 EdU labelling 
One day after fusion, heterokaryons were pulse labelled with 10μM EdU for 45 minutes. 
Samples were fixed in 4% PFA in PBS for 10min and permeabilised in 0.5% Triton-X100 (Sigma) in 
PBS. Washing steps were performed in 3% BSA in PBS. EdU was detected with the Click-iTTM EdU 
Alexa Fluor 647 HCS Assay kit (MolecularProbes, Invitrogen) according to the manufacturer’s 
instructions. 
2.2.10 Cell cycle analysis – Propidium Iodide staining 
Cells were collected, counted, and up to 1x106 cells were fixed by resuspension in 1ml of 
70% EtOH. For propidium iodide (PI) staining, fixed cells were resuspended in PI buffer (PBS-/- 
supplemented with 50μg/ml propidium iodide (Sigma), 1mg/ml RNase A (Life Technologies, 
Invitrogen), and 0.05% v/v NP40 (Calbiochem, Merck Millipore) and incubated on ice for 20 
minutes. Cells were analysed using a FACSCalibur™ flow cytometer. Data were analysed using 
FlowJo software. 
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2.2.11 Fluorescence activated cell sorting (FACS) analysis 
2.2.11.1 Cell surface marker analysis  
Each antibody was resuspended in wash buffer at a 1:100 dilution. Up to 1 x 106 cells were 
resuspended in 50μl of the wash buffer + antibody, and incubated for 20 minutes at room 
temperature in the dark. Cells were then washed once in PBS -/- by centrifuging the cells for 5 
minutes at 12000 rpm or 13000g, removing the antibody solution, resuspending in wash buffer, 
and centrifuging again. Cells were then resuspended in wash buffer for further analysis. Cells were 
analysed using a FACSCalibur™ flow cytometer. Data were analysed using FlowJo software. 
2.2.11.2 Sorting GFP expressing cells 
To sort GFP positive fibroblasts transfected with MSCV-IRES-GFP (MIG) or MSCV-IRES-Cre-
GFP vector, cells were resuspended in FACS buffer (10% FCS in PBS-/-) and subjected to a FACS 
purification using the FACSAria cell sorter (BD Biosciences). 
2.2.12 Bacterial transformation 
BAC DNA or plasmid vector DNA was added to 20μl of 5x KCM buffer (0.5M KCl, 0.15M 
CaCl2, 0.25M MgCl2) and the total volume was adjusted to 100μl with H2O. 100μl of competent 
DHS5α bacteria (Invitrogen) was added to the mixture and incubated on ice for 20 minutes, and 
then at room temperature for 10 minutes. Transformed bacteria were plated into Lysogeny Broth 
(LB) agar supplemented with 50μg/μl of ampicilin and incubated overnight at 37°C. Individual 
colonies were picked and transferred to 3mL of LB broth with ampicilin and left overnight at 37°C 
with agitation. DNA was extracted from exponentially growing cultures with Maxipreps kits 
(Qiagen) according to manufacturer’s instructions. 
2.2.13 293T transfection and virus production 
The pMIG or the Cre-GFP retroviral vector were co-transfected with pCL-Eco (packing 
vector) into 293T cells using a calcium phosphate protocol. Briefly, DNA-containing precipitates 
were formed by slowly adding 500μL of 2x HEBS buffer (280nM NaCl, 10mM KCl, 1.5mM 
Na2HPO4.2H2O, 12mM glucose, 50mM HEPES free acid, pH 7.05 in distilled water) to 500μL of a 
0.4M CaCl2 solution containing 4μg of MSCV plasmid DNA and 4μg packing vector DNA. 1mL of 
DNA precipitate was slowly added to a 40-60% confluent 293T cells cultured in 9mL medium in a 
10cm dish. Cells were fed with fresh media 24h post-transfection and supernatant containing 
retrovirus particles were harvested 48, 60 and 72 hours post-transfection and pooled. 
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2.2.14 Retroviral transduction of fibroblasts 
Confluent fibroblast-like cells were trypsinised and about 0.5x106 cells were plated in each 
well of a 6-well plate.  1ml virus supernatant supplemented with 4μg/mL polybrene and 10mM 
HEPES pH 7.6 (both from Sigma) was added to each well and cells were centrifuged at 900g for 1h 
and 30minutes at 37°C. Cells were then incubated for 4 hours at 37°C when the virus supernatant 
was replaced by fresh MEF media. 
2.2.15 Cell fractionation 
To prepare total cell extracts, tissue-cultured cells were harvested by centrifugation, 
washed in PBS, and directly resuspended in protein sample buffer ( or Laemmli buffer). To isolate 
chromatin, cells were resuspended (4 × 107cells/ml) in buffer A (10 mM HEPES, [pH 7.9], 10 mM 
KCl, 1.5 mM MgCl2, 0.34 M sucrose, 10% glycerol, 1 mM DTT, 5 μg of aprotinin per ml, 5 μg of 
leupeptin per ml, 0.5 μg of pepstatin A per ml 0.1 mM phenylmethylsulfonyl fluoride). Triton X-
100 (0.1%) was added, and the cells were incubated for 5 min on ice. Nuclei were collected in 
pellet 1 (P1) by low-speed centrifugation (4 min, 1,300 × g, 4°C). The supernatant (S1) was further 
clarified by high-speed centrifugation (15 min, 20,000 × g, 4°C) to remove cell debris and insoluble 
aggregates. Nuclei were washed once in buffer A, and then lysed in buffer B (3 mM EDTA, 0.2 mM 
EGTA, 1 mM DTT, protease inhibitors as described above). Insoluble chromatin was collected by 
centrifugation (4 min, 1,700 × g, 4°C), washed once in buffer B, and centrifuged again under the 
same conditions. The final chromatin pellet (P3) was resuspended in Laemmli buffer and 
sonicated for 15sec in a Diagenode sonicator at high intensity. 
2.2.16 Alkaline Phosphatase staining 
Cells were stained for Alkaline phosphatase using the 86-R kit from Sigma following 
manufacturer’s specifications with the following modifications. Briefly, cells were fixed in fixing 
buffer (4.5mM citric acid, 2.25mM sodium citrate, 3mM NaCl, 65% methanol, 4% 
paraformaldehyde) for 15 mins at RT. Fixed cells were rinsed in water and sufficient amount of 
Alkaline-dye mixture ( 1ml Sodium Nitrite solution, 1ml FRV-Alkaline solution, 45ml dH20, 1ml 
Naphthol As-B1 alkaline solution) was added to cover the cells. Cells were incubated at RT for 
15min, away from direct light. Dye mixture was discarded and cells were rinsed with dH2O. 
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2.2.17 Chromatin immunoprecipitation (ChIP) 
2.2.17.1 ChIP in ES cells 
50-100 million cells were harvested by trypsinisation, resuspended in 40ml Serum ES media 
and crosslinked with 1% formaldehyde (0.33M) for 10min at 37°C. After quenching of 
formaldehyde with glycine (both from Sigma) at a final concentration of 125mM for 5min at room 
temperature, cells were washed twice with icecold PBS. Cells were pelleted at 2000rpm for 5min 
at 4°C. Pellets were frozen in dry ice and stored at -80°C for later use.  
Upto 50 million cells were resuspended in Sonication buffer (20mM Tris-HCl pH8, 150mM 
NaCl, 2mM EDTA, 0.1% SDS, 1% Triton X-100) and lysed on ice for 15 mins. All buffers are 
supplemented with protease inhibitor cocktail (Roche, West Sussex, UK) The suspension was 
transferred to polypropylene 15ml Falcon tubes for sonication. Using a Bioruptor (Diagenode, 
Denville, NJ, USA), the chromatin was sonicated for 20min at 4°C to achieve an average size of 
500-1000bp running the settings: output-high, 30sec ON and 30 sec OFF. Chromatin fragment size 
was assessed on 1% agarose gel by running 4uL of sonicated chromatin (supplemented with 2uL 
5% N-lauroylsacrosine, 2uL methyl-orange DNA loading buffer and 2 uL of PBS). Insoluble proteins 
were discarded after centrifugation of the lysate at 14,000 rpm for 30min, at 4°C and DNA 
concentration was quantified by spectrophotometry (NanoDropR ND-1000). 
100µl of protein G magnetic Dynabeads (Sigma) were rinsed twice in 1mL of ice cold 
Sonication buffer. Washed beads were incubated with required amounts of antibody for 4hrs at 
4°C on a rotator. Beads coupled with antibody were again washed twice with sonication buffer 
before an incubation with the chromatin sample.  
Fragmented chromatin (150μg DNA per IP) was diluted to a final volume of 500μl in 
Sonication buffer. 1% (v/v) input sample was collected from the diluted chromatin sample. The 
chromatin samples were then added to Dynabeads coupled with primary antibody and incubated 
at 4°C overnight. Mouse IgG antibody was used as negative control. The 
antibody/bead/chromatin ratio used for different ChIPs is as follows: an equivalent of 50µl beads 
coupled to Rad21 (20µg ab992 antibody), Nipbl (10µg A301-779A antibody) were incubated with 
150µg chromatin in 500µl IP volume. For CTCF ChIP, an equivalent of 25µl beads coupled to 5µg 
CTCF antibody (ab70303) were incubated with 150µg chromatin in 500µl IP volume. 
On the next day, beads were washed 1X with the sonication buffer, 1X with 20mM Tris-HCl 
pH8, 500mM NaCl, 2mM EDTA, 0.1% SDS, 1%Triton X-100, 1X with 10mM Tris-HCl pH8, 250nM 
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LiCl, 2mM EDTA, 1% NP40 and 1X with TE containing 50 mM NaCl. Finally, the samples were 
reverse-crosslinked in 450 μl Elution Buffer (50 mM Tris-HCl, pH 8.0, 10 mM EDTA and 1% SDS, 
220 μg proteinase K and 50 μg RNaseA) for 2 hours at 37°C and overnight at 65°C, shaking at 
1000rpm for 30sec intervals every minute. DNA was sequentially extracted with 
phenol/chloroform/isoamylalcohol and precipitated in EtOH, NaAc and 150µg/ml of glycogen 
carrier (Glycoblue; Ambion, Austin,TX) for 1hr at -80°C. After centrifugation at 14000rpm (13750g) 
for 30min at 4°C, pellets were washed with 70% EtOH and resuspended in 100μl H2O. 1μl of ChIP 
DNA was used per qPCR reaction. 
2.2.17.2 ChIP in MEFs 
About 5-10 million fibroblasts were fixed in a 15cm dish. Media in the dishes was adjusted 
to a known volume and formaldehyde was added directly to the media to a final concentration of 
1%. The dishes were incubated at 37°C for 10 mins. After this, glycine was added to a final 
concentration of 125mM to quench the formaldehyde fixation at RT for 5 min. Subsequent 
procedures were performed on ice. The cells were washed 3x with ice-cold PBS directly in the 
flasks/dishes they were grown in. The PBS was removed and sufficient amount of Swelling buffer 
(25mM HEPES pH7.9, 1.5mM MgCl2, 10mM KCl, 0.1% NP40) was added to cover the cells and 
incubated at 4°C for 10 min. Cells were collected by scraping and dounce homogenised with a 
‘tight’ pestle (50 strokes). Nuclei were collected by centrifugation at 3000xg, 4°C, 5min. The 
pelleted nuclei were stored at -80°C for later use. The pellet containing 5-10 million nuclei was 
resuspended in 500µl RIPA buffer (50mM HEPES pH 7.9, 140mM NaCl, 1mM EDTA, 1% Triton X-
100, 0.1% Na-deoxycholate, 0.1% SDS). Swelling and RIPA buffers were supplemented with 
phosphatase and protease inhibitors. The chromatin was sonicated as described in 2.2.17.1. The 
beads were coupled to antibody as described in 2.2.17.1 but using RIPA buffer.  
The rest of the steps were performed similarly to 2.2.17.1 with the following modifications. 
For histone ChIP, 1µg each of H3 and H3K4me3 antibody was coupled to an equivalent of 10µl 
beads which were then incubated with 10µg chromatin in a total IP volume of 200µl. For 
Polymerase ChIP, antibodies against total Pol II (10µg sc-H224), Ser5-Pol II (2.5µg CTD4H8) and 
Ser2-Pol II (10µg 3E10) were coupled to an equivalent of 10µl beads which were then incubated 
with 100µg chromatin in a total IP volume of 200µl. On the next day, beads were washed 1X with 
the RIPA buffer, 1X with high-salt RIPA buffer (50mM HEPES pH8, 500mM NaCl, 1mM EDTA, 0.1% 
SDS, 1%Triton X-100, 0.1% Na-deoxycholate), 1X with LiCl-RIPA (20mM Tris-HCl pH8, 250mM LiCl, 
1mM EDTA, 0.5% NP40, 0.1% Na-deoxycholate), and 1X with TE containing 50 mM NaCl.  
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Rad21 and CTCF ChIP in fibroblasts was performed as described in 2.2.17.1 except 5µg 
ab154769 was used instead of ab992. 
2.2.18 Chromosome Conformation Capture 
2.2.18.1 Testing chromatin digestion efficiency 
Forward and reverse 20-24mer primers with a Tm range of 60-65°C amplifying a region of 
100-300bp were designed spanning the restriction digestion sites of interest. The primers were 
tested on 2-fold serial dilutions of gDNA (starting conc. 20ng).  
The chromatin samples were digested following the 3C protocol until day 1 and then 
samples were decrosslinked overnight. Digestion efficiency was calculated by PCR amplifying DNA 
from digested and undigested chromatin samples using these primers. SDS and enzyme 
concentration were optimised to yield uniformly high digestion efficiencies across all the tested 
sites at a particular locus.  
2.2.18.2 Designing and testing 3C primers 
BACs spanning the genomic region of interest were purified and 15µg of BAC DNA was 
digested overnight 37°C with the restriction enzyme of interest. The digested BAC fragments were 
isolated by phenol/chloroform extraction. These fragments were resuspended in 10µl water and 
quantified using Nanodrop. 2.5µg BAC DNA was religated at RT for 2 hrs with 400U T4 DNA ligase. 
The religated BAC was purified and resuspended in 20µl volume. BAC concentration was 
measured using Picogreen. 10 fold dilutions of this BAC product were prepared for testing the 
amplification efficiency of each pair of 3C ‘bait’ primer and ‘anchor’ primer.   
The Taqman Probe is designed to be about 30 nucleotides long with a Tm ranging from 68-
75°C. The FAM fluorophore is attached at the 5’end while the 3’ end is covalently attached to the 
quencher BHQ. The probe hybridises to the opposite strand of the PCR products. 
2.2.18.3 3C experiment 
Cells were fixed in 10% FCS, 1% formaldehyde for 10 minutes at room temperature and 
fixation was stopped with glycine (0.125M). 107 cells per sample were lysed in 10mM Tris, pH8, 
10mM NaCl, 5mM MgCl2, 0.2% NP-40 for 30 min on ice. The nuclei were pelleted and re-
suspended in 0.5ml 1.2x digestion buffer (NEB2, New England Biolabs) and permeabilised with 
SDS (0.3% final concentration) for 1 hr at 37°C, shaking at 800rpm and 3.3% Triton X-100 were 
added for an additional 1 hour at 37°C. Required amount of enzyme (New England Biolabs) was 
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added before incubation over night at (37°C, 800rpm) and inactivated with SDS (1.5%, 65°C, 30 
min). The reaction was diluted in 6.2ml 1.1x T4 ligase buffer (New England Biolabs) and incubated 
at 37°C for 1h after addition of 1% Triton X-100. 800U T4 DNA ligase (New England Biolabs) was 
added for 4 hrs at 16°C, crosslinking was reversed by 300μg proteinase K (65°C, 16h). 300μg RNase 
A was added for 1h at 37°C. DNA was isolated by phenol/chloroform extraction and ethanol 
precipitation, quantified using Quant-iT PicoGreen (Invitrogen) and 200ng DNA were used per 
TaqMan PCR reaction (QuantiFast, Qiagen). Data were normalised to the cross-linking frequency 
between the anchor and the neighbouring fragment. The distance of the fragment of interest was 
calculated as the distance between the centre of the anchor fragment and the centre of the 
digested fragment corresponding to the respective reverse primer used for PCR amplification. 
The following digestion setup was used for the different genes analysed: Nanog, Lefty1 
locus - 1500U DpnII enzyme (overnight digestion at 37°C). Klf4 locus - 2500U PvuII enzyme (750U 
for 2hrs + 750U overnight + 1000U for 4hrs). 0.3% SDS was used for permeabilisation in ES cells. 
For the Ciita 3C, fibroblasts were permeabilised with 0.5% SDS and digested with 1000U NcoI 
enzyme (250U for 2hr + 250U O/N + 500U for 4hr).  
Chapter 3 
 
90 
 
Chapter 3 : Role of cohesin in regulating the expression of 
pluripotency associated genes 
Embryonic stem cells possess the remarkable properties of self-renewal and pluripotency. 
Thier unique gene expression profile enables them to continually propagate in the pluripotent 
state and be poised to execute a broad range of developmental programmes. As discussed in 
Section 1.4.2, cohesin subunits have been identified in RNAi screens performed in ES cells, as 
factors required for the maintenance of pluripotency and self-renewal (Ding et al., 2009; Hu et 
al., 2009; Kagey et al., 2010; Nitzsche et al., 2011). However, it is not clear from these studies 
whether the requirement for cohesin stems from its direct involvement in regulation of 
pluripotency genes, or is an indirect effect of the loss of its functions in cell division.  
RNAi mediated knockdown approach requires the culture of ES cells for relatively long 
periods of time to obtain a substantial reduction in cohesin proteins. Consequently, Kagey et al., 
(2010) evaluated gene expression changes in ES cells after 5 days of Smc1 depletion. This 
approach is problematic because ES cells are rapidly dividing cells, and depletion of cohesin for 
such an extended period of time will significantly affect cell cycle progression. Therefore, 
prolonged depletion of cohesin in ES cells will cause activation of stress response pathways and 
result in indirect effects on gene expression. For example, p53 activation in ES cells, in response 
to upstream stress signals, supresses Nanog expression and triggers ES cell differentiation (Lin et 
al., 2005; Maimets et al., 2008; Li et al., 2012). Thus, in order to discern the role of cohesin in 
regulating pluripotency, it is critical to avoid stress induced secondary effects on gene expression. 
Moreover, as discussed previously in Section 1.4.1, conventional ES cell cultures in Serum + LIF 
media display heterogeneous expression of some pluripotency genes and contain a sub-
population of ES cells more prone to differentiation. Hence, it is likely that by the fifth day of 
cohesin knockdown, many of the fast dividing ES cells have died and there is an experimental bias 
to enrich for the slow dividing differentiated cell population. This would further falsely accentuate 
the impact of cohesin depletion on pluripotency. These concerns have been substantiated by 
Gene Ontology (GO) analysis of the microarray dataset from Kagey et al. (2010) by our lab, which 
revealed a significant enrichment for DNA repair and cell stress related pathways (Figure 3.5B, 
left panel) (Mira-Bontenbal, 2011). This indicates that the knockdown methodology is not the 
ideal strategy to investigate the direct role of cohesin in regulation of gene expression in ES cells. 
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In order to overcome these limitations and to truly understand how cohesin regulates gene 
expression, our lab developed an ERT2Cre-lox conditional knockout system for the Rad21 subunit 
of the cohesin complex. LoxP sites flank exons 5 and 6 of the Rad21lox allele while Cre 
recombinase, targeted to the ubiquitously expressed Rosa26 locus, is expressed as a fusion 
partner to the ligand binding domain of a mutated tamoxifen-specific estrogen receptor 2 (ERt2). 
The ERt2-Cre fusion protein remains in the cytoplasm, but translocates to the nucleus after 
addition of 4’hydroxy-tamoxifen (4’OHT). Upon nuclear translocation, Cre excises exons 5 and 6 
of Rad21 gene, which is sufficient to completely inactivate the Rad21 protein. Using this strategy, 
our lab derived ERT2Cre-Rad21lox/lox and ERT2Cre-Rad21WT/WT mouse ES cells in defined N2B27 
media supplemented with LIF and 2i. The use of 2i allows ES cells to be maintained in a ground 
state of pluripotency (Ying et al., 2008; Wray et al., 2010) and enables us to study the impact of 
cohesin depletion in a more uniform ES cell population. 
Using these ES cells, which can be conditionally and rapidly depleted of Rad21, I aim to 
ascertain the role of cohesin in regulating the gene expression programme of pluripotent cells 
independently of its essential functions in cell division. I further intend to gain a mechanistic 
insight into cohesin’s mode of action as a gene regulator by assessing its role in mediating long-
range enhancer-promoter interactions at some key pluripotency associated genes. 
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3.1 The conditional knockout system allows rapid and acute 
depletion of RAD21 within 24 hours 
In order to identify a suitable time for the investigation of the impact of cohesin depletion 
on pluripotency in the absence of any secondary effects due to activation of stress, an in depth 
analysis and characterisation of cohesin depletion was carried out in the conditional ERT2Cre-
Rad21 ES cells by using the following experimental setup (Figure 3.1). ERT2Cre-Rad21lox/lox and 
ERT2Cre-Rad21WT/WT mouse ES cells were treated with either 100 nM 4’OHT to induce deletion of 
the loxed Rad1 allele or with an equivalent volume of 100% ethanol (carrier control) after plating 
the cells and samples were collected for analysis after 24, 36 and 48 hrs. In parallel, ERT2Cre-
Rad21lox/lox ES cells were subjected to differentiation by growing them in N2B27 media without 
LIF and 2i. In the absence of LIF and 2i, retinoic acid present in the N2B27 media induces rapid 
differentiation of ES cells (Ying et al., 2003b). These differentiated cells were used to compare the 
extent of differentiation caused by cohesin depletion during the same time span. ERT2Cre-
Rad21lox/lox ES cells treated with the DNA damage inducing agent doxorubicin (0.5 µM for 6 hours) 
were used as a positive control for the effect of stress on changes in gene expression. 
 
 
Figure 3.1 Schematic outline of the experimental setup. ERT2Cre-Rad21lox/lox ES cells were treated with 
100nM 4’OHT to induce Cre mediated knockout of the Rad21 allele or ethanol as the carrier control. In 
parallel, cells were plated in N2B27 media lacking 2i to induce differentiation. To control for any discrete 
effects of tamoxifen, ERT2Cre-Rad21WT/WT ES cells were also treated with tamoxifen and ethanol. As a 
positive control for the effect of stress on gene expression, cells were treated with .5µM Doxorubicin for 6 
hours. Cells were trypsinised and collected for experiments at 0, 24, 36 and 48 hour time points. 
The kinetics of cohesin depletion post 4’OHT treatment were monitored by analysing the 
deletion of the Rad21 allele and the loss of Rad21 mRNA transcript and protein levels in the 
ERT2Cre-Rad21 ES cells. qPCR on genomic DNA samples showed that the loxed Rad21 allele is 
completely deleted by 24 hours (Figure 3.2B). RT-qPCR analysis showed that negligible amounts 
of Rad21 mRNA were left after 24 hours of 4’OHT-induced Rad21 knockout (Figure 3.2C). 
Quantitative Western analysis showed that 12 hours post 4’OHT treatment, RAD21 protein levels 
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were already reduced by 80% and a 90% reduction was observed by 24 hours (Figure 3.2D). To 
ensure that the loss of cohesin was functionally relevant, 4’OHT treated ERT2-Cre Rad21lox/lox ES 
cells were fractionated into the chromatin bound and cytoplasmic fractions and RAD21 protein 
levels in each fraction were analysed by Western blot. Results showed that cellular depletion of 
RAD21 corresponded with a depletion in the chromatin associated RAD21 protein (Figure 3.2E). 
Together, these experiments show that the ERT2Cre conditional knockout system allows rapid 
depletion of RAD21 protein levels to less than 15% within 24 hrs in ES cells. 
 
Figure 3.2 The conditional knockout system allows rapid and acute depletion of cohesin in ES cells within 
24 hours A) Schematic of the conditional Rad21 allele with LoxP sites (marked in red asterix) flanking exons 
5 and 6. Arrows indicate the position of primers F and R used for estimation of genomic deletion of the 
Rad21 allele. B) Genomic deletion of the loxed allele is complete by 24 hours. Genomic DNA from cells was 
PCR amplified using primers flanking the LoxP sites and normalised to primers binding outside the Rad21 
allele. C) Rad21 mRNA levels reduced by more than 90% within 24hours in the conditional knockout cells. 
Expression is normalised to that of UBC and HAZ genes. D) Rad21 protein levels reduced to 15% in 24hours. 
Protein samples were Western Blotted onto PVDF membranes and probed with appropriate fluorescent 
secondary antibodies. Fluorescence was measured and normalised to Tubulin loading control. E) Cohesin 
depletion is functionally relevant as indicated by the reduction in chromatin bound Rad21. Cells were 
fractionated into the cytoplasmic and chromatin bound components and protein samples from each were 
Western blotted. 
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3.2 Depletion of cohesin predates cell cycle defects and activation of 
stress response 
As cohesin is essential for proper cell cycle progression and DNA repair, cohesin-depleted 
ES cells will eventually arrest during cell cycle and activate stress response pathways. 
Nonetheless, it may still be possible to capture a window of opportunity where the ES cells have 
been substantially depleted of cohesin before the onset of mitotic arrest and activation of stress 
response. With this aim, the cell cycle profile of the ES cells was analysed by propidium iodide (PI) 
staining post tamoxifen treatment. After 24hrs of 4’OHT treatment, the Rad21lox/lox ES cells 
showed the same cell cycle distribution of G1, S and G2 phases as the Rad21WT/WT ES cells. 
However, by 48hrs, majority of the cohesin-depleted ES cells accumulated in G2/M phase (Figure 
3.3). 
 
Additionally, to evaluate cellular stress levels upon cohesin depletion, I checked the 
expression of Trp53 (p53) and its downstream target genes – Cdkn1a (p21) and Mdm2 as markers 
which are upregulated upon activation of stress response pathways. Cells were treated with 
Figure 3.3 Cohesin deplete ES cells show normal cycle profile until 24 hours of 4’OHT treatment and 
arrest in G2 phase thereafter. A) Cells were stained with propidium iodide and analysed by flow 
cytometry. After 24 hours of tamoxifen treatment, cohesin deplete ES cells have normal cell cycle profile 
while majority of them are arrested in G2 phase by 48 hours. B) Proportion of cells in G1, S and G2 phases 
of cell cycle in wildtype and cohesin-depleted ES cells. 
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0.5µM Doxorubicin, for 6hrs to provide a positive control for the impact of stress on changes in 
gene expression. The results showed that Mdm2 mRNA levels at 24hrs were identical to untreated 
cells but increased markedly by 36 and 48hrs of cohesin depletion. Trp53 mRNA levels did not 
change while Cdkn1a was downregulated in response to cohesin loss (Figure 3.4). These 
experiments demonstrate that prolonged periods of cohesin depletion in ES cells activates the 
cellular stress response pathways and renders them unsuitable for gene expression analysis. 
However, the 24hr time point provides the perfect opportunity to study gene expression changes 
where the cohesin levels are already reduced by 90% but the ES cells do not yet show signs of cell 
cycle defects or activation of stress response pathways. 
 
 
Figure 3.4 Cohesin depletion predates activation of stress response. qRT-PCR analysis of mRNA expression 
of stress response genes Mdm2, Cdkn1a (p21), Trp53 (p53). Mdm2 is significantly upregulated only after 
36 hours of cohesin depletion. Cdkn1a is downregulated upon cohesin depletion (Normalised to UBC and 
Ywhaz; mean ± SE; n=3; * p-value ≤ 0.05 from T-test). 
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3.3 Cohesin depletion impacts the gene expression programme of ES 
cells in a locus specific manner, but does not lead to a general 
collapse of pluripotency  
To measure the impact of cohesin depletion on the gene expression programme of ES cells 
at 24 hours post 4’OHT treatment on a genome-wide scale, a colleague in the lab performed 
microarray experiments (Mira-Bontenbal, 2011). Transcriptional profiling showed that 598 genes 
were differentially expressed (p-value < 0.05 with Benjamini-Hochberg correction) of which 257 
were upregulated and 341 were downregulated. It is noteworthy that much lesser number of 
genes were deregulated in our dataset as compared to that published in Kagey et al., 2010 where 
more than 10,000 genes were deregulated (Figure 3.5A, B).  
 
Figure 3.5 Microarray data analysis of RAD21-depleted ES cells at 24 hours shows deregulation of specific 
genes. A) Log2 fold change distribution of the 598 significantly differentially expressed genes upon Rad21 
depletion in ES cells for 24h. Downregulated genes are in green and upregulated genes are in blue. Only a 
limited number of genes show high magnitudes of fold changes. B) Heat map analysis for the Smc1a 5day 
knockdown expression data from Kagey et al., 2010 (left panel) and Rad21 24h KO data (right panel) 
showing –Log10 of the p-values for each GO Term. Genes related to DNA damage and chromosome 
missegregation are preferentially induced by prolonged knockdown of cohesin subunits, but not by acute 
cohesin deletion (black: no enrichment, red: enrichment). 
 
Moreover,  the magnitude of the impact in terms of fold changes in expression was limited 
as majority of the differentially expressed genes were moderately effected (maximal log2 fold 
change from -0.75 to +0.75) and only a few genes showed higher changes in expression (maximal 
log2 fold change less than -1 and greater than +1) (Figure 3.5A). We next performed Gene 
Ontology (GO) analysis on our microarray dataset which revealed that deregulated genes were 
enriched for developmental functions (GO terms in grey type-face in Figure 3.5B). In contrast to 
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prolonged knockdown of Smc1a (Figure 3.5B, left), we found no enrichment of cell cycle and DNA 
damage-related genes (GO terms in red type-face in Figure 3.5B). Integration with published ChIP-
seq data (Kagey et al., 2010), showed that the binding of cohesin, the cohesin loading factor 
NIPBL, Mediator12 subunit and RNA Polymerase II was highly correlated with genes showing 
deregulated expression upon acute cohesin depletion (4.44x10-50, Wilcoxon gene set test) (Mira-
Bontenbal, 2011). Overall, this analysis indicates that rapid and acute depletion of cohesin in ES 
cells within 24 hours is a suitable way to measure direct effects of cohesin depletion on gene 
expression. This strategy avoids secondary effects due to the activation of stress response. Also 
noteworthy is the limited yet specific range of changes observed in gene expression upon cohesin 
depletion. 
I next sought to determine the impact of cohesin depletion on some key pluripotency 
associated genes. Data presented here shows the mRNA expression levels for Nanog, Pou5f1 
(Oct4), Klf4 and Rex1 (Figure 3.6A). At 24 hours, Nanog expression was only marginally reduced 
while Klf4 expression was substantially decreased as compared to control cells. On the contrary, 
Pou5f1 and Rex1 did not show any significant decrease. Even though Nanog expression was 
reduced in Rad21 depleted ES cells at 24 hours, the decrease was much less than that observed 
in differentiating cells in the same time span. The changes in mRNA expression observed for 
Nanog and Oct4 were also reiterated at the protein level. NANOG protein levels showed a 
progressive reduction upon cohesin depletion while OCT4 protein levels remained unchanged 
(Figure 3.6B).  Importantly, doxorubicin induced stress led to significantly reduced expression of 
all the pluripotency genes tested within 6 hours. Also noteworthy is the observation that by 48 
hours of 4’OHT treatment, when the cells start to get stressed due to lack of cohesin, all the genes 
tested showed a more significant decrease in expression as compared to that at 24 hours. 
Altogether, this data indicates that expression of pluripotency genes is strongly affected by the 
activation of stress response pathway in ES cells. This also explains the differences in gene 
expression observed 24 and 48 hours after cohesin depletion. By 48 hours, cells are under stress 
and consequently display a more pronounced downregulation of most pluripotency genes tested, 
as also observed in prolonged Smc1a knockdown studies (Kagey et al., 2010). On the other hand, 
gene expression changes at 24 hours, assessed to be a direct impact of cohesin depletion, are 
restricted to only a few specific pluripotency genes. 
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Figure 3.6 Specific pluripotency associated genes are downregulated upon cohesin depletion. A) qRT-PCR 
analysis of pluripotency associated genes Nanog, Pou5f1 (Oct4), Klf4 and Rex1. Only Nanog and Klf4 
expression is reduced significantly upon cohesin depletion at 24 hours. It is noteworthy that all these genes 
are downregulated in response to Doxorubicin treatment (normalised to Ubc and Ywhaz; mean ± SE; n=3; 
p-value *≤ 0.05, **≤ 0.005, ***≤ 0.0005) B) Western blot showing Nanog and Oct4 protein levels in 
ERT2Cre-Rad21lox/lox ES cells treated with tamoxifen. Levels are compared to differentiating cells in -2i 
media at 24hours. 
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To further extend the scope of this analysis I assessed the impact of acute cohesin depletion 
on the expression of genes assigned to an extended pluripotency network (Kim et al., 2008b). A 
curated list of genes whose promoters are targeted by at least 5 of the pluripotency factors 
Nanog, Dax1, Sox2, Nac1, Oct4, Klf4, Myc, Rex1 and Zfp281 was compiled. Of these 354 genes, 
only 40 (11.3 expected, enrichment significance 8.4 x 10-13) were found to be significantly 
deregulated upon cohesin depletion at 24 hours. Among these 40 genes, 16 were upregulated 
and 24 downregulated (Figure 3.7) with a log2fold change of 0.45 to 1.80 and -0.42 to -1.55, 
respectively. 
 
 
Given the limited number of pluripotency genes being affected, combined with their 
direction (up or down) and extent (magnitude of fold change) of deregulation, this analysis argues 
for locus-specific effects rather than a global collapse of pluripotency gene expression in acutely 
cohesin-depleted ES cells. 
Next, I assessed if differentiation associated genes were preferentially deregulated upon 
cohesin depletion. First, I checked the expression of Phc1 and Lefty1 genes which are expressed 
early during embryonic development and play a role in pattern formation and left-right axis 
determination respectively. Lefty1 was found to be significantly upregulated while Phc1 showed 
no significant difference at 24hours post tamoxifen treatment. The impact on both of these genes 
was opposite to that observed in differentiating ES cells. It is also to be noted that Kagey et al. 
Figure 3.7 Cohesin depletion has limited impact on the expression of pluripotency associated genes. 
A) Within a set of 354 pluripotency associated genes, only 16 were upregulated and 24 downregulated 
in the microarray dataset 24 hours after cohesin depletion B) The distribution of the log2 fold changes 
in gene expression of the 40 pluripotency genes affected by cohesin depletion. 
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(2010), described Lefty1 and Phc1 to be significantly downregulated upon Smc1a knockdown, 
which can be explained by the decreased expression seen upon doxorubicin induced stress. 
Another gene analysed was Sox1, a neural differentiation marker, which also did not show any 
significant upregulation upon cohesin depletion (Figure 3.8). 
 
 
Figure 3.8 Cohesin depletion does not cause an overall upregulation of differentiation associated genes. 
qRT-PCR analysis of embryonically expressed genes important in various stages during differentiation. 
Lefty1 is significantly upregulated 24 hours after cohesin depletion, while Phc1 is downregulated and Sox1 
remains unchanged (normalised to UBC and Ywhaz; mean ± SE; n=3; p-value * ≤ 0.05, ** ≤ 0.005). 
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Key developmental genes are marked by bivalent chromatin marks in ES cells (Azuara et al., 
2006; Bernstein et al., 2006). These genes are maintained in a transcriptionally repressed state in 
ES cells but can be rapidly activated at different stages of differentiation. Therefore, I used 
bivalently marked genes to test if cohesin-depleted ES cells showed a globally increased 
propensity for upregulation of differentiation associated genes. The chromatin state of all the 
genes in our microarray dataset was assessed based on published datasets and the proportion of 
deregulated bivalent genes was calculated (Figure 3.9). Only 125 of a total of 2902 bivalent genes 
were found to be differentially expressed upon cohesin depletion at 24 hours. Of these, 48 were 
upregulated and 77 downregulated. Together, bivalent genes made a very small percentage of 
total deregulated genes and show no indication of a preferential upregulation upon cohesin 
depletion. 
 
 
 
 
Figure 3.9 Cohesin depletion has no preferential impact on upregulation of bivalent genes. A) Bivalent 
genes were identified in the microarray dataset and their proportion in up- and downregulated genes 
was calculated. Even though the overlap between bivalent genes and all deregulated genes was 
significant, upregulation of bivalent genes was not favoured. B) The distribution of the log2 fold changes 
in gene expression of the 40 pluripotency genes affected by cohesin depletion. 
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Wild-type, cohesin-depleted and differentiating ES cells were further analysed for the cell 
surface expression of Alkaline Phosphatase (AP), a pluripotency marker. AP staining was markedly 
reduced in differentiating ES cells while there was no notable difference in wild-type and cohesin 
depleted ES cells at 24 hrs (Figure 3.10). Normal AP expression in cohesin-depleted ES cells further 
contradicts a total loss in pluripotency. 
 
Figure 3.10 Cohesin depleted ES cells are positive for Alkaline phosphatase staining. The relative levels of 
Alkaline Phosphatase staining were compared in wild-type, cohesin-depleted and differentiating ES cells. 
NIH3T3 cells were used as negative control (A). Differentiated ES cells showed a significantly reduced 
expression of AP, while the levels of expression in cohesin-depleted cells were comparable to that of wild-
type cells at 24 hours (B). Presence of Alkaline phosphatase stain in Rad21 depleted ES cells argues against 
loss of pluripotency.  
Overall, this analysis reveals that acutely cohesin-depleted ES cells do not show a global 
collapse in pluripotency or an increased propensity for differentiation. In fact, the impact of 
cohesin depletion seems to be limited to certain genes, and the effect is highly locus-specific.  
Chapter 3 
 
103 
 
It has previously been reported that cohesin depletion in non-cycling double positive 
thymocytes (DPTs) compresses the dynamic range of gene expression. Genes with low expression 
levels are more often upregulated, whereas highly expressed genes are more often 
downregulated (Seitan et al., 2013). In order to check how cohesin depletion affected the overall 
range of gene expression in ES cells, the list of deregulated genes was subjected to a similar 
analysis and genes were stratified into bins according to the mean of their expression in control 
and cohesin depleted cells. The stratified mean expression was plotted against log2 fold changes 
in gene expression (Figure 3.11). Unlike cohesin depleted DPTs, results did not indicate any 
preferential upregulation of lowly expressed genes or downregulation of highly expressed genes. 
In fact, the proportion of upregulated and downregulated genes was mostly similar across the 
whole range of expression (Figure 3.11B). Hence, cohesin depletion in ES cells did not lead to more 
homogenous levels of gene expression. Once more, this observation argues against a universal 
reduction in expression of pluripotency genes and upregulation of lowly/un-expressed 
differentiation genes. Instead it points towards specific gene expression changes across the whole 
range of genes. 
Figure 3.11 Cohesin depletion in ES 
cells does not compress the 
dynamic range of gene expression. 
A) Genes were stratified into 12 
equally sized log intervals from low 
(0-1) to high (11-12) based on the 
average gene expression of control 
and cohesin deficient ES cells. 
Boxplot indicates the distribution of 
gene expression fold changes. Width 
of the box plot is representative of 
number of genes in each bin. Lowly 
expressed genes are not 
preferentially upregulated and vice 
versa. B) Bar plot indicating the 
proportion of up- and down-
regulated genes in each gene 
expression interval. 
 
Taken together, the data presented here suggests that cohesin depletion does not lead to 
a more random gene expression programme resulting in a global collapse of pluripotency, but 
rather has locus-specific effects. 
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3.4 Long-range regulatory DNA interactions can be maintained after 
loss of cohesin and are not sufficient to explain the observed changes 
in gene expression 
To gain insight into the possible mechanisms by which cohesin regulates gene expression, I 
tested the impact of cohesin loss on long-range enhancer-promoter DNA interactions which have 
previously been shown to play an important role in cohesin-mediated gene regulation. For this 
purpose, I selected a subset of genes deregulated upon cohesin depletion based on the 
positioning of their regulatory elements and relevance to the pluripotent state. At these loci, 
chromosome conformation capture (3C) analysis was combined with information regarding the 
binding of Rad21, CTCF and Nipbl using ChIP analysis, to get a more comprehensive view of gene 
expression changes and the role played by cohesin. 
First, I studied the Nanog gene which is downregulated upon cohesin depletion. Nanog 
expression is regulated by an enhancer located 5 kb upstream of the transcription start site (TSS) 
(Wu et al., 2006). This enhancer region is co-occupied by Rad21, Smc1, Nipbl, Mediator, p300 and 
is marked by histone H3K27 acetylation as assessed from published ChIP-sequencing datasets 
(Figure 3.12A). A 3C experiment was designed to map DNA interactions between the TSS (anchor) 
and the upstream enhancer in control, 24h cohesin-depleted and 24h differentiating ES cell 
populations. In accordance with previous observations, enhancer-promoter interactions were 
weakened upon cohesin depletion and differentiation (Figure 3.12A bottom panel). Additionally, 
the extent of loss of interaction was comparable to the reduction in expression (Figure 3.12B). 
However, it is to be noted that even though cohesin binding was reduced by 80% at the Nanog 
enhancer and promoter in cohesin depleted ES cells, the reduction in interaction was not 
proportional. On the other hand, decreased enhancer-promoter interactions upon differentiation 
were accompanied by loss of cohesin binding (Figure 3.12C). No significant binding of CTCF was 
observed at either Nanog enhancer or promoter in the three states of ES cells described here (not 
shown). The binding of cohesin loading factor Nipbl remained unchanged after cohesin depletion, 
but was significantly reduced in response to differentiation (Figure 3.12D). Thus, at the Nanog 
locus, the reduction in gene expression upon cohesin depletion can partly be explained by a 
decrease in enhancer-promoter interactions. It is also highlighted here that Rad21 and Nipbl 
binding is reduced at the Nanog locus in response to differentiation signals which may 
consequently result in decreased enhancer-promoter interactions. 
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Figure 3.12 Cohesin depletion leads to weakened enhancer-promoter interactions at the Nanog locus. 
A) Top panel: Binding of mediator, cohesin subunits and histone modifications at the Nanog locus. 
Restriction digested fragments are marked – Anchor in green and analysed fragments in red. Bottom 
panel: 3C at the Nanog locus. Chromatin was fixed and digested with DpnII enzyme. The religated products 
were PCR amplified and detected using a Taq Probe binding in the TSS anchor fragment. Values for 
interaction frequency were normalised to BAC templates and control regions. DNA interaction between 
the upstream enhancer at 5 kb and TSS was reduced upon cohesin depletion. Differentiated ES cells 
showed more pronounced reduction in this interaction. B) Nanog mRNA expression (normalised to UBC 
and Ywhaz). C) Rad21 ChIP at the Nanog enhancer and promoter. Data is plotted as fold change in Rad21 
enrichment relative to that in control cells. Rad21 binding is reduced by 80% in cohesin-depleted ES cells. 
Rad21 binding also decreases in response to differentiation. D) Nipbl ChIP at the Nanog enhancer and 
promoter. Nipbl enrichment is plotted relative to 1% input chromatin. Nipbl binding is significantly 
reduced upon differentiation but remains unaffected upon cohesin depletion. (Mean ± SE; n = 3; Color 
code: Black - control ES cells, Red - Rad21lox/lox + 4’OHT 24h ES cells, Green – Rad21lox/lox – 2i 24h ES cells) 
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Next, I chose to investigate the impact of cohesin loss on enhancer-promoter interactions 
at genes that are upregulated in cohesin-depleted ES cells. Lefty1 was selected for this analysis. 
Lefty1 expression is tightly regulated during development by a combination of cis-regulatory 
elements comprising of the lateral plate mesoderm specific enhancer (LPE), the neural plate 
enhancer (NPE), located 9.6 kb and 3 kb upstream of TSS respectively, and a promoter-proximal 
right side-specific silencer (RSS) (Saijoh et al., 1999). In ES cells, the Lefty1 enhancer was 
recognised by the presence of H3K4me1 and H3K27ac marks along with the binding of cohesin, 
Nipbl, mediator and p300 approximately 10 kb upstream of Lefty1 TSS (Figure 3.13A). Using Lefty1 
TSS as the anchor, interactions were mapped between the promoter and enhancer using 3C. 
Interestingly, these interactions remained unchanged between wild-type and cohesin-depleted 
ES cells (Figure 3.13A), in spite of a substantial loss in Rad21 binding as confirmed by ChIP (Figure 
3.13C). By contrast, in differentiating ES cells, where Lefty1 expression was found to be reduced 
(Figure 3.13B), the enhancer-promoter interactions were evidently diminished. This 
demonstrated the validity of the 3C assay while also suggesting that the interaction of the 
promoter with this enhancer is functionally relevant for Lefty1 expression. From these 
experiments it can be concluded that Lefty1 enhancer-promoter interactions are maintained at 
wildtype levels despite efficient depletion of cohesin. 
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Figure 3.13 Lefty1 expression and enhancer-promoter interactions can be maintained in the absence of 
cohesin. A) Top panel: Binding of mediator, cohesin subunits and histone modifications at the Lefty1 locus. 
Restriction digested fragments are marked – Anchor in green and analysed fragments in red. Bottom panel: 
3C at the Lefty1 locus. Chromatin was fixed and digested with DpnII enzyme. Religated products were PCR 
amplified and detected using a Taq Probe binding in the TSS anchor fragment. Values for interaction 
frequency were normalised to BAC templates and control regions. The panel above shows the DNA 
interaction between the upstream enhancer and TSS remained unchanged upon cohesin depletion and 
was decreased upon differentiation. B) Lefty1 mRNA expression (normalised to UBC and Ywhaz). C) Rad21 
ChIP at the Lefty1 enhancer and promoter. Results are plotted as fold change in Rad21 enrichment relative 
to that in control cells. Rad21 binding is reduced by 80% in KO ES cells. Rad21 binding decreases partially 
in response to differentiation. D) Nipbl ChIP at the Lefty1 enhancer and promoter. Nipbl enrichment is 
plotted relative to 1% input chromatin. (Mean ± SE; n = 3; Color code: Black - control ES cells, Red - 
Rad21lox/lox + 4’OHT 24h ES cells, Green – Rad21lox/lox – 2i 24h ES cells) 
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I next analysed Klf4, a gene which is substantially downregulated upon cohesin depletion. 
Klf4 enhancers have not been previously functionally tested but putative Klf4 enhancers were 
identified based on ChIP-sequencing data for cohesin, Nipbl, mediator, p300, H3K4me1 and 
H3K27ac marks at around 50 kb downstream of TSS (Figure 3.14A top panel). This region has also 
been recently termed as a super-enhancer (Whyte et al., 2013). 3C experiments at Klf4 locus 
showed that indeed Klf4 promoter (anchor) interacted with this putative enhancer region in 
wildtype ES cells and that the interaction was abolished upon differentiation when Klf4 is 
downregulated. However, despite efficient cohesin depletion and substantial decrease in 
expression in cohesin-depleted ES cells, the enhancer-promoter interactions remained intact 
(Figure 3.14A). Thus, Klf4 provides another example that dissociates cohesin binding and gene 
expression changes from enhancer-promoter interactions. A more detailed analysis highlighted 
the dynamic binding of Rad21, Nipbl and CTCF at the +53kb and +55kb enhancer regions upon 
differentiation. CTCF and Nipbl binding at these two sites was unaffected by cohesin depletion. 
However differentiating ES cells showed significant reduction in Rad21, CTCF and Nipbl binding, 
specifically in the +53, +55kb region (Figure 3.14 C, D, and E). These observations suggest that in 
response to physiological cues, decreased transcription was associated with a loss of cohesin 
binding and a concomitant reduction in enhancer-promoter interactions. However, the reverse is 
not true, i.e. loss of cohesin binding is not sufficient to abrogate the enhancer-promoter 
interactions even though it results in downregulation of Klf4. 
Overall, these experiments indicate that cohesin binding is dynamically and specifically 
regulated in response to physiological cues at enhancers and promoters and is very well 
correlated with the long-range interactions. However, it is also highlighted here that enhancer-
promoter interactions can be maintained upon removal of cohesin as exemplified by the Lefty1 
and Klf4 loci.  
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Figure 3.14 Enhancer-promoter interaction is maintained in spite of Klf4 downregulation upon cohesin 
depletion. A) Top panel: Binding of enhancer associated marks at the Klf4 locus. Digested fragments are 
marked – Anchor in green and analysed fragments in red.  Bottom panel: 3C at the Klf4 locus. Fixed 
chromatin was digested with PvuII enzyme. The religated products were PCR amplified using TSS as the 
anchor fragment. Values for interaction frequency were normalised to BAC templates and control regions. 
The panel above shows the DNA interactions between the putative downstream enhancer and TSS remain 
unchanged upon cohesin depletion and are reduced upon cohesin depletion. B) Klf4 mRNA expression 
normalised to UBC and Ywhaz. C) Rad21 ChIP at the Klf4 enhancer and promoter. Results are plotted as 
fold change in Rad21 enrichment relative to that in control cells. Rad21 binding is reduced by 80% in KO ES 
cells and specifically decreases at the +53 and +55 kb sites upon differentiation. D) and E) CTCF and Nipbl 
ChIP at the Klf4 locus. Enrichment is plotted relative to 1% input chromatin. CTCF binding reduced at +53kb 
site while Nipbl reduced at both +53 and +55kb sites upon differentiation. (Mean ± SE; n = 3; Color code: 
Black - control ES cells, Red - Rad21lox/lox + 4’OHT 24h ES cells, Green – Rad21lox/lox – 2i 24h ES cells) 
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3.5 Discussion and future perspectives 
Embryonic stem cells possess a unique transcriptional programme which allows them to 
perpetually self-renew while still being capable of giving rise to progenitors of the various 
different cell types in an organism. Cohesin has previously been reported to play an important 
role in these process (Ding et al., 2009; Hu et al., 2009; Kagey et al., 2010; Nitzsche et al., 2011). 
However, prolonged RNAi mediated knockdown of cohesin fails to dissociate essential cohesin 
functions in mitosis from its role as a regulator of transcription. In order to overcome such 
limitations, a conditional knockout system was used in this study to rapidly deplete the Rad21 
subunit. I combined the use of ERT2Cre-Rad21lox conditional allele with the culture of ES cells in 
2i media. This provided a suitable system to study the direct impact of cohesin depletion on 
pluripotency. Additionally, as ES cells in 2i media show a more homogeneous transcriptional 
profile akin to a ‘naïve’ state of pluripotency (Ying et al., 2008; Silva et al., 2009), any bias for the 
selection of differentiated cells was avoided. Data presented here shows that cohesin protein 
levels were reduced to less than 10% within 24 hours of inducing Rad21 knockout, before the 
onset of mitotic arrest and activation of stress response pathways. Thus in essence, any gene 
expression changes observed at 24 hours post Rad21 knockout should be independent of any 
secondary effects due to cohesin depletion. Genome-wide transcriptional analysis of cohesin-
depleted ES cells by microarrays at this time point revealed modest yet significant changes in the 
expression of a specific set of genes. I did not observe a global collapse in pluripotency nor a 
prominent upregulation of differentiation associated genes. On the contrary, the limited scale 
(598 genes), direction (up- or down-regulated) and magnitude of the gene expression changes 
observed, suggest that cohesin has locus-specific impacts on transcriptional regulation. 
Deregulated genes are enriched for developmental functions and are found to be bound by 
cohesin or Nipbl at the promoters and distal regulatory elements, again supporting a direct role 
of cohesin in the regulation of these genes. These observations are in agreement with studies in 
CdLS animal models where depletion of Nipbl and cohesin subunits also leads to modest yet 
specific gene expression changes (Kawauchi et al., 2009; Muto et al., 2011).  
These results are in disagreement with previously published work by Kagey et al., (2010) 
who have done a similar analysis but using the knockdown strategy in serum ES cultures. They 
reported a massive downregulation of pluripotency genes. However, this observed discrepancy 
can be attributed to a bias for selection of differentiated ES cells due to prolonged cohesin 
depletion and the consequent stress induced secondary effects on gene expression. This 
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speculation is supported by the fact that their dataset is highly enriched for cell cycle and DNA 
damage related genes. Activation of cell cycle and DNA damage checkpoints has already been 
shown to supress the expression of key pluripotency genes like Nanog and trigger ES cell 
differentiation (Lin et al., 2005; Maimets et al., 2008; Li et al., 2012). Thus, the gene expression 
changes observed by Kagey et al, (2010) might in large part be a secondary effect of stress induced 
differentiation. The same effect is observed when ES cells were forcefully stressed by the use of 
doxorubicin leading to the downregulation of all the pluripotency associated genes tested in this 
study. In fact, closer examination of gene expression changes at 48 hours post cohesin depletion, 
when ES cells are arrested in G2 phase and show upregulation of stress markers like Mdm2, also 
reveals a more pronounced downregulation of pluripotency genes as compared to that at 24 
hours. Thus, in addition to delineating cohesin’s role in pluripotent gene expression programme, 
this study also points to critical shortcomings in existing knockdown studies. It provides further 
evidence that activation of stress responses in ES cells can lead to differentiation, and emphasises 
on the avoidance of such stress while analysing cohesin’s role in regulating gene expression in 
cycling cells. 
Having ascertained that cohesin plays a direct role in the transcriptional regulation of 
specific genes expressed in ES cells, I selected a few key pluripotency associated genes to 
understand the mechanisms of cohesin action. Given the previously reported roles of cohesin in 
mediating long-range DNA interactions between cis-regulatory elements (Kagey et al., 2010; 
Seitan et al., 2011; Merkenschlager and Odom, 2013), I focused on analysing how enhancer-
promoter interactions are affected by the loss of cohesin and how does this relate to observed 
changes in gene expression. At the Nanog locus, reduction in expression upon cohesin depletion 
and differentiation at the 24 hour time point was associated with a similar decrease in enhancer-
promoter interactions. At the Klf4 locus, however, enhancer-promoter interactions were 
maintained in the absence of cohesin even though Klf4 expression was significantly reduced. 
Another interesting contrast was observed in case of Lefty1 where the gene displayed intact 
enhancer-promoter contacts and was in fact upregulated upon cohesin depletion. In contrast to 
the impact of cohesin depletion, enhancer-promoter interactions at both Klf4 and Lefty1 locus 
were diminished in response to differentiation and were associated with reduced Rad21 and Nipbl 
binding. These observations highlight several aspects of cohesin’s role in mediating enhancer-
promoter interactions and the resultant impact on gene expression.  
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The first intriguing observation is that cohesin depletion does not necessarily lead to a loss 
in enhancer-promoter interactions at deregulated genes. This is particularly evident at the Lefty1 
and Klf4 loci. Even at the Nanog locus, it is striking that >80% depletion in cohesin binding is 
accompanied by only a small reduction in enhancer-promoter interactions. These findings suggest 
that even though cohesin associated active enhancers are engaged with their respective target 
promoters via long-range DNA interactions, some of these established interactions can be 
maintained in the absence of cohesin. This is in agreement with the observation that cohesin’s 
impact on pluripotency is locus-specific because if cohesin was required to maintain all enhancer-
promoter interactions, cohesin depletion would be accompanied by downregulation of most 
active genes. Rather, it is more probable that some genes and enhancer-promoter interactions 
are more sensitive to perturbations upon cohesin depletion. In addition, the actual maintenance 
of DNA looping between enhancers and promoters in the absence of cohesin may be attributed 
to interactions between transcription factors like Oct4, Nanog and components of the mediator 
complex that are bound to enhancers and promoters. This hypothesis is supported by previous 
studies which show that Oct4, Sox2 and Nanog cluster together at regions involved in long-range 
DNA interactions and that loss of either Oct4 or Nanog diminishes these contacts. In fact, insertion 
of an ectopic Nanog binding site is sufficient for the formation of DNA contacts with other 
endogenous OSN bound regions (de Wit et al., 2013; Denholtz et al., 2013). Thus, it is possible 
that preformed enhancer and promoter DNA interactions, probably mediated by cohesin, are 
supported by protein-protein interactions which are strong enough to maintain these DNA 
contacts upon later removal of cohesin. 
Another important characteristic of cohesin mediated gene regulation illustrated in this 
study is the dynamic nature of cohesin binding in response to cellular cues. This is clearly evident 
at the Klf4 locus where there are several cohesin and CTCF binding sites across the 70kb region 
analysed. The +55kb region is a CTCF independent cohesin and Nipbl binding site with a high 
interaction frequency with Klf4 TSS in ES cells. Upon differentiation, cohesin binding at the CTCF 
sites remains invariant but is specifically reduced at the +55kb enhancer region. Similarly, Nipbl 
binding is also specifically decreased at the +55kb region. Importantly, the reduced cohesin and 
Nipbl binding is associated with decreased enhancer-promoter interactions. The same was 
observed at the Nanog locus, where cohesin and Nipbl binding and DNA contacts were reduced 
at the enhancer and promoter regions upon differentiation. These results show that cohesin 
loading at cis-regulatory elements is highly responsive to cellular signals like differentiation. As 
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cohesin binding at enhancer regions was reduced in both cohesin-depleted ES cells and 
differentiating ES cells, but reduced DNA interactions were observed only in differentiating ES 
cells, cohesin binding alone cannot be the sole determinant of the formation of long-range DNA 
interactions. It can be surmised that cohesin unloading in response to differentiation signals 
accompanied by reduced binding of downregulated pluripotency associated TFs might together 
result in decreased enhancer-promoter interactions. 
An additional feature that emerges from this study is that enhancer-promoter interactions 
alone cannot explain the observed gene expression changes upon cohesin depletion. For example, 
Lefty1 upregulation could not be ascribed to increase enhancer-promoter interactions. It is 
possible that Lefty1 overexpression is caused due to the loss of an interaction with a repressor 
element or a gain in interaction with additional enhancer elements both of which could be made 
possible due to the breakdown of the existing chromatin framework in the absence of cohesin. 
However, these hypotheses could not be tested in the present study which relies on the use of 3C 
technique. 3C is dependent on pre-existing knowledge of DNA elements whose interactions are 
to be measured. Even the Nanog gene has been reported to be involved in multiple long-range 
DNA interactions apart from the 5kb upstream enhancer. However, the functional significance of 
any of these other interactions for transcriptional regulation has not been tested. Nevertheless, 
it is possible that the impact of cohesin depletion is a combined result of the effect on each of 
these individual interactions and not a single regulatory element. As such, it would be useful to 
extend the scope of this analysis to more genes and study the associated DNA interactions on a 
more global scale by using 4C or Hi-C. However, increasing coverage with these technologies 
would be limited by the loss of resolution and it might not be possible to pick up small differences 
in interactions at shorter ranges as assessed here by 3C. The Klf4 locus also provides a rather 
contrasting observation where gene transcription is significantly reduced even when enhancer-
promoter contacts are maintained in the absence of cohesin. This suggests a dissociation of the 
mere presence of enhancer-promoter contacts from their role in activating transcription i.e. 
bringing of an enhancer element in close proximity of a gene promoter is not necessarily sufficient 
for the activation of transcription, and signifies the role of other TFs and regulatory factors in 
making this association a productive one. At the same time, downregulation of Klf4 in the absence 
of cohesin implicates cohesin’s role in transcription beyond its role in mediating enhancer-
promoter interactions.  
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Altogether, this work shows that cohesin plays a direct role in regulating specific genes in 
ES cells. Furthermore, the data presented here, even though limited, provides strong evidence 
that enhancer-promoter interactions can be maintained upon cohesin removal.  
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Chapter 4 : Cohesin functions in regulation of Myc 
expression 
Myc is one of the genes that is significantly upregulated in the microarray dataset of cohesin 
deficient ES cells. Myc is involved in several cellular processes including stem cell self-renewal and 
pluripotency. Its expression is precisely regulated in response to several extracellular and 
intracellular signals and deregulated Myc expression can lead to malignant transformation of cells 
(Meyer and Penn, 2008; Dang, 2012). Interestingly, previous reports suggest that depletion of 
cohesin and its regulatory subunits results in Myc downregulation (Rhodes et al., 2010; McEwan 
et al., 2012). However, these studies also reported an accompanied upregulation of p53 and 
Mdm2 expression. Thus it is difficult to conclude whether Myc deregulation was a direct effect of 
cohesin depletion, or an indirect impact of activated stress response. Nevertheless, the observed 
contrast between the upregulation of Myc in ES cells, and the previously reported downregulation 
of Myc in the absence of cohesin, is extremely intriguing. Furthermore, cohesin mutations have 
been identified in several types of tumors but the underlying cause is not yet understood. It is 
possible that the cancerous growth of cells results from deregulated Myc expression due to 
cohesin mutations. Therefore, it is of tremendous value to understand if and how cohesin 
regulates Myc expression. 
The work in this chapter explores the upregulation of Myc expression in cohesin deficient 
ES cells and further attempts to examine the impact of cohesin depletion on Myc expression in 
various different cell types.  
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4.1 Myc expression is post-transcriptionally upregulated in cohesin 
deficient ES cells growing in 2i media 
To study the impact of cohesin depletion on Myc expression in ES cells, I first used the 
previously described ERT2Cre-Rad21WT/WT and ERT2Cre-Rad21lox/lox ES cells growing in 2i 
supplemented media. The cells were treated with 4’OHT and RNA samples were collected at 
different time points. Myc mRNA levels were assessed by qRT-PCR analysis using primers spanning 
the exon2-exon3 junction, which is common to both isoforms A and B of Myc transcripts. Results 
clearly showed that Myc mRNA levels were markedly upregulated upon 24 hours of cohesin 
depletion and the increased levels were maintained even after 48 hours (Figure 4.1B left). Primers 
designed to amplify the exon1-exon2 junction exclusively present in isoform A also confirmed the 
observed upregulation of Myc mRNA (Figure 4.1B right). Western blot analysis revealed that even 
MYC protein levels were significantly increased upon cohesin depletion. The presence of Ser62 
and Thr58 phosphorylated forms of MYC protein indicates that the upregulated MYC is 
functionally active (Figure 4.1C).  
I further analysed the transcriptional status of the Myc gene by designing primers which 
bind to an intron-exon pair and thus amplify the primary transcript. As the RNA samples were 
subjected to DNAse treatment prior to cDNA preparation, amplification of gDNA was avoided and 
intron-exon spanning primers specifically detected primary transcripts. Results showed that the 
untreated ERT2Cre-Rad21lox/lox ES cells at 0 hour already displayed slightly higher levels of Myc 
transcripts as compared to ERT2Cre-Rad21WT/WT ES cells. The Myc gene also demonstrated 
changes in gene expression with changing cellular density in the culture dish with increasing time 
(Appendix 1). This accounts for the observed increase in Myc transcripts at 24 hours and the 
subsequent reduction in both ERT2Cre-Rad21WT/WT and ERT2Cre-Rad21lox/lox ES cells. After 
accounting for the cell-variant and density-dependent differences, the qRT-PCR analysis 
surprisingly revealed that the primary transcript levels did not show an equivalent increase in 
levels as was observed for Myc mRNA upon cohesin depletion (Figure 4.1D). While Myc mRNA 
showed more than 5-fold increase in the absence of cohesin, the impact on primary transcript 
levels was minor at best. This indicates that cohesin depletion did not affect Myc transcription 
and the impact on increased Myc mRNA and protein is post-transcriptional. As the Myc mRNA is 
short-lived with a half-life of only 15-20 minutes, the sustained increase in mRNA and protein 
levels without increased transcription can be attributed to an increase in mRNA stability in the 
absence of cohesin. 
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Figure 4.1 Myc expression is post-transcriptionally upregulated upon cohesin depletion in ES cells 
growing in 2i media. A) Schematic representing the two isoforms of Myc transcripts. B) qRT-PCR analysis 
of Myc mRNA isoforms A and B (left) or A only (right). Myc mRNA is highly upregulated upon cohesin 
depletion. C) Western blot analysis shows an increase in the total and phosphorylated forms of MYC 
protein. D) Myc primary transcript analysis by qRT-PCR with primers binding in the indicated exons and 
introns. Transcription of Myc gene was not markedly upregulated upon cohesin depletion. (Normalised to 
Ubc and Ywhaz; mean ± SE; n≥3)  
Although further experiments are required to prove that the observed Myc upregulation is 
due to an increase in mRNA and protein stability, these experiments provide the first instance 
where cohesin’s involvement in gene regulation is post-transcriptional. Since cohesin is 
predominantly a nuclear DNA associated protein in its functional form, it is highly unlikely that 
cohesin directly interacts with Myc mRNA or protein to affect its stability. On the other hand, it is 
quite possible that increased Myc stability is a consequence of the direct impact of cohesin on the 
transcription of another regulatory factor, like RNA binding proteins or non-coding RNAs. A 
Chapter 4 
 
118 
 
cursory look at the list of deregulated genes from the microarray dataset did not reveal any 
obvious possible regulators of protein stability. However, I noted that Pvt1 (plasmacytoma variant 
translocation), a long non-coding RNA (lncRNA) encoded within the 8q24 gene desert containing 
the Myc gene, is significantly upregulated upon cohesin depletion. The upregulation of Pvt1 was 
also confirmed by qRT-PCR analysis (Figure 4.2). Until now, the function of Pvt1 was not known. 
However, a recent study reported that PVT1 interacts with and stabilises MYC protein by 
preventing MYC phosphorylation and degradation, and depletion of PVT1 reduced the half-life of 
MYC protein (Tseng et al., 2014). Therefore, it is possible that increased Myc levels are a 
consequence of Pvt1 upregulation due to cohesin depletion. Altogether, these experiments 
provide an intriguing novel mechanism of cohesin-mediated gene regulation, where cohesin 
regulates the expression of a lncRNA which in turn post-transcriptionally regulates the expression 
of an important gene like Myc. 
 
Figure 4.2 The lncRNA Pvt1 is upregulated upon cohesin depletion in ES cells growing in 2i media. qRT-
PCR analysis shows that Pvt1 expression is significantly upregulated in cohesin depleted ES cells. 
(Normalised to Ubc and Ywhaz; mean ± SE; n=2)  
 
The stability of MYC is determined in part by the combined activity of ERK and GSK3β 
signalling (Sears, 2004). Consequently, ES cells growing in 2i media have lower levels of Myc mRNA 
and protein due to ERK and GSK3β inhibition, as compared to ES cells growing in Serum + LIF 
culture conditions (Ying et al., 2008). Since the impact of cohesin depletion on ES cells may vary 
depending on extracellular and intracellular signalling in different culture conditions, I decided to 
check if Myc upregulation in the absence of cohesin was a feature of ES cells in general, or a 
culture-dependent phenomenon. For this, the ERT2Cre-Rad21WT/WT and ERT2Cre-Rad21lox/lox ES 
cells originally derived and cultured in 2i media were adapted to serum + LIF culture conditions. 
The cohesin depletion experiments were performed as previously described (Figure 3.1). 
Interestingly, cohesin depletion in serum adapted ES cells did not cause Myc upregulation. In fact, 
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both Myc mRNA and primary transcript levels were unaffected in cohesin depleted serum ES cells 
(Figure 4.3A). MYC protein levels were unchanged at 24 hours post cohesin depletion, but were 
drastically reduced thereafter (Figure 4.3B). The reduced MYC levels observed in spite of proper 
Myc transcription indicate that MYC protein is degraded, possibly due to the activation of stress 
response pathway after 24 hours.  
 
Figure 4.3 Cohesin depletion does not affect Myc expression in serum ES cells. A) qRT-PCR analysis for 
Myc mRNA and primary transcript levels shows no significant difference between widltype and cohesin 
depleted ES cells growing in serum + LIF media (Normalised to Ubc and Ywhaz; mean ± SE; n=3). B) Western 
blot analysis shows that MYC protein levels are not affected until 24 hours of cohesin depletion but are 
significantly reduced afterwards.  
The striking difference between the observed impact of cohesin depletion on Myc 
expression in 2i and serum ES cells shows that cohesin functions in gene regulation are sensitive 
to extracellular and intracellular signalling. Thus, the stabilisation of MYC in cohesin depleted 2i 
ES cells could possibly be a combined effect of Pvt1 overexpression and alleviation of the 
inhibitory effect of the 2i inhibitors. The impact of cohesin depletion on Pvt1 expression in serum 
ES cells remains to be determined in order to be able to dissect the molecular differences between 
Myc expression in 2i and serum ES cells. 
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4.2 Serum stimulated activation of Myc in serum starved MEFs is 
independent of cohesin 
Given the observed disparity between the impact of cohesin depletion on Myc expression 
in ES cells growing in 2i media and those growing in serum + LIF media, I decided to extend the 
analysis to several different cell types to further understand the role of cohesin in Myc regulation.  
MEFs can be arrested in a G1/G0 phase by serum starvation. Serum starved resting MEFs have 
very low levels of Myc mRNA which are dramatically increased when cells are stimulated with 
serum (Blanchard et al., 1985). I decided to check if cohesin is required for Myc expression in 
response to serum stimulation. For this purpose, I used MEFs derived from ERT2Cre-Rad21lox/lox 
embryos which can be conditionally depleted of Rad21 upon 4’-OHT treatment. Briefly, ERT2Cre-
Rad21lox/lox MEFs were treated with 100nM 4’-OHT or 100% ethanol for 2 days in serum 
supplemented media (DMEM + 10% FCS), after which they were serum starved (DMEM + 0.1% 
FCS) for 6 days. This allowed for proper cohesin depletion and as the serum starved MEFs are 
arrested in G1/G0 phase, it provided a system where gene expression changes can be analysed 
independently of cohesin’s role in cell division (refer to Section 5.1 for detailed characterisation 
of the system). At the end of 6 days, cells were re-introduced into serum supplemented media 
and Myc expression was analysed 6 and 12 hours post serum stimulation. 
 
Figure 4.4 Myc activation in MEFs upon serum stimulation does not require cohesin. A) qRT-PCR analysis 
in ERT2Cre-Rad21lox/lox MEFs shows Myc transcription is appropriately activated upon 6 and 12 hours of 
serum stimulation in the absence of cohesin (Normalised to 18S rRNA; mean ± SE; n=3) B) Western blot 
confirms MYC induction in both wildtype and Rad21-/- MEFs 6 hours post serum treatment. 
 
Results showed that even though both Myc mRNA and primary transcript levels were 
reduced in serum starved cohesin deficient MEFs, Myc activation upon serum stimulation was not 
affected (Figure 4.7A) and MYC protein levels were equivalently increased in both wildtype and 
Rad21-/- MEFs (Figure 4.7B). These experiments indicate that cohesin is not necessary for the 
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increased transcription and expression of MYC protein when serum starved MEFs are stimulated 
by serum growth factors. 
4.3 Cohesin depletion does not affect Myc expression in G1 arrested 
preB cells. 
Next I decided to analyse the dependence of Myc expression on cohesin in Abelson 
transformed preB cells, which can be arrested in G1 phase by the addition of imatinib (STI-571), 
an inhibitor of the Abelson protein tyrosine kinase (Schindler et al., 2000). Mouse ERT2Cre-
Rad21lox/WT and ERT2Cre-Rad21lox/lox preB cells containing a Bcl2 transgene were derived in our 
laboratory. These cells were transformed by the Abelson murine leukaemia virus allowing for the 
prolonged culture of these cells in vitro. By preventing apoptosis, the Bcl2 transgene ensured 
survival of these cells upon STI treatment. The ERT2Cre-Rad21lox/WT and ERT2Cre-Rad21lox/lox preB 
cells were treated with 400nM 4’-OHT to induce cohesin deletion and then arrested in G1 by the 
addition of 2µM STI (Figure 4.8A, C). Rad21 mRNA (Figure 4.8D) and protein (Figure 4.8B) were 
efficiently depleted in ERT2Cre-Rad21lox/lox preB cells 4 days after 4’-OHT addition. Therefore, G1 
arrested preB cells with the conditional cohesin allele also provide a valuable system where the 
effects of cohesin depletion on Myc gene expression can be studied in non-dividing cells.  
qRT-PCR analysis revealed that Gapdh and Myc mRNA levels were significantly reduced 
upon STI treatment in both heterozygous and homozygous cohesin depleted preB cells. 
Expression of other housekeeping genes like Ubc, β-Actin and 18SrRNA, however, remained 
unaffected. Myc transcription was also effectively reduced in the presence of STI (Figure 4.8D) 
and MYC protein was undetectable in Western blot (not shown). The repression of Gapdh and 
Myc could likely be a consequence of the inhibition of Abl kinase by STI, which influences the 
growth and survival of the cells (Roskoski, 2003). Thus, the cell cycle arrest of preB cells appears 
to be accompanied by a decline in growth and metabolic activities as well. Myc levels were 
similarly reduced in both heterozygous and homozygous cohesin deficient cells treated with STI. 
However, this system is not ideal to evaluate cohesin function in Myc regulation because of the 
unavoidable inhibitory effect of STI treatment. 
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Figure 4.5 Cohesin depletion does not affect Myc downregulation in G1 arrested preB cells. A) Schematic 
outline of the experimental setup. ERT2Cre-Rad21lox/WT and ERT2Cre-Rad21lox/lox preB cells were treated 
with 400nM 4’-OHT or ethanol for 2 days before the addition of 2µM STI. Cells were collected for analysis 
at the end of 4 days. B) Western blot analysis shows that RAD21 protein levels are efficiently reduced in4’-
OHT treated ERT2Cre-Rad21lox/lox preB cells. C) Cell cycle analysis shows that majority of the STI treated 
cells are arrested in G1 phase. D) qRT-PCr analysis of RNA samples shows similar reduction in Myc and 
Gapdh expression upon STI treatment (Normalised to Ubc expression; mean ± SE; n=3). 
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4.4 Cohesin depletion does not affect Myc expression in resting 
thymocytes 
Developing thymocytes go through several stages of maturation that are associated with 
the expression of specific cell surface markers. Late stage CD4-CD8- double negative (DN) 
thymocytes go through a phase of proliferation that extends to the early CD4+ CD8+ double-
positive (DP) stage. Shortly after the acquisition of CD4 and CD8, DP thymocytes lose the 
expression of the transferrin receptor CD71 and become small, non-proliferating CD71− DP cells, 
comprising the majority of cells in the thymus. At this stage, successful TCRα gene rearrangement, 
surface expression and the engagement of TCRαβ heterodimer selects a minority (3–5%) of DP 
thymocytes for differentiation towards long-lived CD4 or CD8 single-positive (SP) cells, again with 
minimal proliferation (Figure 4.9A) (Seitan et al., 2011). These non-proliferating thymocytes 
provide another opportunity to study the role of cohesin in gene regulation. 
 
Figure 4.6 Cellular profile of CD4+ non-cycling 
thymocytes.  
A) Schematic of thymocyte differentiation and cell 
cycle profiles. From left to right: CD4− CD8− double 
negative (DN) stages 1 to 4; CD4+ CD8+ double 
positive (DP), CD4+ CD8lo DP transitional stage; CD4+ 
or CD8+ single positive (SP) cells. Proliferative stages 
are represented in green, cell cycle arrest in red. 
Histograms show DNA content.  
B) Cell numbers and flow cytometric analysis of 
thymocyte subsets in 6-week-old CD4-Cre 
Rad21lox/lox and CD4-Cre Rad21lox/wt mice 
(mean ± standard deviation, n = 12). 
 
 
 
 
 
 
Chapter 4 
 
124 
 
In order to conditionally deplete RAD21 in resting thymocytes, Rad21lox/lox mice were 
crossed with mice expressing a Cre transgene under the control of Cd4 regulatory elements. The 
CD4Cre transgene is activated just before the transition from the DN to DP stage, when 
developing thymocytes initiate Cd4 expression and enter the non-proliferative stage. As a result, 
CD4Cre selectively drives the loss of cohesin in non-dividing thymocytes. Rad21 genomic deletion 
is essentially complete and Rad21 mRNA and protein levels are substantially reduced in CD4+ CD8+ 
DP and CD4+ SP thymocytes from CD4Cre-Rad21lox/lox mice (Figure 4.10A, B). Importantly, CD4Cre-
Rad21lox/lox DP thymocyte numbers were normal. Intermediate CD4+ CD8lo and mature CD4 SP and 
CD8 SP thymocytes accumulated slowly in CD4Cre-Rad21lox/lox mice due to reduced efficiency of 
differentiation but were present in normal numbers by 6 weeks of age (Figure 4.9B) (Seitan et al., 
2011). RNA-seq showed that Myc was expressed at very low levels in both CD4Cre-Rad21lox/lox and 
control (CD4Cre-Rad21lox/WT) DP thymocytes (Figure 4.10C). Furthermore, cohesin depletion also 
did not have a significant effect on Myc expression in CD4 SP thymocytes (Figure 4.10D). 
 
Figure 4.7  Conditional cohesin depletion in resting DP and CD4 SP thymocytes does not affect Myc 
expression. A) & B) Genomic deletion of the Rad21 allele and mRNA as assessed by RT-PCR, Rad21 Western 
blot shows efficient cohesin depletion in CD4Cre-Rad21lox/lox and control (CD4Cre-Rad21lox/lox) DP and CD4 
SP thymocytes. C) RNA-seq reads at the Myc locus in control and CD4 DP thymocytes. D) qRT-PCR analysis 
for Myc mRNA in CD4 SP thymocytes (Normalised to Ubc, Ywhaz expression; mean±SE; n=3). Myc 
expression remains unaffected upon cohesin depletion in both DP and CD4 SP thymocytes. 
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4.6 Discussion and future perspectives 
4.6.1 Upregulation of Myc upon cohesin depletion in 2i cultured ES cells  
Myc plays an important role in the maintenance of ES cell pluripotency and Myc expression 
is tightly regulated during developmental processes. Interestingly, cohesin depletion in ES cells 
growing in 2i media lead to increased Myc mRNA and protein levels. Interestingly, the loss of 
cohesin did not affect the transcriptional status of Myc but the cause of Myc upregulation was 
post-transcriptional. I speculate that cohesin depletion resulted in an increased Myc mRNA and 
protein stability but further experiments like mRNA half-life analysis are required to confirm this.  
So far, cohesin’s role in the regulation of gene expression has essentially been attributed to its 
ability to associate with DNA, and there is no evidence for a direct interaction of cohesin with 
mRNAs and soluble proteins which may influence their stability. Therefore, it is conceivable that 
cohesin depletion directly deregulates the expression of another factor which in turn is an 
important determinant of Myc stability.  
Both Myc mRNA and protein have a very rapid turnover. Degradation of Myc mRNA is 
regulated by several mechanisms, including the activity of RNA binding proteins and microRNAs 
(Ross, 1995; Jackstadt and Hermeking, 2014). In addition, translation-coupled mechanisms have 
also been proposed where association with ribosomes protects Myc mRNA from degradation 
(Bernstein et al., 1992). On the other hand, MYC protein stability is determined mainly by post-
translational modifications. While phosphorylation of the Ser62 residue on MYC increases protein 
stability and causes rapid accumulation of MYC, phosphorylation of Thr58 directs MYC 
ubiquitination and proteasomal degradation causing rapid downregulation (Sears, 2004). 
Therefore, it will be useful to study if cohesin depletion disrupts the precise balance between the 
Ser62 and Thr58 phosphorylations by using specific antibodies against both of these modifications 
to observe the changes at protein level. Investigation into whether MYC protein is stabilised due 
to increased Ser62 phosphorylation or due to decreased Thr58 phosphorylation or a combination 
of both, will further help us deduce other effector molecules which may be involved in the 
cohesin-dependent upregulation of MYC.  It would also be interesting to explore whether the 
absence of cohesin stabilises both mRNA and protein independently of each other or increased 
amounts of protein are a consequence of increased mRNA levels in a process that is 
translationally-coupled. Experiments comparing the half-life of Myc mRNA and protein in cohesin-
depleted ES cells treated with a transcriptional inhibitor (like Actinomycin D) or an inhibitor of 
Chapter 4 
 
126 
 
translation elongation (like Cycloheximide) or both, will help us further understand the role of 
cohesin in this process.  
In order to make a mechanistic link between cohesin and Myc upregulation, the list of 
deregulated genes in cohesin-depleted ES cells was scrutinised for the indication of any prominent 
RNA binding protein genes known to be involved in Myc regulation. Although, this basic analysis 
did not reveal any definitive targets, it is interesting that the expression of Pvt1, a long non-coding 
RNA gene located adjacent to the Myc gene within the 8q24 gene desert region, was significantly 
upregulated upon cohesin depletion. A recent study shows that PVT1 interacts with and stabilises 
MYC protein by preventing its degradation. Depletion of PVT1 reduces the half-life of MYC protein 
(Tseng et al., 2014). Further experiments will address whether increased Myc levels are a 
consequence of Pvt1 overexpression. As it stands, the work presented here shows that cohesin 
prevents Pvt1 overexpression in ES cells growing in 2i media and Pvt1 upregulation in the absence 
of cohesin might be responsible for the observed increase in Myc levels. It remains to be seen if 
cohesin regulates Pvt1 expression in other cell types as well, or if this function is specific to ES 
cells growing in 2i media. Cohesin-mediated regulation of Pvt1 may be of significance for 
evaluating the role of cohesin in the development of cancer.  
In addition to its role in the maintenance of pluripotency, Myc also plays an important role 
in somatic cell reprogramming. Myc is one of the original Yamanaka factors that mediate the 
formation of iPS cells (Takahashi and Yamanaka, 2006). Ectopic c-Myc is dispensable for the 
creation of iPS cells, but acts as an enhancer of kinetics and efficiency of reprogramming 
(Nakagawa et al., 2008; Wernig et al., 2008). It has been proposed that Myc facilitates 
reprogramming by increasing the proliferation of iPS cells (Hanna et al., 2009) and by cooperating 
with other reprogramming factors in the transcriptional regulation of target genes (Soufi et al., 
2012). In the context of cell-fusion mediated heterokaryon formation, where the early steps of 
reprogramming occur without cell division, a recent study (Lavagnolli et al., 2015) provides 
evidence that Myc enhances reprogramming efficiency by promoting DNA replication. The 
observed upregulation of Myc in cohesin-depleted ES cells was shown to cause the unexpected 
increase in their potential to reprogram somatic cells. Together, these experiments show that 
unlike previous reports claiming that cohesin is required for iPS reprogramming (Apostolou et al., 
2013; Zhang et al., 2013a), cohesin is not necessary for the ability of ES cells to induce the 
expression of pluripotency genes in somatic cells during cell-fusion mediated reprogramming. In 
fact, cohesin depletion increased the reprogramming potential of ES cells in part by promoting 
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Myc-dependent DNA replication. As somatic cell reprogramming occurs in the absence of cell 
division in interspecies heterokaryons, they provide an ideal system to study the role of cohesin 
in initiation of somatic cell reprogramming. Since iPS cell formation typically requires cellular 
proliferation, it is likely that the requirement of cohesin for iPS reprogramming stems from its 
essential functions in cell division (Lavagnolli et al., 2015). 
4.6.2 Myc expression is not dependent on the availability of cohesin  
The upregulation of Myc in cohesin-deficient ES cells growing in 2i media was in striking 
contrast with the previously reported positive correlation between cohesin and Myc gene 
expression (Rhodes et al., 2010; McEwan et al., 2012). Consequently, the role of cohesin in 
regulation of Myc expression was further analysed in various different cellular systems. 
Interestingly, in ES cells the impact of cohesin depletion on Myc expression varied depending 
upon culture conditions. The upregulation of Myc in cohesin-deficient ES cells was seen only when 
they were cultured in 2i media. In serum + LIF culture conditions, cohesin depletion in ES cells of 
the same genetic background did not have any effect on Myc mRNA levels. These experiments 
show that the impact of cohesin depletion is not only cell-type specific but is also sensitive to 
extracellular signalling.  
The analysis was extended to study the impact of cohesin depletion in non-dividing somatic 
cells. Very low amounts of Myc transcripts were present in resting preB cells, CD4+CD8+ double 
positive and CD4 single positive thymocytes.  These levels of Myc remained unaffected by cohesin 
depletion. Experiments in serum starved MEFs showed that although steady state levels of Myc 
mRNA were reduced upon cohesin depletion, cohesin was essentially dispensable for activation 
of Myc transcription in response to stimulation by serum growth factors.  
The above experiments in non-proliferating cells avoid secondary effects due to disruption 
of cell cycle functions in cohesin-deficient cells and collectively show that cohesin is not necessary 
for appropriate Myc transcription. It was also highlighted that impact of cohesin depletion on 
gene expression was determined in part by extracellular signals. And finally, this work suggests 
that cohesin might play an important role in the regulation of the lncRNA Pvt1 and may help 
explain the high incidence of cohesin mutations in human malignancies. 
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Chapter 5 : IFNγ mediated activation of MHC class II genes 
requires cohesin 
Results from 3C experiments indicated that long-range enhancer-promoter interactions at 
the tested deregulated genes can be maintained even after cohesin depletion and are not enough 
to explain the observed changes in gene expression. This questions the prevailing model of 
cohesin mediated gene regulation and calls for alternative explanations to how loss of cohesin 
leads to changes in expression of genes associated with cohesinopathies. An insight into this 
problem can be gained by careful observation of patients with Cornelia de Lange syndrome who 
regularly show developmental defects in limb formation, a process which requires spatio-
temporally coordinated activation of Hox genes (Mallo and Alonso, 2013). One might surmise that 
cohesin is important for the limb development programme. But in the larger context, one can 
hypothesise that cohesin is required for the establishment of a new gene expression programme. 
Hence, this chapter focuses on testing the hypothesis that cohesin is necessary for the process of 
gene activation and in exploring the various components of the transcriptional machinery 
associated with this process. 
I decided to use the IFNγ inducible expression of MHC genes in fibroblasts as the model 
system for this analysis. As discussed earlier, MHC class I molecules are expressed on the surface 
of most vertebrate cells and are over-expressed in response to IFNγ exposure. MHC II gene 
expression, on the other hand, is restricted to professional antigen presenting cells. However, 
most cells can be stimulated to express MHC II genes when exposed to IFNγ. Therefore, using IFNγ 
to induce MHC expression would potentially allow me to delineate the requirement of cohesin 
for induction of previously expressed genes (MHC class I) as opposed to that for the initiation of 
new gene expression (MHC class II).  
Mouse embryonic fibroblasts (MEFs) isolated from Rosa26ERT2Cre/ERT2CreRad21WT/WT 
(ERT2Cre-Rad21WT/WT) or Rosa26ERT2Cre/ERT2CreRad21lox/lox (ERT2Cre-Rad21lox/lox) embryos were used 
as the cellular model for these studies as they do not express MHC II molecules on cell surface 
unless stimulated by IFNγ. Moreover, MEFs can be arrested in a quiescent state (G0) by serum 
starvation and thus provide an ideal system where effects of cohesin depletion on gene 
expression can be studied in non-dividing cells. 
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5.1 IFNγ stimulated activation of MHC class II genes in fibroblasts 
requires cohesin 
Using MEFs extracted from ERT2Cre-Rad21WT/WT or ERT2Cre-Rad21lox/lox embryos, a cohesin 
depletion system was setup as depicted in Figure 5.1A, which allowed for gene expression analysis 
upon IFNγ induction in non-dividing cells. Briefly, early passage MEFs were grown in serum 
containing media (DMEM + 10% FCS) and treated with 100nM 4’OHT for 24 hours. Cells were 
washed with PBS and seeded with fresh serum media for another 24 hours after which the cells 
were serum starved (DMEM + 0.1% FCS) for 6 days. At this point (d0 or 0 hour) cells were induced 
with 100U/ml IFNγ and samples were collected after 6 hours, 24 hrs (d1) and 48 hrs (d2). 
 
Figure 5.1 Serum starved ERT2Cre-Rad21 MEFs can be efficiently depleted of cohesin. A) Schematic 
outline of the experimental setup - MEFs were treated with 100nM 4’-OHT while growing in serum media 
for 24h. Cells were then supplemented with fresh serum media for additional 24h before being left in serum 
starvation media for 6 days. These cells were then induced with 100U/ml IFNγ. B) Analysis of genomic DNA 
depletion of the Rad21 allele, Rad21 mRNA (normalised to Ubc, Ywhaz) and Rad21 protein in tamoxifen 
treated MEFs. C) Rad21 protein depletion was confirmed by IF. 
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Tamoxifen-treated serum starved ERT2Cre-Rad21lox/lox MEFs at day0 (Rad21-/- MEF) showed 
complete loss of the loxed Rad21 allele, Rad21 mRNA as compared to tamoxifen-treated ERT2Cre-
Rad21WT/WT MEFs (Rad21+/+ MEF) (Figure 5.1B). RAD21 protein was not detectable in Rad21-/- 
MEFs by Western and IF (Figure 5.1B, C). Importantly, both cohesin wildtype and cohesin 
knockout MEFs were arrested in G1 (or G0) phase upon serum starvation as compared to cycling 
MEFs growing in serum media as assessed by propidium iodide staining (Figure 5.2A). Also, there 
was no indication of cellular stress as determined by p53, p21 and Mdm2 mRNA expression. 
Specifically, Mdm2 expression was not elevated upon cohesin depletion and was similar to 
wildtype levels (Figure 5.2B). Thus this setup allows us to efficiently deplete cohesin and study its 
requirement for gene activation in non-dividing cells while avoiding any secondary effects due to 
activation of stress response in the absence of cohesin. 
 
Figure 5.2 Serum starved cohesin deficient MEFs are arrested in G1. A) Propidium iodide staining. MEFs 
growing in serum media are actively cycling but become arrested in G1 (or G0) phase upon serum starvation 
and stop dividing. B) qRT-PCR analysis of wildtype and cohesin deficient serum starved MEFs for the 
expression of stress response genes. Trp53 (p53), Cdkn1a (p21) and Mdm2 expression is not elevated upon 
cohesin depletion and is maintained at wildtype levels. 
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Using the above setup, I next treated wildtype and cohesin deficient MEFs with IFNγ and 
checked the expression of MHC genes by qRT-PCR analysis at different time points. The induction 
of MHC class I gene H2-K was moderately affected in cohesin deficient MEFs as compared to 
wildtype MEFs while the expression of H2-D was similar to that observed in wildtype MEFs. 
However, the MHC class II genes – H2-Aα and H2-Aβ, failed to be induced in the absence of 
cohesin (Figure 5.3).   
 
Figure 5.3 MHC class II genes fail to be induced by IFNγ in the absence of cohesin. qRT-PCR analysis of for 
MHC genes in wildtype and cohesin deficient serum starved MEFs at 0h and 6h, 24h (d1), 48h (d2) post 
IFNγ treatment. MHC class II genes failed to express in the absence of cohesin but MHC class I genes 
remained unaffected (Normalised to Ubc, Ywhaz; mean ± SE; n=3). 
 
This observation was further confirmed by analysing the cell surface presentation of MHC 
molecules in MEFs upon IFNγ treatment using FACS analysis (Figure 5.4). Uninduced serum 
starved MEFs were used as negative controls. As the ERT2Cre-Rad21 mice were C57BL/6 
background with haplotype b, antibodies against haplotype d and k were used as isotype controls. 
H-2Db MHC class I molecules were efficiently presented on the cell surface in both wildtype and 
cohesin deficient MEFs. However, MHC class II presentation of I-Ab molecules was severely 
reduced in cohesin deficient cells where the levels were close to that observed in untreated cells. 
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Figure 5.4 FACS analysis for MHC presentation on MEF cell surface upon IFNγ induction. Uninduced or 
48h IFNγ induced wildtype and cohesin deficient MEFs were stained with isotype specific antibodies against 
MHC class I and class II molecules and subjected to FACs analysis. Number of cells and the observed 
fluorescence intensity are plotted. Mean fluorescence intensity is indicated by the side of each sample. 
Middle panel: Staining for MHC class I H-2D molecules. H-2Dd was used as isoptype control. H-2Db 
expression is similar in Rad21+/+ and Rad21-/- MEFs. Lower panel: Staining for MHC class II molecules – I-Ak 
(or H-2Ak) (isotype control), I-Ab (or H-2Ab). Rad21 KO MEFs displayed negligible amounts of MHC class II 
molecules. 
 
The observed MHC II activation defect could be the result of a direct requirement of cohesin 
for the expression of these genes, or could even result from the lack of another downstream 
factor involved in IFNγ induction. So, I decided to check the expression of the factors known to be 
required in the IFNγ induction pathway. Almost all these accessory factors, Stat1, Tap1, Rfx1, Rfx5, 
Irf1 and Irf2 were induced at wildtype levels and were not affected by cohesin depletion 
(Figure5.5).  
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Figure 5.5 Expression of accessory factors remains unaffected by cohesin depletion. qRT-PCR analysis of 
WT and Rad21 KO MEFs induced with IFNγ for the shown genes (Normalised to Ubc, Ywhaz; mean±SE; n=3) 
 
The expression of MHC class II genes, additionally requires the master regulatory 
transcription factor CIITA. qRT-PCR analysis revealed that Ciita specifically failed to be activated 
in the absence of cohesin. The reduced expression of Ciita was a transcriptional defect as assessed 
by quantification of primary Ciita transcripts (Figure 5.6) 
 
Figure 5.6 Ciita expression is abrogated in the absence of cohesin. qRT-PCR analysis of WT and Rad21 KO 
MEFs induced with IFNγ. mRNA levels were assessed by designing primers binding in two successive exons 
while primary transcript primers spanned an exon and the subsequent intron (Normalised to Ubc, Ywhaz; 
mean±SE; n=3). 
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As Ciita expression can be repressed by factors like Prdm1 (Blimp-1), TGFβ and SOCS1, it 
was tested if the observed defect in Ciita induction was due to the upregulation of these inhibitory 
factors. qPCR analysis did not indicate any increase in the expression of these factors in cohesin 
depleted cells above those observed in wildtype cells (Figure 5.7).  
 
Figure 5.7 Ciita inhibitory factors are not overexpressed in cohesin deficient MEFs. qRT-PCR analysis of 
wildtype and cohesin depleted MEFs induced with IFNγ (Normalised to Ubc, Ywhaz; mean ± SE; n=3). 
 
Since, all the factors regulating Ciita expression are normally expressed (Figure 5.5) and 
none of the known negative regulators of Ciita are overexpressed (Figure 5.7) in cohesin depleted 
cells, it can be concluded that cohesin is required for the activation of Ciita expression.  
To verify if depletion of other subunits of the cohesin complex had the same effect on MHC 
II activation, I made use of MEFs that can be conditionally depleted of Smc3. Experiments were 
performed on the ERT2Cre-Smc3 MEFs as described previously in Figure 5.1A. Tamoxifen-treated 
ERT2Cre-Smc3lox/lox MEFs showed efficient depletion of both Smc3 mRNA and protein as 
compared to tamoxifen-treated wildtype MEFs (Figure 5.8B, C). The absence of Smc3 had the 
same effect as that of Rad21 loss and MEFs failed to induce Ciita and MHC class II genes while the 
MHC class I genes and accessory factors were induced at normal levels (Figure 5.7D, E, F). 
Altogether, these experiments provide compelling evidence that MHC class I genes and the 
accessory factors which are already expressed at basal level before IFNγ induction, do not require 
cohesin for increased expression. However, cohesin is essential for the activation of previously 
silent master regulator Ciita and MHC class II genes in response to IFNγ treatment. 
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Figure 5.8 Cohesin subunit Smc3 is essential for the activation of Ciita and MHC class II genes upon IFNγ 
induction. A) Schematic of the conditional Smc3 allele with loxP sites flanking exon 4. B) and C) Efficient 
Smc3 mRNA and protein depletion in serum starved MEFs respectively. D), E) and F) qRT-PCR analysis for 
the expression of Ciita, MHC genes and associated factors respectively in response to IFNγ treatment 
(Normalised to Ubc, Ywhaz; mean ± SE; n=2). Similar to Rad21 depletion, activation of Ciita and MHC class 
II genes was severely affected. 
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5.2 HDAC8 inhibition mimics the effect of cohesin deficiency on Ciita 
induction 
Smc3 acetylation promotes stable loading of cohesin complexes onto DNA by counteracting 
the anti-establishment action of Pds5-Wapl (Unal et al., 2008; Zhang et al., 2008). Once cohesin 
is released from chromatin, Smc3 is deacetylated by HDAC8. This is a critical step in the cohesin 
cycle (Figure 1.2) and is required for reusing the pool of cohesin unloaded from chromatin by the 
prophase pathway (Beckouët et al., 2010; Borges et al., 2010). If HDAC8 activity is inhibited, 
acetylated levels of Smc3 increase in the cell (Deardorff et al., 2012a). This would essentially 
diminish the pool of ‘usable’ cohesin available for loading onto chromatin and in effect create a 
cellular state depleted of cohesin. This phenomenon can potentially explain how mutations in 
HDAC8 lead to a CdLS phenotype (Deardorff et al., 2012a). However, the role of HDAC8 and Smc3 
acetylation in gene regulation remains to be explored further. Here, I hypothesize that using a 
specific inhibitor for HDAC8 would have the same effect on IFNγ mediated MHC class II induction, 
as would cohesin depletion.  
In order to test this hypothesis, I treated serum starved MEFs with 25µM PCI (selective 
inhibitor for HDAC8) for 8 hours before inducing them with IFNγ for 24 hours (Figure 5.8A). Cells 
treated with a low (20nM) and a high (100nM) concentration of Trichostatin A (TSA), which 
inhibits class I and class II mammalian HDACs, were used as a control to assess the general impact 
of increased acetylation on gene expression. Cells treated with the HDAC8 inhibitor selectively 
showed reduced induction of Ciita and MHC class II genes – H2-Aα and H2-Aβ. PCI treated MEFs 
also showed a slight increase in the activation of MHC class I genes – H2-K and H2-D, and the 
accessory factors Stat1, Tap1, Irf1. In contrast, TSA treatment lead to an overall decrease in the 
induction of Ciita and both MHC class I and MHC class II genes along with reduction in Stat1 and 
Tap1 expression (Figure 5.9).  
These results show that HDAC8 inhibition specifically impaired Ciita and MHC class II gene 
activation while only moderately enhancing the expression of MHC class I genes and accessory 
factors. On the other hand, TSA treatment resulted in a ubiquitously reduced expression of IFNγ 
induced genes. Further experiments are required to verify these findings and to understand the 
mechanistic details. One possible explanation is that inhibition of HDAC8 causes increased Smc3 
acetylation and a consequent reduction of the ‘usable’ pool of Smc3 required for initiating the 
expression of Ciita and MHC class II genes. At active genes where Smc3 is already present, the 
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inhibition of the HDAC8 deactylation activity favours cohesin association with DNA and supports 
the expression of pre-existing gene transcription. Overall these experiments support the previous 
results that cohesin is required for appropriate induction of Ciita and MHC class II genes in 
response to IFNγ stimulation. 
 
Figure 5.9 HDAC8 inhibition specifically impairs Ciita and MHC class II gene expression. A) Experimental 
setup: MEFs were treated with either DMSO, 25µM PCI (HDAC8 inhibitor) or with 20nM and 100nM TSA 
and induced with IFNγ 8h afterwards, for 24h when samples were collected for RNA extraction. B), C) and 
D) qRT-PCR analysis of Ciita, MHC and associated gene expression respectively. PCI treatment specifically 
impaired Ciita and MHC II expression. TSA treatment, on the other hand, lead to an overall decrease in the 
expression of IFNγ induced genes (Normalised to Ubc, Ywhaz; mean ± SE; n=3). 
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5.3 Cohesin depletion impairs the progression but not recruitment 
of RNA polymerase during activation of gene transcription 
Having ascertained that cohesin is required for IFNγ mediated activation of Ciita, I next 
sought to elucidate the mechanisms by which cohesin controls Ciita activation. Given the role of 
cohesin in mediating looping between cis-regulatory elements, I first explored the chromatin 
landscape around the Ciita locus. I analysed published ChIP-sequencing datasets to identify 
possible enhancers for Ciita expression. Because little information was available for chromatin 
signatures on IFNγ activated non-classical MHC class II presentation, information was collected 
from uninduced MEFs and mES cells – both of which do not express MHC class II genes. This was 
compared to datasets from cells of the B cell lineage and IFNγ induced macrophages, which do 
express Ciita and MHC class II molecules. In addition, data on cohesin and CTCF binding, enhancer-
associated chromatin modifications – H3K4me1, H3K27ac, Nipbl, p300 binding and specific 
transcription factors like Stat1 was compiled and assessed. ChIA-PET experiments which 
combined Polii ChIP with 3C technology were also used to evaluate DNA interactions in ES cells 
and B cells at the Ciita locus (Figure 5.10).  
This helped to identify conserved CTCF binding sites which were found to be associated 
with CTCF in ES cells, MEFs and pre-B cells and will henceforth be called CTCF1, CTCF2 and CTCF3 
peaks. As expected, Ciita promoters were not associated with any Polii and H3K4me3 
modifications in MEFs nor did they show any association with CTCF. Macrophages showed STAT1 
(a pioneer transcription factor) binding associated with increased H3K27ac and H3K4me1 marks 
in response to IFNγ activation at the regions demarcated as enhancer 2 (Enh2) and enhancer 3 
(Enh3). These modifications were specifically enriched in activated macrophages at the putative 
enhancer regions and were absent or diminished in both MEFs and ES cells, indicating their 
possible role in Ciita expression in macrophages. B cells also did not show enhancer associated 
modifications at the Enh2 and Enh3 regions but Nipbl and p300 binding was instead observed at 
the region demarcated Enh4. Closer inspection revealed that Enh4 was not enriched for enhancer-
associated marks in macrophages suggesting that Enh4 might act as a B cell-specific enhancer. 
This idea is also supported by the presence of DNA interactions between Enh4 and Ciita gene body 
as judged from the presence of ChIA-PET signals in B cells and their absence in ES cells. Thus this 
analysis revealed that Ciita expression is not only controlled by cell-type specific promoters but 
also probably by previously under-appreciated action of cell-type specific enhancers. 
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Figure 5.10 Localisation of relevant proteins and histone modifications along with DNA interactions at 
the Ciita locus. Top - Polii ChIA-PET DNA interactions Ciita expressing B cells and non-expressing ES cells. 
Below – illustration for the binding of Smc1, Rad21, CTCF, Polii, H3K4me3 and enhancer associated marks 
– H3K4me1, p300, Nipbl, H3K27ac in ES cells, MEFs, B cell lineage and IFNγ treated macrophages. The grey 
regions highlight the conserved cohesin, CTCF binding sites across all cell types called as CTCF1, CTCF2 and 
CTCF3 peaks. In yellow are highlighted the putative enhancers specific to macrophages – Enh2 and Enh3. 
Region highlighted in red, demarcated as Enh4 has B cell specific enhancer features. 
 
Using this information, I next tested if any of these regulatory elements were involved in 
IFNγ mediated induction of Ciita expression in MEFs. First, I analysed cohesin and CTCF binding at 
the Ciita locus in MEFs both pre- and post-induction (Figure 5.11). Low levels of cohesin binding 
were detected at Tap1 and H2-K1 TSS which remain unchanged upon induction. No cohesin was 
detected at the IFNγ responsive promoter IV of Ciita (similar to negative controls) in uninduced 
MEFs. However, cohesin binding was significantly increased at Ciita promoter IV upon IFNγ 
treatment. Cohesin was also found to be associated with the CTCF sites studied but more 
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experimental replicates are required to check if cohesin binding at these sites was significantly 
increased upon IFNγ treatment. Likewise, cohesin binding at Enh2 site did not show a significant 
increase upon induction. Enh3 (not shown) and Enh4, however, were not found to be associated 
with cohesin at all. Also, Rad21 ChIP in cohesin-deficient MEFs showed a uniformly abolished 
cohesin loading across all sites studied (Figure 5.11A).  
 
 
Figure 5.11 Cohesin is recruited to Ciita promoter IV in response to IFNγ treatment. A) and B) Rad21 and 
CTCF ChIP in uninduced, Rad21+/+ IFNγ induced, Rad21-/- IFNγ induced MEFs. Left panels show enrichment 
in negative and positive controls. Right panel shows binding at Tap1, H2-K1 TSS and Ciita locus. Enrichment 
is plotted relative to 1% input DNA. Rad21 binding is specifically increased at Ciita promoter IV (Ciita prm4) 
region. 
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Binding of CTCF was similar to that of Rad21 at the above tested sites. CTCF binding was 
also increased at Ciita promoter IV and the CTCF1,2,3 sites and more replicates are required to 
confirm this. In contrast to Rad21 binding in cohesin-deficient MEFs, CTCF binding largely 
remained unaffected by reduced cohesin levels (Figure 5.11B). 
Overall, this analysis showed that cohesin binding was significantly increased at the Ciita 
promoter IV in response to IFNγ stimulation, and revealed other cohesin and CTCF associated sites 
with likely important roles in the regulation of Ciita expression. 
One of the possibilities of how cohesin helps initiate expression of a gene is by mediating 
intra-chromosomal interactions between enhancers and promoter. To explore this prospect, I 
performed 3C experiments using Ciita promoter IV as the anchor and measured its interactions 
with the above described putative cis-regulatory sites and CTCF binding sites around the Ciita 
locus.  
 
Figure 5.12 DNA interactions at the Ciita locus. 3C performed at the Ciita locus with pIV as the anchor in 
uninduced, Rad21+/+ induced and Rad21-/- induced MEFs. Formaldehyde fixed chromatin was digested with 
NcoI and religated. Interactions were quantified by PCR after normalising to BAC templates. Results 
indicate a possible reduction in interaction with CTCF3 peak upon induction. Also WT induced MEF Ciita 
pIV possibly interacts with Enh2 (Mean ± SE; n=2) which is lost in Rad21 KO MEFs (n=1). 
 
Preliminary results showed that the chromatin conformation around the Ciita promoter 
changes dramatically upon IFNγ induction in both wildtype and cohesin-deficient MEFs. It is likely 
that in the basal state, Ciita promoter IV interacts with the CTCF3 site. Possibly, this interaction is 
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lost after IFNγ induction and instead the Ciita promoter IV interacts with the Enh2 region. No 
evident interactions with the Enh3 and Enh4 regions were observed upon induction. IFNγ induced 
cohesin depleted cells also showed the loss of interaction with the CTCF3 site but no interactions 
at the Enh2 were observed (Figure 5.12). The differences in Ciita promoter IV interaction between 
wildtype and cohesin deficient cells could potentially help explain the cohesin-dependent 
induction defect. However, a more detailed analysis is required to be able to assess the 
importance of these interactions 
Results from 3C experiments so far have repeatedly underscored the need to evaluate 
alternate roles of cohesin in mediating gene regulation. As cohesin is often found at the 
promoters of active genes (Kagey et al., 2010; Faure et al., 2012) and has been shown to be 
associated with subunits of the Mediator complex (Kagey et al., 2010), it is possible that cohesin 
may have a direct role in influencing RNA polymerase activity. Keeping this in mind, I next studied 
the effects of cohesin depletion on the steps of RNA polymerase recruitment and its licensing to 
successful initiation and elongation phases.  
First, I assessed the H3K4me3 chromatin modification which marks the TSS of active genes. 
H3K4me3 mark was completely absent from Ciita promoters in uninduced MEFs where Ciita is 
silent. Upon IFNγ induction, H3K4 was selectively trimethylated at the promoter IV. The gain of 
H3K4me3 remained unaffected by cohesin depletion (Figure 5.13A), indicating that cohesin 
deficient cells received proper signals to initiate transcription and were appropriately primed to 
do so. 
The next step was to test if RNA polymerase could be efficiently recruited to the primed 
promoter in the absence of cohesin. For this, I performed a ChIP with an antibody recognising the 
N-terminus of RNA Pol II. Results showed that Pol II recruitment was increased to similar levels in 
both wildtype and cohesin depleted MEFs induced with IFNγ at Tap1, H2-K1 TSS and specifically 
at Ciita promoter IV sites. Therefore, even though Ciita transcription was severely abrogated in 
cohesin-deficient cells, Pol II recruitment at promoter IV was not affected (Figure 5.13B). 
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Figure 5.13 RNA polymerase is recruited to Ciita pIV 
in cohesin-depleted MEFs upon induction but 
elongation is impaired.  
A) H3K4me3 ChIP. Enrichment is plotted relative to H3 
binding. H3K4me3 modification is specifically gained 
at Ciita pIV upon IFNγ stimulation and remains 
unaffected by cohesin depletion.  
B) Total Pol II ChIP with an antibody against the N-
terminal. Enrichment is plotted relative to 1% input 
DNA. Pol II is also specifically binds to Ciita pIV upon 
IFNγ stimulation in both WT and Rad21 KO MEFs. 
Cohesin depletion does not affect Pol II recruitment. 
C) and D) ChIP against the Ser5 and Ser2 modifications 
of the Pol II CTD representative of initiation and 
elongation state of Pol II. Enrichment is plotted 
relative to 1% input DNA. While Ser5 and Ser2 
modifications at most sites tested remained 
unaffected by cohesin depletion, their incidence at 
Ciita pIV was reduced in cohesin deficient IFNγ 
induced MEFs. This indicates that the recruited Pol II 
could not initiate and elongate effectively. 
(Mean ± SE; n=3). 
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But the presence of Pol II at the promoter is not enough to ensure successful transcription 
of a gene. The entry of Pol II into the initiation and elongation phase is also carefully regulated. 
The CTD of Pol II is phosphorylated at Ser5 and Ser2 during the initiation and elongation phase 
respectively (Saunders et al., 2006; Zhou et al., 2012). ChIP experiments were performed using 
antibodies against the Ser5 or Ser2 modified CTD of Pol II. Results showed that appropriate levels 
of Ser5 and Ser2 phosphorylated forms of Pol II were present at Gapdh, Tap1 and H2-K1 TSS, in 
both wildtype and cohesin deficient IFNγ treated MEFs. Specifically at the Ciita promoter IV, 
however, a decrease was observed in the binding of the Ser5, Ser2 modified Pol II in the absence 
of cohesin (Figure 5.13C, D).  
Thus, these experiments indicate that cohesin depletion did not affect the recruitment of 
Pol II in response to IFNγ treatment but prevented the progression of Pol II into the initiation and 
elongation phase which may account for the observed abrogation of Ciita expression. 
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5.4 Paxip1 deficient fibroblast-like cells also show reduced Ciita 
induction upon IFNγ stimulation 
It is possible that cohesin impacts enhancer function by more than being a mediator of 
enhancer-promoter interactions. Perhaps, it is also important for the designation and activation 
of enhancer activity, a process which is associated with histone modifications like H3K4me1 and 
H3K27ac (Creyghton et al., 2010; Rada-Iglesias et al., 2011). The deposition of H3K4me1 marks is 
attributed to the methyltransferase activity of the MLL3/4 complexes (Lee et al., 2013). Given the 
phenotypic overlap between the impact of cohesin depletion with that of the depletion of MLL3/4 
subunit - PTIP at the Igh locus (Daniel et al., 2010), along with the similarity between CdLS and 
Kabuki phenotype, as discussed earlier (Section 1.3.4), it can be speculated that cohesin functions 
through modulating the activity of the MLL3/4 complex. One can hypothesize that if cohesin 
functioned through the MLL3/4 complex, the absence of MLL3/4 complex would have the same 
effect on IFNγ induction as that of cohesin depletion.  
In order to test this, I obtained ES cells with a floxed Paxip1 allele (as described in Kim et al., 
2009) where Paxip1 – a component of the MLL3/4 complex, can be deleted by transfecting with 
Cre recombinase. As ES cells failed to induce Ciita expression upon IFNγ treatment (not shown) as 
previously reported (Morris et al., 2000; van den Elsen et al., 2000), these ES cells were 
differentiated into fibroblast-like cells. Several strategies for differentiation were tested. Cells 
remained immune to IFNγ induction even 10 days after embryoid body formation post LIF removal 
from the media. Differentiating these ES cells as a monolayer on gelatin in the absence of LIF for 
extended periods of time also did not alleviate this immunity. Treatment of these monolayer 
differentiated ES cells with factors like Activin A or Fgf2, known to promote differentiation into 
ectodermal lineages, also did not yield cells that could be induced to express Ciita by IFNγ 
treatment (not shown). Eventually, treatment of monolayer differentiated ES cells with high 
concentrations of Retinoic acid for more than 4 days gave rise to population of fibroblast-like cells 
which could be induced with IFNγ to express Ciita and MHC class II genes. These fibroblast-like 
cells were then used for further analysis. 
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Figure 5.14 Paxip1 is required for optimal activation of Ciita and MHC class II genes in response to IFNγ. 
A) Schematic experimental setup: ES cells were differentiated into fibroblast-like cells by LIF withdrawal 
and subsequent retinoic acid treatment. These cells were then transfected with either empty vector-GFP 
(mig) or Cre-GFP vector (cre). Sorted cells were IFNγ induced for 48h. B) qRT-PCR analysis showed efficient 
Paxip1 mRNA depletion. Ciita and MHC class II gene activation was impaired upon Paxip1 depletion but 
MHC class I and other genes remained unaffected (Normalised to Ubc, Ywhaz; mean ± SE; n=3). 
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Briefly, the Paxip1fl/fl ES cells growing in serum media were allowed to differentiate by LIF 
withdrawal into a monolayer on gelatin for 4 days. These cells were trypsinised and replated 
sparsely onto gelatin for 10 days in ES serum media supplemented with 1µM Retinoic acid without 
LIF. The cells were then transfected with either the retroviral MSCV-IRES-Cre-GFP vector or the 
empty MSCV-IRES-GFP (MIG) vector as control. Cells were sorted 5 days post transfection based 
on GFP expression. These cells were replated and induced with 100U/ml of IFNγ for 48 hours 
before collecting for analysis (Figure 5.14A). 
qRT-PCR analysis on the collected samples revealed that Paxip1 mRNA was efficiently 
depleted upon Cre transfection. These Paxip1 depleted fibroblast-like cells also showed a 
significantly reduced induction of Ciita and MHC class II genes while MHC class I gene activation 
remained unaffected (Figure 5.14B). Thus, the effects of Paxip1 depletion on IFNγ stimulation 
mirrored those observed upon cohesin depletion and HDAC8 inhibition in being selectively 
restrictive to Ciita and MHC class II gene expression. This shows that PTIP subunit is required for 
the proper activation of these genes and suggests that cohesin might function through the action 
of the PTIP subunit of the MLL3/4 complex. 
5.5 Knockout of MLL3 and MLL4 subunits in preadipocytes does not 
impair Ciita induction 
To better understand the role of MLL3/4 complex in IFNγ mediated gene activation, I used 
SV40 immortalised preadipocytes from Mll3-/-Mll4flox/flox mouse. Preadipocytes are not classical 
antigen presenting cells, thus their response to IFNγ stimulation should be similar to that 
observed in fibroblasts. Mll3/Mll4 double knockout was achieved by stable transduction with 
adenoviral Cre (Ad-Cre) vector. Adenoviral GFP (Ad-GFP) transfected preadipocytes served as a 
control (as described in Lee et al., 2013). The Ad-GFP or Ad-Cre transfected Mll3-/-Mll4flox/flox 
preadipocytes were induced with IFNγ for 48 hours and gene expression changes were analysed 
by qRT-PCR. Interestingly, and in contrast to deletion of the PTIP subunit of the MLL3/4 complex, 
Mll3/Mll4 double knockout itself did not impair the activation of Ciita and MHC genes (Figure 
5.15). 
These results suggest that cohesin mediated gene activation requires the activity of specific 
subunits of the MLL3/MLL4 complex like PTIP. Other components like the MLL3 and MLL4 
subunits, are not essentially required. 
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Figure 5.15 Mll3/Mll4 double knockout does not impair IFNγ induction. Ad-Cre or Ad-GFP transfected 
Mll3-/-Mll4fl/fl preadipocytes were induced with IFNγ for 48h and samples were collected for RNA analysis. 
qRT-PCR results show that Mll3/Mll4 double knockout did not affect the induction of Ciita, MHC and other 
genes tested (Normalised to Ubc, Ywhaz; mean ± SE; n=3). 
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5.6 Ciita and MHC class II gene expression can be rescued by TSA 
treatment in cohesin deficient fibrobalsts 
Activation of Ciita expression from pIV is accompanied by increased histone acetylation 
(Morris et al., 2002), and loss of Ciita expression is associated with decreased acetylation 
(Majumder et al., 2008). Thus, it is possible that absence of cohesin impairs the critical process of 
histone acetylation required for Ciita activation.  If that is the case, an increased histone 
acetylation should help to recover from the effect of cohesin deficiency.  
To test this hypothesis, I pharmacologically inhibited class I and class II HDACs by using TSA 
which increases the global acetylation levels. First, serum starved MEFs were treated with 20nM 
and 100nM TSA alone for 24h to control for any effects of increased acetylation in the absence of 
IFNγ stimulation (Figure 5.16A top). Notably, TSA treatment alone did not activate the expression 
of Ciita and MHC class II genes. For the rescue experiment, ERT2Cre-Rad21 MEFs were treated 
with tamoxifen and serum starved as described previously in Figure 5.1A. Wildtype and cohesin 
depleted MEFs thus obtained were induced with 100U/ml of IFNγ. 6h post IFNγ induction, cells 
were treated with DMSO or 20nM TSA or 100nM TSA and samples were collected at the end of 
24h (Figure 5.16A bottom). As observed from the qRT-PCR analysis, TSA treatment post IFNγ 
induction did in fact increase the transcription of Ciita and MHC class II genes in cohesin deficient 
cells (Figure 5.16B).The higher the TSA concentration, the greater was the increase in expression 
of these genes. Even though TSA treatment did not affect the transcription of most genes in WT 
MEFs, it did reduce the expression of Ciita and H2-Aa. This can be explained by the observation 
that Ciita recruits HDACs to gene promoters to promote gene expression and therefore optimal 
expression is a result of a balance of acetylation and deacetylation activity of HATs and HDACs, 
respectively. Thus while TSA treatment increased Ciita and MHC class II gene expression in 
cohesin deficient cells, it inevitably lead to a decrease in their expression in WT cells. 
Altogether, these experiments indicate that cohesin might also be playing an important role 
in modulating histone acetylation facilitating activation of transcription. In addition, they point 
towards the potential use of HDAC inhibitors to partially rescue the activation defect of genes in 
the absence of cohesin. 
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Figure 5.16 TSA can rescue cohesin-dependent Ciita induction defect. A) Experimental setup. Top: Serum 
starved MEFs treated with 20nM or 100nM TSA for 24h. Bottom: WT and Rad21 KO serum starved MEFs 
were treated with TSA 6h post IFNγ induction and RNA samples collected at the end of 24h. B) qRT-PCR 
analysis for the expression of Ciita, MHC and associated genes. TSA treatment increases transcription of 
Ciita and MHC class II genes in the absence of cohesin (Normalised to Ubc, Ywhaz; mean ± SE; n=2). 
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5.7 Discussion and future perspectives 
The work presented in this chapter was aimed at investigating the role of cohesin in the 
activation of gene expression and focused on the study of MHC induction by IFNγ stimulation in 
serum starved MEFs. This system has two major advantages. Firstly, serum starvation arrests the 
MEFs in a G1 (or a quiescent G0) phase. This allowed me to analyse the impact of cohesin 
depletion on gene expression in non-dividing cells, thus avoiding secondary effects due to cell 
cycle stress. Secondly, MEFs express very low basal levels of MHC class I molecules and do not 
express MHC class II genes at all. But they can be stimulated by IFNγ to increase the expression of 
MHC class I genes as well as to induce the expression of MHC class II genes which is otherwise 
restricted to antigen-presenting cells only. Therefore, this system allowed me to study if cohesin 
was required for the activation of MHC genes in response to IFNγ in non-dividing cells.  
The results clearly showed that MHC class II genes failed to be induced normally in the 
absence of cohesin. In contrast, the upregulation of MHC class I genes remained mostly 
unaffected by cohesin depletion. Detailed examination revealed that cohesin depletion abolished 
the induction of Ciita, the master regulator essential for the expression of MHC class II genes. 
Since all the regulatory factors known to be important for Ciita expression were appropriately 
expressed and none of the factors known to negatively impact Ciita expression were upregulated, 
it is likely that cohesin is directly involved in Ciita activation. At this stage, it is not clear whether 
the MHC class II induction defect is a direct effect of cohesin depletion or a consequence of the 
lack of Ciita. Further experiments based on ectopic expression of Ciita in cohesin deficient cells 
can help determine if cohesin is directly required for the activation of MHC class II genes in 
response to IFNγ stimulation. It is noteworthy that cohesin depletion did not affect the induction 
of all MHC genes. In fact, the genes which were already expressed at basal levels prior to IFNγ 
stimulation, like MHC class I genes and the associated regulatory factors, did not require cohesin 
for upregulation. On the contrary, MHC class II genes and Ciita are silent in MEFs and their 
promoters are not associated with RNA polymerase prior to IFNγ treatment. To test if the absence 
of pre-bound RNA polymerase was the determining factor for cohesin sensitivity, the expression 
of Irf8 was analysed.  IRF8 is another regulatory factor upregulated upon IFNγ stimulation, but 
like Ciita it also does not have bound RNA polymerase as seen from Pol II ChIP-sequencing data in 
MEFs. Unlike Ciita, Irf8 expression could be induced in the absence of cohesin, albeit with a slower 
kinetics (Figure 5.5). This suggests that not all inactive genes require cohesin for activation and it 
remains to be seen what characterises the activation of a gene to be cohesin-dependent.  
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Nevertheless, these experiments show that cohesin plays a crucial role in the initiation of the 
expression of specific genes.  
To elucidate the specific role of cohesin in the induction of Ciita, I did ChIP and 3C 
experiments. ChIP experiments showed that Rad21 binding was significantly increased at the 
activated Ciita promoter IV upon IFNγ induction. Given the role of cohesin in mediating long-range 
DNA interactions, it is possible that cohesin facilitates activation of transcription by establishing 
contacts between the promoter and the enhancer. This was tested by 3C experiments. In the 
absence of information regarding enhancer elements required for IFNγ mediated Ciita activation 
in non-hematopoietic cells, preliminary results did not reveal a prominent role of cohesin in 
bridging distant regulatory elements to Ciita promoter IV. Still, small differences in the genomic 
architecture around CTCF binding sites and putative enhancer regions were observed. The 
functional significance of these changes remains to be validated. As the genomic landscape plays 
a significant role in determining the potential for gene activation, it is of great interest to explore 
this further. A 4C or a 5C experiment centred around the Ciita locus would extend the scope of 
this analysis. Coupled with ChIP data for enhancer-associated chromatin marks like H3K27ac, 
H3K4me1 and for Nipbl, Mediator and STAT1 binding, this analysis would help us understand the 
role of cohesin in mediating DNA looping between regulatory DNA elements as required for gene 
activation. 
It is possible that cohesin can directly impact transcription initiation independently of its 
role in mediating enhancer-promoter interactions. Some of the early steps of transcriptional 
initiation involve the deposition of the H3K4me3 mark and recruitment of RNA polymerase at the 
promoter. ChIP results showed that appropriate amounts of H3K4me3 and Pol II were present at 
Ciita promoter IV after IFNγ induction in cohesin deficient cells. However, ChIP for the Ser5 and 
Ser2 modified CTD of Pol II indicated a reduction in the initiating and elongating forms of Pol II 
specifically at Ciita promoter in the absence of cohesin. This suggests that even though Pol II is 
recruited to the Ciita promoter upon IFNγ induction, it may not proceed into productive 
transcription. Cohesin may therefore, play an important role in licensing RNA polymerase into 
successful initiation and elongation, either directly or through the recruitment of other factors. 
This work made use of different antibodies directed against NTD and the modified CTD of 
Pol II to assess the state of transcription and the analysis was limited to the promoters of Ciita 
gene. As the presence of Pol II does not indicate its transcriptional status, it would be interesting 
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to further analyse the role of cohesin in modulating polymerase activity with greater refinement 
using GRO-seq (Global Run ON sequencing). GRO-seq allows profiling of nascent transcripts 
produced by Pol II activity by the incorporation of biotinylated nucleotides thus providing a 
genome-wide snapshot of transcriptionally engaged polymerase. Thus the GRO-seq profile across 
the Ciita gene body would essentially be able to clarify if indeed cohesin depletion does not allow 
the progression of recruited polymerase into active transcription. Further to this aim, it would 
also be interesting to asses if cohesin depletion affects the recruitment of elongation factors like 
pTEFb or NELF, thus causing polymerase pausing.  
In addition to cohesin’s role in DNA looping and RNA polymerase processivity, this work also 
explored the role of MLL3/4 complex subunits in the regulation of IFNγ mediated gene activation. 
Interestingly it was observed that while the depletion of MLL3 and MLL4 subunits had no effect 
on Ciita induction, depletion of the PTIP subunit of the same complex specifically impaired the 
activation of Ciita and MHC class II genes, but not the other IFNγ responsive genes tested. 
Moreover, since the deposition of H3K4me3 at Ciita promoter IV upon IFNγ induction is not 
affected in cohesin-deficient cells, it is unlikely that cohesin functions in gene activation by 
modulating the methyltransferase activity of MLL3/MLL4 at promoters. It is possible that PTIP 
plays a role in Ciita activation independently of cohesin. However, given the similarity in the 
impact of deletion of both Paxip1 and Rad21 selectively on Ciita and MHC class II genes, and the 
observation that the effect of Paxip1 deletion is milder than that of cohesin depletion, it is 
possible that PTIP is one of the effectors of cohesin function in gene activation.  
The apparent disparity in the impact of the absence of different subunits of the same 
complex may be due to a role of PTIP in gene regulation independent of its role as part of the 
MLL3/4 complex or due to a possible redundancy of the MLL3, MLL4 subunits with the activity of 
MLL1 and MLL2 subunits. It has previously been shown that PTIP itself is not required for the 
methyltransfearse activity of the MLL3/4 complex and its absence does not affect the integrity of 
the complex (Cho et al., 2007). In addition, studies at the Igh locus reveal that PTIP is required for 
the association of RNA polymerase at regions which show PTIP dependent H3K4me3 marks. The 
authors also suggest an alternate model where PTIP regulates gene expression via direct 
interaction with DNA binding transcription factors (Daniel et al., 2010). My results show that PTIP 
depletion, but not MLL3/MLL4 depletion, specifically impacts induction of Ciita and MHC class II 
genes upon IFNγ stimulation. This is consistent with the idea of a direct role of PTIP in gene 
regulation. As PTIP and SMC1 have previously been shown to interact (Patel et al., 2007), it may 
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be that cohesin directs PTIP to gene promoters in response to gene activation signals. Further 
experiments, including PTIP ChIP at the Ciita promoter in the presence or absence of cohesin, are 
required to validate this hypothesis. Nevertheless, the overlapping impact of cohesin and PTIP 
depletion on gene expression can possibly explain the similarities in the phenotypic features 
associated with CdLS and Kabuki syndrome. The observation that mutations in cohesin subunits 
lead to similar developmental defects as mutations in other regulatory proteins, should be 
explored in greater detail. This would help us explain the occurrence of CdLS in patients which 
show no mutations in cohesin and its regulatory subunits. It also emphasises on the need to check 
for the incidence of cohesin mutations in other broad spectrum complex genetic disorders like 
Kabuki syndrome. 
So far, there is no remedial treatment to alleviate the various problems faced by CdLS 
patients. Medical care is mostly focused at disease management rather than treatment. Here, I 
showed that treatment of cohesin deficient cells with the HDAC inhibitor TSA, could partly rescue 
the Ciita induction defect. Even though TSA would not be a feasible remedy due to its systemic 
toxicity, these preliminary results point towards the exciting potential for the development of 
drugs based on targeting epigenetic modifiers involved in the process of cohesin mediated gene 
regulation. 
Therefore, the work presented here explores the potential role of cohesin in gene activation 
and provides strong experimental evidence that cohesin is required for the expression of Ciita and 
MHC class II genes in response to IFNγ stimulation. This cohesin-dependent Ciita induction defect 
can possibly contribute to the increased incidence of recurrent infections in CdLS patients, where 
the patients display impaired immune responses. Preliminary results further implicate cohesin 
functions beyond DNA looping potentially via regulating the transition of paused RNA polymerase 
into active transcription and through the action of DNA binding factors like the PTIP subunit of 
the MLL3/4 complex. Altogether, this study underscores the role of cohesin during transcriptional 
activation, and uncovers previously unexplored possibilities of cohesin mediated gene regulation. 
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Chapter 6 : General discussion  
The cohesin complex was initially recognised for its essential functions in chromosome 
segregation during cell division and DNA repair. During the last decade, several studies have 
shown that cohesin also plays an important role in regulating gene expression. Moreover, defects 
in cohesin functions in gene regulation are thought to be the major cause of human genetic 
disorders like CdLS and are suspected to be involved in the development of several cancers. 
However, mechanistic details of how cohesin contributes to the characteristic features associated 
with CdLS patients and occurrence of human malignancies remain unknown. The work presented 
here highlights some interesting aspects of cohesin mediated gene regulation.  
6.1 Cohesin depletion in mouse ES cells does not cause a global 
collapse in pluripotency but deregulates specific genes 
The use of ERT2Cre mediated conditional deletion of Rad21 in mouse ES cells proved to be 
a better strategy for analysing the impact of cohesin depletion, than previously published 
knockdown studies. The conditional Rad21 knockout strategy was particularly useful as it allowed 
us to rapidly deplete chromatin bound cohesin in cycling ES cells within 24 hours.  This permitted 
me to analyse gene expression changes prior to arrest in G2 and before the onset of stress 
responses due to the loss of cohesin functions in cell division. Therefore, secondary effects on 
gene expression were avoided. Transcriptional analysis post 24 hours of cohesin depletion in ES 
cells revealed about 600 deregulated genes. However, not all pluripotency associated genes were 
downregulated nor was there a preferential upregulation of differentiation associated genes. In 
fact, the impact of cohesin depletion was found to be highly locus specific. This observation 
contrasts with previously published reports, which suggest that cohesin is required for the 
maintenance of pluripotency (Ding et al., 2009; Hu et al., 2009; Kagey et al., 2010; Nitzsche et al., 
2011). The observed differences may be attributed to the activation of stress response due to 
prolonged culture of ES cells (5 days) with reduced cohesin levels using the RNAi knockdown 
strategy (Figure 3.5B). This speculation is supported by the evidence that stress signals trigger the 
differentiation of ES cells (Lin et al., 2005; Maimets et al., 2008; Li et al., 2012). In fact, gene 
expression changes observed in my conditionally cohesin depleted ES cells at 48 hours and upon 
doxorubicin treatment, showed a more drastic impact on pluripotency and resembled the 
changes observed in the knockdown studies. Therefore, the loss of pluripotency-associated 
transcriptional profile most likely results from indirect effects of stress response due to prolonged 
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cohesin loss and is not a true indication of cohesin functions in ES cell gene regulation. These 
results illustrate the importance of avoiding the activation of stress response due to cell cycle 
defects while studying cohesin functions in gene regulation. This study also establishes that 
limited number of genes are affected by perturbations in cohesin levels in the cell and the impact 
is context dependent. 
6.2 Cohesin is not essential for the maintenance of enhancer-
promoter interactions 
In this study I compared the enhancer-promoter interactions at some key pluripotency 
associated genes in ES cells with or without cohesin and with ES cells which had been 
differentiated for 24 hours. The chromatin interactions were assessed by 3C while the presence 
of cohesin on DNA was quantified by ChIP. These experiments unexpectedly revealed that 
enhancer-promoter interactions at certain loci in cohesin deficient ES cells were not affected even 
though loss of cohesin binding was associated with deregulation of the expression of those genes. 
This was true for the Lefty1 and Klf4 loci. Even at the Nanog locus, where both gene expression 
and enhancer-promoter interactions were reduced in response to cohesin loss, the loss in 
interactions was much smaller than the loss in the amount of DNA bound cohesin at the enhancer. 
Incidentally, the enhancer-promoter interactions at the same loci were more significantly reduced 
upon differentiation and showed an associated loss in cohesin binding specifically at the enhancer 
region. Taken together, it can be concluded that enhancer-promoter interactions can be 
maintained in the absence of cohesin at the genes tested. Additionally, it also suggests that 
changes in enhancer-promoter interactions alone cannot explain the observed changes in gene 
expression and cohesin may impact on other aspects of transcriptional regulation. Although, it is 
noteworthy that in this study only interactions between the promoter and the corresponding 
functional enhancer region were measured. It is possible that gene promoters are involved in 
additional chromatin interactions which may also play a part in transcriptional regulation. 
Mechanistically, it is possible that the cohesin ring structure stabilises the DNA loop formed 
between enhancers and promoters but the loop is actually maintained by multiple protein-
protein interactions between the several proteins associated at enhancer and promoter regions. 
This hypothesis is supported by the observation that transcription factors like OCT4, SOX2 and 
NANOG are directly involved in both higher order genome organisation and local chromatin 
conformation. Moreover, loss of either OCT4 or NANOG diminishes long-range interactions 
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between OSN bound region (de Wit et al., 2013; Denholtz et al., 2013). Additionally, many other 
factors like SATB1 and LDB1 have also been shown to contribute to genome organisation and 
transcriptional regulation (Cai et al., 2006; Soler et al., 2010). In cohesin-deficient ES cells, OCT4 
is still expressed appropriately and NANOG only shows a small reduction. Therefore, enhancer-
promoter interactions may in part be maintained by protein-protein interactions centred around 
the OSN cluster in the absence of cohesin. And upon differentiation, OCT4 and NANOG expression 
is significantly reduced.  
 
Figure 6.1 A schematic depiction of possible chromatin landscape changes in ES cells associated with 
cohesin depletion and with differentiation. Cohesin rings are depicted in light blue and the target gene as 
small black rectangle. Enhancer-promoter interactions can still be maintained at certain loci after cohesin 
depletion, possibly through interactions between associated transcription factors. Differentiation, 
however, is associated with reduced expression of pluripotency associated transcription factors. It is also 
accompanied by loss of Nipbl binding and consequently cohesin loading. In the absence of a physical 
trapping of chromatin by cohesin as well as loss of transcription factor based interactions, chromatin 
looping is no longer maintained. 
 
Thus, together with loss of cohesin binding at enhancer, reduced protein-protein 
interactions between transcription factors, might together be responsible for reduced enhancer-
promoter interactions in differentiating ES cells. If this is the case, these experiments indicate that 
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mere contact between enhancer and promoter does not specify the transcriptional status of the 
gene. It also suggests that the changes observed in long-range cis-regulatory interactions upon 
cohesin depletion can possibly be a consequence rather than being the cause of the associated 
transcriptional changes. 
6.3 Cohesin plays essential roles in the activation of specific gene 
transcription  
While most studies so far have relied on the analysis of the impact of cohesin depletion on 
the steady state of the cellular system, I have here explored the possibility of cohesin being 
involved in the process of gene activation. Experiments in IFNγ induced MEFs showed that cohesin 
is required for the activation of Ciita gene expression. Ciita and MHC class II genes, which are not 
expressed in MEFs unless treated with IFNγ, failed to be induced in the absence of cohesin. On 
the other hand, the induction of MHC class I genes, which are expressed at basal levels in all cell 
types, was not affected by cohesin depletion. These observations show that cohesin is essential 
for the establishment of a new gene expression programme upon IFNγ treatment and regulates 
the activation of master regulators like Ciita. Contrarily, upregulation of previously expressed 
genes does not require cohesin. This provides a new paradigm in the field of cohesin mediated 
gene regulation whereupon cohesin is necessary for the successful activation of key transcription 
factors in response to cellular signals. It opens up several directions of future investigation like 
the impact of cohesin mutations in the process of limb and brain development, cognition and 
mounting of immune response – some typical processes affected in CdLS patients. In fact, reduced 
MHC class II expression might in part be responsible for the increased incidence of infections in 
CdLS patients (Jyonouchi et al., 2013) and needs to be investigated further in patient cell lines. 
This activity of cohesin is in some way similar to that of pioneer transcription factors which 
play critical roles in gene activation (Zaret and Carroll, 2011). However, unlike pioneer factors, 
cohesin functions are limited to only select genes within the same pathway. It will be of utmost 
importance to determine what features demarcate genes that show cohesin-dependent gene 
activation. Not all genes which were silent in uninduced MEFs showed cohesin-dependent 
activation. Therefore, a genome-wide analysis of several chromatin features like histone marks, 
RNA polymerase binding and binding of chromatin remodelling factors might be useful in 
discovering what makes some genes cohesin-sensitive and others not. In fact, it might be more 
interesting to find what makes the other genes, which also show increased cohesin binding upon 
induction, to not be dependent on it. Additionally, further investigation is required to figure out 
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what brings or signals cohesin loading at activated genes. In this respect, an examination into the 
requirement of CTCF or NIPBL in this process might give some perspective.  
6.4 Cohesin can potentially operate by regulating the activity of RNA 
polymerase and recruitment of PTIP 
The data presented here shows that cohesin can potentially regulate transcription by 
modulating the activity and processivity of RNA polymerase but further experiments are required 
to clarify this role. It will be useful to compare the transcriptional profile of Ciita gene in the 
absence of cohesin with that of cells treated with specific inhibitors which block the initiation or 
elongation phase of Polymerase activity.  
Another interesting observation made here is that the phenotype or the impact of Paxip1 
deletion on Ciita induction is similar to that of cohesin depletion but this is not the case for 
Mll3/Mll4 deletion. These experiments were done contemplating cohesin functions in depositing 
histone methylation marks at enhancers and promoters through the activity of MLL3/MLL4 
complex. Given the striking similarity between the clinical features of Kabuki syndrome and CdLS 
patients, it is still promising to explore this possibility further. Consequently, it will be useful to 
map H3K4me1 marks around the Ciita locus. The impact of PTIP depletion further argues for the 
role of MLL complexes in cohesin mediated gene regulation. It is probable that at the Ciita locus, 
MLL3/MLL4 subunit function is redundant with that of the MLL1/MLL2 subunits. It would be 
interesting to check the impact of depleting other individual subunits of the MLL complexes on 
Ciita induction. Additionally, it is also possible that PTIP functions independently of the MLL 
complexes to regulate gene expression.  
Given the role of cohesin in mediating long-range enhancer promoter interactions, it will 
be valuable to evaluate the connection between enhancer looping and polymerase activity. 
Recent reports have shown that preformed enhancer-promoter interactions exist  prior to 
activation of gene transcription (Fanucchi et al., 2013; Jin et al., 2013) and are frequently 
associated with paused Polymerase (Ghavi-Helm et al., 2014). It remains to be seen if cohesin is 
bound at the sites of preformed chromatin interactions or is loaded in response to gene activating 
stimuli. In another scenario, cohesin initiated looping of an enhancer close to a promoter region 
might trigger the elongation of polymerase into successful transcription. 
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Figure 6.2 Possible mechanism of cohesin-mediated Ciita activation. A) The Ciita gene locus is not 
transcribed in uninduced MEFS. B) Stimulation of MEFs with IFNγ causes STAT1 binding along with the 
associated regulatory factors like RFX1, RFX5, IRF1, IRF2, to the Ciita promoter. This is accompanied by 
cohesin loading which is known to occur at active regulatory elements. The histones are modified to 
H3K4me3 at the TSS and Ser5/Ser2 phosphorylated polymerase actively transcribes Ciita gene. C) 
Stimulation of MEFs in the absence of cohesin results in the failure to induce Ciita transcription. The 
absence of cohesin could potentially affect any of the steps mentioned in B). Based on the data presented 
in this study, I speculate that in the absence of cohesin, the enhancer cannot form stable contacts with the 
Ciita promoter. Absence of cohesin also prevents the release of polymerase into active elongation due to 
reduced Ser5 and Ser2 phosphorylation. A role for PTIP in the induction of Ciita transcription is suggested 
by the failure of Paxip1-deficient MEFs to express Ciita in response to IFNγ. Together these events prevent 
the successful transcription of the Ciita gene.  
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6.5 The impact of cohesin depletion on Myc expression is context 
dependent 
Experiments in fibroblasts showed that cohesin is not essential for appropriate induction of 
Myc expression. Steady state levels of Myc were reduced in G1 arrested cohesin deficient preB 
cells but not in resting CD4 DP and SP thymocytes. More interestingly, Myc was post 
transcriptionally upregulated in cohesin depleted ES cells cultured in 2i media but not in those 
cultured in serum + LIF media. These observations show that cohesin does play a role in fine tuning 
Myc expression but is not essential for its expression. Moreover, the post-transcriptional 
regulation of Myc provides yet another novel mechanism of cohesin mediated gene regulation. It 
remains to be confirmed if the upregulation is mediated through stabilization of Myc by the action 
of Pvt1, which is also upregulated in the absence of cohesin. If confirmed, the deregulation of 
Pvt1 expression in human malignancies, which show mutations in cohesin and its regulatory 
subunits, provides a promising avenue for exploring cohesin functions in cancerous cells. 
Taken together, this work shows that cohesin impacts gene expression not only by 
regulating chromatin interactions but also influences transcription more directly by modulating 
the activity of components of the transcriptional machinery. This work also provides evidence 
that cohesin plays an essential role in the process of Ciita gene activation.  
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Appendix 1: Gene expression in ES cells changes with 
cellular density in the culture dish over time 
A confluent well of a 6-well plate of ES cells growing in 2i media was trypsinised (0h sample) 
and 0.5x106 cells were replated onto new wells and seeded with fresh media. Samples were 
collected at the indicated time points below and gene expression was analysed by RT-qPCR. 
Results showed that Lefty1, Lefty2 and Myc expression varied over time after the initial replating 
of the cells while oct4 was more uniform. At lower density at 12h, Lefty genes showed reduced 
expression while Myc expression was increased. The gene expression profile of confluent cells 
was regained after 48 hours. Therefore, the gene expression changes were inherently dynamic 
and not a permanent effect.  
 
 
Figure: Relative gene expression profiles of pluripotency associated genes after different times of 
plating the ES cells on culture dish. Expression is normalised to Ubc and Ywhaz. 
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Appendix 2: Nipbl depletion does not affect the upregulation 
of Myc expression upon activation of naïve CD4+CD25- T cells 
Naïve CD4+ T cells are quiescent non-dividing cells. These cells can be activated by 
simultaneous engagement of the TCR-CD3 complex and the co-stimulatory molecule CD28. Upon 
activation, CD4+ T cells undergo a growth phase of ∼24 hr, followed by massive clonal expansion 
and differentiation phases that are essential for appropriate immune defence and regulation. This 
process of CD4+ T cell activation is accompanied by the induction of Myc expression (Wang et al., 
2011b). Therefore, the activation of CD4+ T cells provides another opportunity to investigate the 
role of cohesin in regulating Myc expression in response to extracellular signals. However, the 
number of peripheral T cells in CD4Cre-Rad21lox/lox mice is greatly reduced, probably due to the 
requirement of RAD21 in proper TCRα rearrangement (Seitan et al., 2011). Instead, I sought to 
determine if the cohesin loading factor NIPBL is required for the induction of Myc expression.  
For this purpose, I used CD4+ T cells from the lymph nodes of CD4Cre-Nipbl lox/WT and 
CD4Cre-Nipbl lox/lox mice. The CD4Cre-Nipbllox mice were generated by crossing the mice carrying 
Cre recombinase transgene under the control of Cd4 regulatory elements with those containing 
the floxed Nipbl allele where two loxP sites flank exon 2. Cre-mediated recombination results in 
a Nipbl null allele lacking exon 2 and the start codon (Smith et al., 2014). CD4+CD25- naïve T cells 
were isolated by FACS (Figure 4.11A) and activated using anti-CD3 plus anti-CD8 coated 
Dynabeads in vitro. RNA was extracted from the activated CD4+ T cells obtained from CD4Cre-
Nipbl lox/WT and CD4Cre-Nipbl lox/lox mice. Gene expression was analysed by qRT-PCR. Experimental 
results showed an effective depletion of Nipbl mRNA in CD4Cre-Nipbl lox/lox CD4+ T cells (Figure 
4.11B). The reduced Nipbl mRNA levels observed in activated CD4Cre-Nipbl lox/WT T cells is an 
artefact of PCR normalisation (T cell activation leads to an overall increased gene expression 
including that of housekeeping genes but not Nipbl. Therefore, standard PCR normalisation using 
housekeeping genes shows an apparent decrease in Nipbl expression. mRNA copy number 
analysis should instead be used ideally to compare changes in gene expression – unpublished 
work by Luke Williams). The expression of Il2 was analysed as an indicator of CD4+ T cell activation. 
The Il2 expression was reduced in activated CD4Cre-Nipbl lox/lox T cells as compared to the Nipbl 
heterozygous (CD4Cre-Nipbl lox/WT) T cells. Myc mRNA levels, on the other hand, were 
appropriately upregulated in both CD4Cre-Nipbl lox/lox and CD4Cre-Nipbl lox/WT T cells. Interestingly, 
Myc primary transcript levels were not increased upon T cell activation (Figure 4.11B). This shows 
that the T cell activation-associated Myc upregulation is a consequence of increased stability of 
References      
 
190 
 
the Myc transcript and not due to an increase in transcription of the Myc gene. Overall, this 
experiment showed that Nipbl is not required for increased Myc expression upon CD4+ T cell 
activation.  
 
Figure : Myc upregulation upon CD4+ T cell activation does not depend on Nipbl. A) FACS profile of the 
CD4 and CD25 stained cells from lymph node. The sorted CD4+CD25- naïve T cells from CD4Cre-Nipbllox/WT 
and CD4Cre-Nipbl lox/lox mice were collected and activated by simultaneous stimulation of the CD3 and CD28 
receptors. B) qRT-PCR gene expression analysis in naïve and activated CD4+ T cells. Myc mRNA levels 
appropriately upregulated in the absence of Nipbl (Normalised to bActin).  
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Appendix 3: Publications 
 
Parts of the work presented here have been published as follows: 
Lavagnolli, T., Gupta, P., Hörmanseder, E., Mira-Bontenbal, H., Dharmalingam, G., Carroll, T., 
Gurdon, J.B., Fisher, A.G., and Merkenschlager, M. (2015). Initiation and maintenance of 
pluripotency gene expression in the absence of cohesin. Genes Dev. 29, 23–38. 
 
